Patent Grant
12029646
Some applications of the present invention relate in general to valve replacement. More specifically, some applications of the present invention relate to prosthetic valves for replacement of a cardiac valve.
Ischemic heart disease causes regurgitation of a heart valve by the combination of ischemic dysfunction of the papillary muscles, and the dilatation of the ventricle that is present in ischemic heart disease, with the subsequent displacement of the papillary muscles and the dilatation of the valve annulus.
Dilation of the annulus of the valve prevents the valve leaflets from fully coapting when the valve is closed. Regurgitation of blood from the ventricle into the atrium results in increased total stroke volume and decreased cardiac output, and ultimate weakening of the ventricle secondary to a volume overload and a pressure overload of the atrium.
For some applications, an implant is provided having a valve body that defines a lumen, an upstream support portion, and a plurality of legs. The implant is percutaneously deliverable to a native heart valve in a compressed state, and is expandable at the native valve. The implant comprises an inner frame and an outer frame. Typically, the upstream support portion is at least partly defined by the inner frame, and the legs are at least partly defined by the outer frame. The implant is secured at the native valve by sandwiching tissue of the native valve between the upstream support portion and the legs. For some applications, a flexible pouch extends radially outward from the valve body. For some such applications, the arms and the legs narrow the pouch therebetween to form a narrowed portion of the pouch, thereby dividing an interior space of the pouch into (a) an inner portion, radially inward from the narrowed portion, and in fluid communication with the lumen, and (b) an outer portion, radially outward from the narrowed portion, and in fluid communication with the inner portion via the narrowed portion.
There is therefore provided, in accordance with an application of the present invention, apparatus, including:
In an application, at the narrowed portion, the legs extend in an upstream direction past the arms.
In an application, the arms are disposed inside the pouch.
In an application, the arms and the legs are arranged such that, at the narrowed portion, the arms and the legs alternate circumferentially.
In an application, the inner portion of the interior space is in fluid communication with the lumen via a plurality of discrete windows defined by the apparatus.
In an application, the apparatus further includes a belt wrapped around the frame assembly downstream of the windows, circumscribing the lumen, each of the windows being bounded, at a downstream edge of the window, by the belt.
In an application, the leaflets are arranged to form a plurality of commissures therebetween, and are attached to the frame assembly at the commissures, and the belt is disposed over the commissures.
In an application:
In an application, at the narrowed portion, each of the legs pushes the downstream surface into contact with the upstream surface.
In an application, at the narrowed portion, each of the legs forms a respective bulge in the upstream surface by pressing the downstream surface against the upstream surface.
In an application, the pouch is stitched to the arms.
In an application, at the narrowed portion, the pouch is stitched to the arms but not to the legs.
In an application, the frame assembly includes (i) a valve frame that defines the valve body and the plurality of upstream arms, and (ii) an outer frame that circumscribes the valve frame, and defines the plurality of downstream legs.
In an application, an upstream portion of the pouch is attached to the valve frame, and a downstream portion of the pouch is attached to the outer frame.
In an application, the apparatus further includes at least one coagulation component, disposed within the outer portion of the interior space, and configured to promote blood coagulation within the outer portion of the interior space.
In an application, the coagulation component is annular, and, within the outer portion of the interior space, circumscribes the longitudinal axis.
There is further provided, in accordance with an application of the present invention, apparatus, including:
In an application, the arms are disposed inside the pouch.
In an application, each of the legs forms a respective bulge in the first sheet by pressing the second sheet against the first sheet.
In an application, the legs extend in an upstream direction past the arms.
In an application, the frame assembly includes (i) a valve frame that defines the valve body and the plurality of upstream arms, and (ii) an outer frame that circumscribes the valve frame, and defines the plurality of downstream legs.
In an application, an upstream portion of the pouch is attached to the valve frame, and a downstream portion of the pouch is attached to the outer frame.
In an application, the plurality of legs forms a narrowed portion of the pouch by pressing the second sheet into contact with the first sheet, the narrowed portion of the pouch circumscribing the valve body.
In an application, at the narrowed portion, the second sheet is not stitched to the legs.
In an application, the arms and the legs are arranged such that, at the narrowed portion, the arms and the legs alternate circumferentially.
In an application, the narrowed portion of the pouch shapes the pouch to define:
In an application, the apparatus further includes at least one coagulation component, disposed within the outer portion of the interior space, and configured to promote blood coagulation within the outer portion of the interior space.
In an application, the coagulation component is annular, and, within the outer portion of the interior space, circumscribes the longitudinal axis.
In an application, the interior space is in fluid communication with the lumen via a plurality of discrete windows defined by the apparatus.
In an application, the apparatus further includes a belt wrapped around the frame assembly downstream of the windows, circumscribing the lumen, each of the windows being bounded, at a downstream edge of the window, by the belt.
In an application, the leaflets are arranged to form a plurality of commissures therebetween, and are attached to the frame assembly at the commissures, and the belt is disposed over the commissures.
The present invention will be more fully understood from the following detailed description of applications thereof, taken together with the drawings, in which:
Reference is made to
Implant 20 has an upstream end 24, a downstream end 26, and defines a central longitudinal axis ax1 therebetween. Frame assembly 22 comprises a valve frame 30 that comprises a valve body (which is a generally tubular portion) 32 that has an upstream end 34 and a downstream end 36, and is shaped to define a lumen 38 through the valve body from its upstream end to its downstream end. Valve body 32 circumscribes axis ax1, and thereby defines lumen 38 along the axis. Throughout this application, including the specification and the claims, unless stated otherwise, “upstream” and “downstream,” e.g., with respect to the ends of implant 20, are defined with respect to the longitudinal axis of implant 20, by the orientation and functioning of leaflets 58, which facilitate one-way upstream-to-downstream fluid flow through lumen 38.
Valve frame 30 further comprises a plurality of arms 46, each of which, in the expanded state, extends radially outward from valve body 32. In this context, the term “extends radially outward” is not limited to extending in a straight line that is orthogonal to axis ax1, but rather, and as shown for arms 46, includes extending away from axis ax1 while curving in an upstream and/or downstream direction. Typically, and as shown, each arm 46 extends from valve body 32 in an upstream direction, and curves radially outward. That is, the portion of arm 46 closest to valve body 32 extends primarily upstream away from the valve body (e.g., extending radially outward only a little, extending not at all radially outward, or even extending radially inward a little), and the arm then curves to extend radially outward. The curvature of arms 46 is described in more detail hereinbelow.
Valve body 32 is defined by a repeating pattern of cells that extends around central longitudinal axis ax1. In the expanded state of each tubular portion, these cells are typically narrower at their upstream and downstream extremities than midway between these extremities. For example, and as shown, the cells may be roughly diamond or asteroid in shape. Typically, and as shown, valve body 32 is defined by two stacked, tessellated rows of cells—an upstream row 29a of first-row cells, and a downstream row 29b of second-row cells. Frame 30 is typically made by cutting (e.g., laser-cutting) its basic (i.e., raw) structure from a tube of, for example, Nitinol (followed by re-shaping and heat treating to form its shape-set structure). Although valve body 32 is therefore typically monolithic, because the resulting cellular structure of valve body 32 resembles an open lattice, it may be useful to describe it as defining a plurality of joists 28 that connect at nodes 100 to form the cellular structure.
Typically, and as shown, each arm 46 is attached to and extends from a site 35 that is at the connection between two adjacent cells of upstream row 29a. That is, site 35 is a connection node between first-row cells. The tessellation between rows 29a and 29b is such that site 35 may alternatively be described as the upstream extremity of cells of downstream row 29b. That is, the upstream extremity of each second-row cell is coincident with a respective connection node between first-row cells. Site 35 is therefore a node 100 that connects four joists 28. Upstream end 34 of valve body 32 may be described as defining alternating peaks and troughs, and sites 35 are downstream of the peaks (e.g., at the troughs).
It is hypothesized by the inventors that connecting arm 46 to valve body 32 at site 35 (instead of at upstream end 34) maintains the length of the lumen of the tubular portion, but also advantageously reduces the distance that the tubular portion extends into the ventricle of the subject, and thereby reduces a likelihood of inhibiting blood flow out of the ventricle through the left ventricular outflow tract. It is further hypothesized by the inventors that because each site 35 is a node 100 that connects four joists (whereas each node 100 that is at upstream end 34 connects only two joists), sites 35 are more rigid, and therefore connecting arms 46 to valve body 32 at sites 35 provides greater rigidity to each arm.
Sheeting 23 may comprise one or more individual sheets, which may or may not be connected to each other. The individual sheets may comprise the same or different materials. Typically, sheeting 23 comprises a fabric, e.g., comprising a polyester, such as polyethylene terephthalate. Arms 46 are typically covered with sheeting 23. Typically, and as shown in
Alternatively, each arm 46 may be individually covered in a sleeve of sheeting 23, thereby facilitating independent movement of the arms.
Arms 46, and typically the sheeting that covers the arms, define an upstream support portion 40 of implant 20.
Other surfaces of frame assembly 22 may also be covered with sheeting 23. Typically, sheeting 23 covers at least part of valve body 32, e.g., defining a liner 27 that lines an inner surface of the valve body, and thereby defining lumen 38.
Support 40 has an upstream surface, and a downstream surface. Each arm 46 is typically curved such that a downstream surface of support 40 defines an annular concave region 152, and an annular convex region 154 radially outward from the concave region. That is, in region 152 the downstream surface of support 40 (e.g., the downstream surface of each arm 46 thereof) is concave, and in region 154 the downstream surface of the support is convex.
Concave region 152 extends radially between a concave-region inner radius r1 and a concave-region outer radius r2. Convex region 154 extends radially between a convex-region inner radius r3 and a concave-region outer radius r4. It is to be noted that in this context (including the specification and the claims), the term “radius” means a radial distance from axis ax1.
For some applications, and as shown, each arm 46 has a serpentine shape, such that there is no discernable gap between concave region 152 and convex region 154. For such applications, each arm 46 has an inflection point where region 152 transitions into region 154. For such applications, radius r2 and radius r3 are coincident, and collectively define an inflection radius at which the inflection point of each arm lies.
For some applications, radius r1 is the radius of tubular portion 32. For some applications, there is a discernable gap between regions 152 and 154. For example, each arm may be curved in regions 152 and 154, but have a straight portion between these regions.
Although regions 152 and 154 may be locally defined with respect to one or more particular arms 46, these regions typically completely circumscribe axis ax1.
Frame assembly 22 further comprises a plurality of legs 50, each of which, in the expanded state, extends radially outward and in an upstream direction from a respective leg-base 66 to a respective leg-tip 68. Each leg 50 defines a tissue-engaging flange 54, which is typically the most radially outward part of the leg, and includes leg-tip 68. Typically, legs 50 are defined by an outer frame (or “leg frame”) 60 that circumscribes and is coupled to valve frame 30.
Frames 30 and 60 define respective coupling elements 31 and 61, which are fixed with respect to each other at coupling points 52. For some applications, frames 30 and 60 are attached to each other only at coupling points 52. Although frames 30 and 60 are attached to each other at coupling points 52, radial forces may provide further coupling between the frames, e.g., frame 30 pressing radially outward against frame 60.
Typically, coupling points 52 are circumferentially aligned with legs 50 (and flanges 54 thereof), but circumferentially offset with respect to arms 46. That is, the coupling points are typically at the same rotational position around axis ax1 as the legs, but are rotationally staggered with respect to the rotational position of the arms.
Coupling points 52 are typically disposed circumferentially around frame assembly 22 on a transverse plane that is orthogonal to axis ax1. That is, coupling points 52 are typically all disposed at the same longitudinal position along axis ax1. Typically, coupling points 52 are disposed longitudinally between upstream end 24 and downstream end 26 of frame assembly 22, but not at either of these ends. Further typically, coupling points 52 are disposed longitudinally between upstream end 34 and downstream end 36 of tubular portion 32, but not at either of these ends. As shown, tubular portion 32 is typically barrel-shaped—i.e., slightly wider in the middle than at either end. For some applications, and as shown, coupling points 52 are disposed slightly downstream of the widest part of tubular portion 32. For example, coupling points 52 may be 0.5-3 mm downstream of the widest part of tubular portion 32. Alternatively or additionally, the longitudinal distance between the widest part of tubular portion 32 and coupling points 52 may be 20-50 percent (e.g., 20-40 percent) of the longitudinal distance between the widest part of the tubular portion and downstream end 36.
Coupling elements 31 are typically defined by (or at least directly attached to) legs 50. Therefore legs 50 are fixedly attached to frame 30 at coupling points 52. Despite the fixed attachment of legs 50 to frame 30, frame 60 comprises a plurality of struts 70 that extend between, and connect, adjacent legs. Struts 70 are typically arranged in one or more rings 72, e.g., a first (e.g., upstream) ring 74 and a second (e.g., downstream) ring 76. For some applications, and as shown, frame 60 comprises exactly two rings 72. Each ring is defined by a pattern of alternating peaks 64 and troughs 62, the peaks being further upstream than the troughs. Each ring is typically coupled to legs 50 at troughs 62—i.e., such that peaks 64 are disposed circumferentially between the legs. Peaks 64 are therefore typically circumferentially aligned with arms 46. That is, peaks 64 are typically at the same rotational position around axis ax1 as arms 46.
The elongate element of frame 60 that defines leg 50 continues in a downstream direction past ring 74 and coupling element 61, and couples ring 74 to ring 76. However, throughout this patent application, leg 50 itself is defined as the free portion of this elongate element that extends from ring 74. Leg-base 66 may be defined as the region of leg 50 that is coupled to the remainder of frame 60 (e.g., to ring 74). Because each leg 50 extends in a generally upstream direction, leg-base 66 may also be defined as the most downstream region of leg 50.
In the expanded state, the leg-tip 68 of each leg is typically disposed radially between radius r3 and radius r4. That is, the leg-tip 68 of each leg is aligned with convex region 154.
Frame 60 is typically cut from a single tube, e.g., of Nitinol. Therefore, the radial thickness of the frame is typically consistent throughout—e.g., it is the wall thickness of the tube from which it was cut. However, the circumferential width of components of frame 60 (i.e., the width of the component measured around the circumference of the frame) may differ. For example, for some applications, a circumferential thickness W2 of legs 50 may be at least three times greater than a circumferential thickness W1 of struts 70. Greater circumferential thickness typically provides the component with greater rigidity.
Valve frame 30 and outer frame 60 are typically each cut from respective metallic tubes, e.g., of Nitinol. This is typically the case for each of the implants described herein. More specifically, for each of the implants described herein:
Prosthetic leaflets 58 are disposed within lumen 38, and are configured to facilitate one-way liquid flow through the lumen from upstream end 34 to downstream end 36. Leaflets 58 thereby define the orientation of the upstream and downstream ends of valve body 32, and of implant 20 in general.
Typically, implant 20 is biased (e.g., shape-set) to assume its expanded state. For example, frames 30 and 60 may be constructed from a shape-memory metal such as Nitinol or a shape-memory polymer. Transitioning of implant 20 between the respective states is typically controlled by delivery apparatus, such as by constraining the implant in a compressed state within a capsule and/or against a control rod, and selectively releasing portions of the implant to allow them to expand.
In the compressed state, frame assembly 22 defines a waist 56 (i.e., is waisted) at a longitudinal site between the valve body and the ball. For some applications, and as shown, waist 56 is longitudinally upstream of frame 60, and is therefore primarily defined by valve frame 30. However, for some such applications, the downstream limit of the waist may be defined by the upstream limit of frame 60 (e.g., flanges 54 thereof).
It is to be noted that, typically, the bulbous shape of ball 48 is interrupted at waist 56, i.e., where the frame transitions from the ball to the waist. For some applications, and as shown, valve frame 30 is monolithic (e.g., cut from a single metal tube), and defines both valve body 32 and arms 46. For some applications, and as shown, in the compressed state, the overall shape of valve frame 30 resembles that of an air rifle pellet or a shuttlecock (e.g., see the cross-section in
For some applications, at waist 56, frame 30 (and typically frame assembly 22 overall) has a transverse diameter d10 that is less than 5 mm (e.g., 2-4 mm). For some applications, ball 48 has a greatest transverse diameter d11 of 8-12 mm (e.g., 9-11 mm). For some applications, transverse diameter d10 is less than 40 percent (e.g., less than 30 percent, such as 10-30 percent) of transverse diameter d11.
Due to waist 56, while implant 20 is in its compressed state and disposed within capsule 90, the implant and capsule define a toroidal gap 57 therebetween. Toroidal gap 57 circumscribes longitudinal axis ax1 of the implant around waist 56. Therefore, valve body 32 extends in a first longitudinal direction (i.e., in a generally downstream direction) away from gap 57, and arms 46 extend in a second longitudinal direction (i.e., in a generally upstream direction) away from the gap. For applications in which implant 20 is delivered to the native valve transfemorally, valve body 32 is closer to the open end of capsule 90 than is gap 57, and arms 46 (e.g., ball 48) are further from the open end of capsule 90 than is gap 57. For some applications, and as shown, a downstream limit of gap 57 is defined by the tips of flanges 54. For some applications, and as shown, an upstream limit of gap 57 is defined by the downstream side of arms 46.
It is to be noted that, typically, frame 60 is disposed only downstream of toroidal gap 57, but the frame 30 is disposed both upstream and downstream of the toroidal gap.
Reference is again made to
Typically, ring 78 covers downstream end 26 of the implant (e.g., covers the frames at the downstream end). It is hypothesized by the inventors that ring 78 advantageously protects tissue (e.g., native leaflets and/or chordae tendineae) from becoming damaged by downstream end 26 of implant 20. There is therefore provided, in accordance with some applications of the invention, apparatus comprising:
Reference is made to
Implant 20 is delivered, in its compressed state, to native valve 10 using a delivery tool 160 that is operable from outside the subject (
Subsequently, flanges 54 are deployed—i.e., are allowed to protrude radially outward, e.g., by releasing them from capsule 170 (
Typically, and as shown in
Alternatively, flanges 54 may be initially deployed within ventricle 8.
Subsequently, implant 20 is moved upstream, such that flanges 54 engage leaflets 12 of valve 10 (
Subsequently, delivery tool 160 is transitioned into its intermediate state, thereby allowing implant 20 to assume a partially-expanded state in which upstream support portion 40 is expanded, e.g., by releasing the upstream support portion from capsule 170 (
In the intermediate state, leaflets 12 of native valve 10 are sandwiched between upstream support portion 40 (e.g., annular sheet 25 thereof) and legs 50 (e.g., flanges 54 thereof). It is to be noted that appendages 80 remain engaged with mount 166.
Subsequently, delivery tool 160 is transitioned into its open state, thereby allowing implant 20 to expand toward its expanded state (i.e., such that tubular portion 32 widens to its fully-expanded state) (
In the expanded state of implant 20, each leg-tip 68 is radially aligned with convex region 154. That is, each leg-tip 68 is disposed radially between convex-region inner radius r3 and convex-region outer radius r4. This is also illustrated in
Tool 160 (e.g., capsule-portion 172 thereof) may then be withdrawn via lumen 38 of implant 20, and removed from the body of the subject.
Reference is made to
Implants 120 and 220 are typically the same as implant 20, described hereinabove, except where noted. Sheeting 23 forms annular sheet 25 that is disposed over and typically stitched to arms 46. Implant 120 thereby comprises valve body 32 (e.g., as described hereinabove), and an upstream support portion 140 that itself comprises arms 46 and annular sheet 25. Similarly, implant 220 comprises valve body 32 and an upstream support portion 240 that itself comprises arms 46 and annular sheet 25.
Implants 120 and 220 each further comprises a respective plurality of elongate projections 146 or 246. Whereas arms 46 are covered by sheeting 23, the projections extend in an upstream direction through sheeting 23. For some applications, and as shown for projections 146, the projections extend through annular sheet 25. For some applications, and as shown for projections 246, the projections extend between annular sheet 25, and a portion of sheeting 23 that lines valve body 32 (e.g., at a seam where these two portions of sheeting 23 are joined). The projections and arms 46 are both configured to be positioned in atrium 6 of the heart. For some applications, and as shown for projections 146, the projections extend through annular sheet 25.
It is to be noted that projection 146 and 246 are distinct from appendages 80, which are disposed at the other end of the valve body.
Each projection terminates in a nub 148 or 248 that facilitates snaring of the projection using a transcatheter snare, lasso, or similar tool. It is to be understood that the shapes shown for the nubs are merely examples, and that the scope of the invention includes any suitably shaped nub. It is hypothesized by the inventors that the projections facilitate repositioning and/or retrieval of the implant during and/or after implantation, using a snare, lasso, or similar tool. The projections are typically positioned and/or shaped such that nubs 148 or 248 are not in contact with annular sheet 25 or atrial tissue (e.g., are disposed at least 5 mm away (e.g., 5-25 mm away) from annular sheet 25 or atrial tissue). For some applications, and as shown for projections 146 of implant 120, the projections curve outwards and then inwards toward the central longitudinal axis of the implant (i.e., are shaped to be concave toward the axis). For some applications, and as shown for projections 246 of implant 220, the projections do not extend radially outward from the valve body. Projections 246 typically extend axially in an upstream direction away from the valve body (i.e., generally parallel to axis ax1, i.e., within 10 degrees of axis ax1).
Regarding implant 120 (
Except where noted, frame assembly 222, valve frame 230, and outer frame 260 are typically identical to frame assembly 22, valve frame 30, and outer frame 60, mutatis mutandis. For some applications, implant 220 is identical to implant 20 except for projections 246.
In contrast to projections 146 of implant 120, each projection 246 of implant 220 extends from a respective site 37 that is at the upstream extremity (i.e., peak) of a respective first-row cell of upstream row 29a of valve body 32 (i.e., from upstream end 34 of the valve body). Projections 246 thereby alternate with, rather than replace, arms 46. Therefore, it is possible for implant 220 to comprise projections 246 in addition to twelve arms 46. Implant 220 may comprise an equal number of projections 246 and arms 46, but typically, the implant comprises fewer projections than arms. For example, implant 220 may comprise half as many, or fewer, projections 246 than arms 46—e.g., a third as many, or a quarter as many projections as arms. Projections 246 and arms 46 are typically evenly distributed circumferentially, and therefore typically at least two arms (e.g., at least three arms, such as at least four arms) are disposed circumferentially between each projection and each of its circumferentially-neighboring projections.
Each projection 246 has a projection-length d13, measured from the upstream extremity of the respective first-row cell (i.e., from site 37). Each of the arms has an arm-length d14, measured from the upstream extremity of the respective second-row cell (i.e., site 35). Arm-length d14 is greater than projection-length d13 (e.g., 2-20 times greater, e.g., 4-20 times greater, such as 4-10 times greater). For some applications, arm-length d14 is 20-28 mm, such as 22-26 mm (e.g., 22-23 mm, 23.5-24.5 mm, or 25-26 mm). For some applications, projection-length d13 is 2-10 mm (e.g., 3-8 mm, e.g., 4-6 mm, such as about 5 mm).
Typically, each arm 46 (i) has a narrow portion 46a that is attached to, and extends from, the upstream extremity of the respective second-row cell, and (ii) at a widening zone 46b, widens into a wide portion 46c that extends from the narrow portion, and is wider than the narrow portion. Narrow portion 46a has a narrow-portion length d20 that is typically at least 30 percent of arm-length d14 (e.g., at least 40 percent, such as 40-80 percent, such as 40-60 percent). Wide portion 46c has a wide-portion length that is at least 30 percent of arm-length d14 (e.g., at least 40 percent, such as 40-80 percent, such as 40-60 percent).
Wide portion 46c has a width d15 that is typically 1.5-6 times greater (e.g., 2-4 times greater, such as 2.5-3.5 times greater) than a width d16 of narrow portion 46a. For some applications width d15 is 1-2 mm (e.g., 1.4-1.8 mm, such as 1.6 mm). Width d16 is typically 0.2-0.8 mm (e.g., 0.4-0.6 mm, such as 0.5 mm). It is to be noted that, although individual parts of arm 46 within portion 46c may be narrower than within portion 46a, these individual parts form a back-and-forth pattern that results in wide portion 46c being, overall, wider than narrow portion 46a. Typically, wide portion 46c is more flexible, in at least one plane, than narrow portion 46a. Therefore, wide portion 46c is also a flexible portion of arm 46.
Each projection 246 has a width d17 that is typically 0.2-0.8 mm (e.g., 0.4-0.6 mm, such as 0.5 mm). Each nub has a nub-width d18 that is typically 1-2 mm (e.g., 1.4-1.8 mm, such as 1.6 mm), and a nub-length d19 that is typically 0.5-1 mm (e.g., 0.7-0.9 mm, such as 0.8 mm). Wide portion 46c is typically at least 3 times (e.g., at least 10 times) longer than nub-length d19.
As described hereinabove, the valve frame is typically monolithic, cut from a single tube. Typically, and as shown in
Reference is now made to
Reference is made to
Reference is made to
Outer frame 60b comprises (or defines) (1) a first (e.g., upstream) ring 74b defined by a pattern of alternating first-ring peaks and first-ring troughs, (2) a second (e.g., downstream) ring 76b defined by a pattern of alternating second-ring peaks and second-ring troughs, and a plurality of legs 50, each of the legs coupled to the first ring and the second ring, and extending radially outward.
Valve frame 30b comprises a tubular portion (e.g., a tubular frame) that has a cellular structure defined by a plurality of metallic elements with spaces therebetween a e.g., as described for valve frame 30, mutatis mutandis.
The cellular structure of the valve frames described herein may also be viewed as defining rings of alternating peaks and troughs, the rings circumscribing the longitudinal axis of the implant. Whereas the waveform (i.e., the peak-trough waveform) of the rings of the outer frame are in phase with each other, the phase of the waveform of the rings of the valve frame typically alternate with respect to each other. That is, for the valve frame, the waveform of one ring is out of phase (e.g., is in antiphase) with that of its axially-adjacent rings. For example, and with reference to
Typically, and as shown for each of the implants described herein, when the frame assembly is assembled, (1) the waveform of one of outer frame rings is in-phase with the waveform of the inner frame ring with which it is axially aligned, and (2) the waveform of one of outer frame rings is out of phase (e.g., is in antiphase) with the waveform of the inner frame ring with which it is axially aligned. For example, and with reference to
Because ring 76b is in antiphase with ring 186b, the peaks of ring 76b are not disposed directly radially outward from respective parts of frame 30b, and therefore are not in contact with frame 30b. However, despite ring 74b being in phase with ring 184b, and the peaks of ring 74b being disposed directly radially outward from respective parts of frame 30b, the peaks of ring 74b are also not in contact with frame 30b. That is, frame assembly 22 defines a radial gap 188 between frames 30 and 60 at the peaks of ring 74b. Typically, therefore, none of the peaks of the rings of frame 60b is in contact with inner frame 30b. In contrast, for frame assembly 22, although the peaks of ring 76 are not in contact with frame 30, the peaks of ring 74 typically are in contact with frame 30.
The features of frame assembly 22b may be used in combination with other implants described herein. For example, other frame assemblies described herein may be shaped to define gap 188, mutatis mutandis.
Reference is made to
Valve body 332a has a cellular structure defined by a plurality of joists 28 connected at a plurality of nodes 102, the joists and nodes delimiting cells of the cellular structure. Except where noted, inner frame 330a is generally the same as inner frame 230 (or inner frame 30), mutatis mutandis, and valve body 332a is generally the same as valve body 32, mutatis mutandis. Compared to valve body 32, valve body 332a comprises additional joists 28, which are hypothesized by the inventors to increase strength and rigidity. In particular, the additional joists are hypothesized by the inventors to increase the resistance of the valve body to compression toward axis ax1, including resistance to circumferential compression (e.g., compression that would otherwise reduce the diameter of the valve body, but that would retain the valve body in a generally cylindrical shape) and localized compression (e.g., compression that would otherwise reduce the diameter of the valve body at only certain locations, causing the valve body to become more oval in transverse cross-section).
Referring back to
Similarly to valve body 32 of frame 30, the cells of the cellular structure of valve body 332a comprise a first circumferential row 109a of cells, and a second circumferential row 109b of cells. That is, row 109a is a row of first-row cells, and row 109b is a row of second-row cells. Each of the cells of row 109a is connected to each of its circumferentially-adjacent first-row cells at a respective major node 106. Typically, and as shown, each of the cells of row 109a is longitudinally delimited by two minor nodes 104 (i.e., the upstream end and the downstream end of each cell is at a respective minor node). It is to be noted that, typically, each of the cells of row 109a is not connected to another cell at these minor nodes 104 (i.e., the minor nodes that longitudinally delimit the first-row cell).
Each of the cells of row 109b is connected to each of its circumferentially-adjacent second-row cells at a respective major node 106. Typically, and as shown, each of the cells of row 109b is longitudinally delimited by at least one major node 106 (e.g., is delimited by one major node at an upstream end of the cell). Typically, and as shown, each of the cells of row 109b is also longitudinally delimited by a minor node 104 (e.g., at a downstream end of the cell). For some applications, and as shown, each of the major nodes 106 at which circumferentially-adjacent first-row cells are connected is also the major node that longitudinally-delimits a respective second-row cell (e.g., at the upstream end of the second-row cell). In the example shown, that common major node 106 is also site 35, at which arms 46 are attached to the valve body.
The cells of the cellular structure of valve body 332a are typically delimited by exactly four nodes 102.
Frame 330a defines coupling elements 31, which are fixed to coupling elements 61 of frame 60 at coupling points, as described hereinabove for frame assembly 22, mutatis mutandis. For some applications, and as shown, coupling elements 31 are defined by respective major nodes 106. Therefore, for some applications, a frame assembly comprises (i) inner frame 330a that defines valve body 332a, and (ii) an outer frame (e.g., frame 60) that circumscribes the valve body, and is coupled to the inner frame by being fixed to major nodes of the valve body. For such applications, coupling elements 31 are typically defined by the major nodes at which circumferentially-adjacent second-row cells are connected.
For some applications, and as shown, valve body 332a is defined by exactly two stacked, tessellated rows 109 of cells. That is, typically, first row 109a is the most upstream row, second row 108b is the most downstream row, and these two rows are tessellated with each other. Therefore, for some applications, all the cells of the cellular structure of valve body 332a are either first-row cells or second-row cells.
Valve body 332a may be described as comprising pairs 108 of joists 28 that run generally parallel to each other. In the expanded state of the valve body (i.e., the state shown in
For some applications, and as shown, the arrangement of joists 28 in pairs 108 results in the joists that delimit the cells of first row 109a not delimiting the cells of second row 109b. That is, for some applications, no individual joist 28 delimits both a first-row cell and a second-row cell.
Another aspect of valve body 332a is as follows: Major nodes 106 are typically arranged in major-node rows, each major-node row circumscribing longitudinal axis ax1 at a respective major-node-row longitudinal site, and minor nodes 104 are typically arranged in minor-node rows, each minor-node row circumscribing the longitudinal axis at a respective minor-node-row longitudinal site. Along at least part of axis ax1, the minor-node-row longitudinal sites alternate with the major-node-row longitudinal sites. For some applications, along at least this part of axis ax1, at least 3 minor-node-row longitudinal sites alternate with at least 2 major-node-row longitudinal sites, e.g., in the order minor-major-minor-major-minor, as shown.
Reference is now made to
Inner frame 330b comprises a valve body (which is a generally tubular portion) 332b that has an upstream end 334b and a downstream end 336b, and is shaped to define a lumen through the valve body from its upstream end to its downstream end. Valve frame 330b further comprises a plurality of arms 46, each of which, in the expanded state, extends radially outward from valve body 332b. Inner frame 330b is typically the same as inner frame 330a, except where noted. Compared to inner frame 330a, inner frame 330b comprises additional joists 28 at upstream end 334b. That is, in contrast to inner frame 330a, for inner frame 330b pairs 108 of joists are also disposed at the upstream side of the upstream row of cells.
In frame 330a, sites 37 are coincident with the upstream extremity of a respective upstream-row cell. In contrast, in frame 330b, sites 37 are not coincident with the upstream extremity of a respective upstream-row cell. Rather, sites 37 are coincident with a minor node that joins the joists that are paired with (e.g., that are parallel with) the joists of the respective upstream-row cell.
Implant 320b is typically the same as implant 320a, except that it comprises inner frame 330b instead of inner frame 330a.
Reference is now made to
Inner frame 330c comprises a valve body (which is a generally tubular portion) 332c that has an upstream end 334c and a downstream end 336c, and is shaped to define a lumen through the valve body from its upstream end to its downstream end. Valve frame 330c further comprises a plurality of arms 46, each of which, in the expanded state, extends radially outward from valve body 332c. Inner frame 330c is typically the same as inner frame 330b, except where noted.
In general, for implants having an expandable cellular structure, such as the valve bodies described herein, for a given size of the implant, a cellular structure that defines fewer, larger cells, advantageously facilitates radial compression (i.e., “crimping”) to a smaller diameter than does a comparable cellular structure that defines more, smaller cells. However, this is typically at the expense of strength and rigidity of the expanded valve. As described hereinabove, the presence of additional joists 28 (e.g., in inner frames 330a, 330b, and 330c) to form pairs 108 is hypothesized to increase strength and rigidity, in particular with respect to compression toward the central longitudinal axis. As a result, it is further hypothesized by the inventors that using such a paired joist cellular structure facilitates reducing the number, and increasing the size, of the cells of the valve body, in order to achieve a valve body that is radially compressible to a smaller diameter while maintaining sufficient strength and rigidity.
Accordingly, valve body 332c of inner frame 330c has fewer, larger cells compared to valve body 32 of inner frame 30, and is therefore radially compressible to a smaller diameter. Whereas each row of cells of valve body 32 includes 12 cells, each row of cells of valve body 332c includes 9 cells. More generally, whereas the rotationally-symmetrical pattern of valve body 32 has 12 repeats (e.g., 12 cells per cell row, 12 minor nodes per minor-node row, 12 major nodes per major-node row, 12 coupling elements, 12 arms 46), the rotationally-symmetrical pattern of valve body 332c has only 9 repeats. (Both valve body 32 and valve body 332c typically have 3 appendages 80 and 3 projections 246.) Both valve body 32 and valve body 332c define two rows of cells. Therefore, whereas valve body 32 defines 24 cells in total, valve body 332c defines 18 cells in total. Whereas valve body 32 defines exactly 24 major nodes, valve body 332c defines exactly 18 major nodes.
For some applications, and as shown, inner frame 330c comprises additional joists 28 at upstream end 334c (e.g., similarly to inner frame 330b). That is, for such applications, pairs 108 of joists are typically also disposed at the upstream side of the upstream row of cells of inner frame 330c. For such applications, implant 320c is typically the same as implant 320b, except that implant 320c comprises 9 rotationally-symmetrical repeats, rather than 12.
For some applications, inner frame 330c does not comprise additional joists 28 at upstream end 334c, and is instead more like inner frame 330a in this regard.
Reference is again made to
Reference is made to
Models 302 are then removed from flanges 54 (
The technique described with reference to
An alternative solution is also contemplated by the inventors, in which an annular bath is positioned circumscribing the central portion of the prosthetic valve or frame assembly, such that all flanges can be placed into the fluid substances even when the flanges are not all disposed on the same side of a prosthetic valve or frame assembly.
For some applications, substance 310 and/or substance 312 may be a mixture of constituents that is initially fluid upon mixing, and that solidifies as the constituents react with each other. For some applications, fluid substance 310f and/or fluid substance 312f is fluid because it is in a molten state, and solidifies as it cools. When solidified, second substance 312 is typically soft, flexible, and/or resilient. For some applications, second substance 312 (or at least solidified second substance 312s) is a foam. For some applications, second substance 312 comprises silicone, polyurethane, a thermoplastic elastomer such as Santoprene™, and/or polyether block amide.
For some applications, the techniques described with reference to
Reference is made to
Each leaflet 58 is attached (e.g., stitched) to liner 427 along a line (e.g., a stitch line) 437. Each leaflet 58 defines a free edge 458, which is typically straight, and at which the leaflet coapts with the other leaflets 58. Stitch line 437 is typically curved. Each leaflet typically defines a curved edge (e.g., an upstream edge) 456 at which the leaflet is attached to liner 427. The curve of edge 456 and/or stitch line 437 is concave toward the downstream end of valvular assembly 430, such that edge 456 and/or stitch line 437 (i) become closer to the downstream end of the valvular assembly at connectors 432, and (ii) are closest to the upstream end of the valvular assembly about midway circumferentially between the connectors. That is, edge 456 has an apex about midway circumferentially between connectors 432.
Typically, and as shown, leaflets 58 extend further axially downstream (i.e., downstream with respect to axis ax1) than does liner 427. Therefore, a downstream portion of each leaflet 58 is typically circumferentially exposed from liner 427. For some applications, and as shown, liner 427 is shaped to define regions 428 at which a downstream edge 436 of the liner recedes from the downstream end of valvular assembly 430. At each region 428, more of the respective leaflet 58 is circumferentially exposed. Each region 428 is typically circumferentially aligned with the concavity defined by edge 456 and/or stitch line 437. At regions 428, downstream edge 436 of liner 427 is typically stitched to ring 182 of frame 230. Therefore, for some applications, the most upstream parts of downstream edge 436 of liner 427 are closer to the upstream end of the implant than is the most downstream parts of arms 46. As described in more detail hereinbelow, in implant 420, regions 428 of liner 427 facilitate the provision of windows 482 into a pouch 490.
As indicated by the reference numeral 23, sheets 440, 450, and 460 may all be considered components of sheeting 23. For some applications, liner 427, sheet 440, sheet 450, and/or 460 comprise (e.g., consist of) the same material as each other. Typically, sheets 440, 450, and 460 are provided as flat, and are subsequently shaped during assembly of implant 420, e.g., as described hereinbelow.
For applications in which sheet 440 is provided flat and in the shape of a major arc of an annulus, sheet 440 is shaped into an open frustum by attaching (e.g., stitching) ends 442a and 442b together (
Smaller perimeter 448 of sheet 440 is stitched to an upstream edge 434 of liner 427, to form a substantially sealed channel through implant 420. This stitching is represented by a stitch line 435. Typically, and as shown, projections 246 extend between, and are sandwiched between, perimeter 448 of sheet 440 and upstream edge 434 of liner 427. Upstream edge 434 is typically circular.
Downstream edge 436 of liner 427 is stitched to valve body 32 of frame 30. Typically, downstream edge 436 is shaped and positioned to approximately conform to rings 182 and 184, and is stitched to these rings.
It is to be noted that throughout this patent application (including the specification and the claims) stitching of a perimeter or edge of a sheet to a perimeter or edge of another sheet, does not necessarily mean that the sheets are stitched at their absolute edges (i.e., their free edges). Rather, in this context, the “perimeter” or “edge” also includes the adjacent area of the sheet, as is understood by one of ordinary skill in the stitching art, and as is typically required for effective stitching.
Valvular assembly 430 is typically positioned within frame assembly such that the apex of curved edge 456 of each leaflet 58 is disposed axially close to (e.g., axially within 2 mm of, e.g., within 1 mm of) an upstream end 34 of valve body 32. Valvular assembly 430 is also typically positioned within frame assembly such that free edge 458 of each leaflet 58 is disposed downstream of leg 50.
Subsequently, sheet 450 is attached to frame assembly 222 (
Subsequently, sheet 450 is everted by bringing inner perimeter 452 toward frame assembly 222, and passing the inner perimeter around the tips of arms 46—i.e., axially past the tips of all of the arms (
Inner perimeter 452 is advanced over at least part of valve body 32 toward a downstream end of frame assembly 222, and is stitched in place. Typically, perimeter 452 is advanced between the valve body and legs 50, such that perimeter 452 circumscribes valve body 32, and legs 50 are disposed radially outside of sheet 450. As described hereinabove, each leg 50 extends radially outward and in an upstream direction from a respective leg-base 66 to a respective leg-tip 68. Each leg therefore extends at an acute angle to define a respective cleft 250 between the leg and valve body 32 (e.g., the tubular portion), the cleft open to the upstream direction. Typically, perimeter 452 is tucked into clefts 250, and is stitched into place. Frame assembly 222 defines a distance d22, measured along a straight line, between the ends of arms 46 and clefts 250. For clarity, distance d22 may be defined as a distance between (i) an imaginary ring described by the ends of arms 46, and (ii) an imaginary ring described by clefts 250.
The dimensions and positioning of sheet 450 defines an inflatable pouch 490 that is bounded by sheet 450 (e.g., defining an outer and/or downstream wall of the pouch), sheet 440 (e.g., defining an upstream wall of the pouch), and liner 427 (e.g., defining an inner wall of the pouch). Pouch 490 typically circumscribes the longitudinal axis of the implant and/or the valve body of frame assembly 222 (e.g., the pouch is a cuff), and further typically extends radially outward from the valve body. Typically, an upstream portion of pouch 490 is attached to valve frame 30 (e.g., and is not attached to outer frame 60), and a downstream portion of the pouch is attached to the outer frame. As described in more detail hereinbelow, at least one respective window 482 into pouch 490 is defined between each leaflet 58 and perimeter 452.
For some applications, a soft pad 476 is provided in each pocket 478, typically at tip 472. For some such applications, and as shown in
Alternatively, pads 300 may be used in place of pads 476, and may be added to flanges 54 as described with reference to
For applications in which pad 476 is used, each strip-portion 464a and 464b typically defines a widened region 479 adjacent to fold-line 463, such that when pockets 478 are formed, a receptacle for pad 476 is formed.
Pockets 478 are subsequently slid onto legs 50, and belt 462 is wrapped around frame assembly 222 downstream of legs 50 (e.g., downstream of the axial level at which the legs are coupled to the valve body). Belt 462 is typically positioned such that it is disposed over the commissures of leaflets 58 and/or over connectors 432. That is, the belt is typically wrapped around the frame assembly at an axial level such t For applications in which pads 476 are used, flanges 54 of legs 50 are typically advanced into niches 477 of the pads. Belt 462 (e.g., the edge of the belt from which pockets 478 extend) is stitched to sheet 450. More specifically, the upstream edge of belt 462 is stitched circumferentially to perimeter 452 of sheet 450. This is represented by a stitch line 465. Therefore, once implant 420 is assembled, the edge of belt 462 from which pockets 478 extend is an upstream edge of the belt, while the edge that is closest to the downstream end of the implant is a downstream edge of the belt. Legs 50, within pockets 478, extend radially outward from between belt 462 and sheet 450 (e.g., at stitch line 465).
For some applications, tips 472 and/or pads 476 are further secured to flanges 54 by stitching 475, which may pass through a hole 55 (labeled in
As shown in
As described with reference to
Windows 482 open into pouch 490 from the lumen of the valve body. Once implant 420 has been implanted at the native valve, windows 482 are disposed functionally within ventricle 8, whereas at least portions of pouch 490 are disposed functionally within atrium 6. Therefore, during ventricular systole, ventricular pressure (which is much greater than atrial pressure) forces blood into pouch 490, thereby inflating the pouch. This inflation presses pouch 490 against the tissue of the native valve. It is hypothesized by the inventors that this inhibits paravalvular leakage of blood, especially during ventricular systole. For example, the pouch may seal a paravalvular gap at the commissures of the native valve. For some applications, inflation of pouch 490 squeezes tissue of the native valve (e.g., native leaflets) between the pouch and flanges 54. Pouch 490 is typically dimensioned such that if, in a particular region, tissue is not disposed between a flange 54 and pouch 490, inflation of the pouch presses the pouch against the flange.
There is therefore provided, in accordance with an application of the present invention, apparatus, comprising:
The first sheet, the second sheet, and the liner define inflatable pouch 490 therebetween, the first sheet defining an upstream wall of the pouch, the second sheet defining a radially-outer wall of the pouch, and the liner defining a radially-inner wall of the pouch. The apparatus defines a plurality of windows (e.g., windows 482) from the lumen into the pouch, each of the windows bounded by the liner at upstream edges of the window, and bounded by the second perimeter and/or belt 462 at a downstream edge of the window. Each window 482 is typically discrete—i.e., bounded on all sides, and separate from other windows. For some applications in which downstream edge 436 of liner 427 is stitched to ring 182 of frame 230, the most upstream parts of windows 482 are closer to the upstream end of the implant than are the most downstream parts of arms 46
Typically, and as shown, pouch 490 circumscribes the valve body of implant 420.
Typically, and as shown in
For some applications, the upstream edge of each window 482 is the shape of a capital letter M, e.g., with the apices of the letter M at upstream end 34 of the valve body, and with the vertex of the letter M at a site 35. Because region 428 of liner 427 follows, and is stitched to, the joists of valve frame 230 at region 428 of the liner, it is hypothesized by the inventors that this arrangement reinforces the upstream edge of window 482, e.g., increasing durability compared to an arrangement in which the upstream edge of the window crosses between joists of the valve frame.
As described hereinabove, sheet 440 typically covers an upstream side of arms 46. Once pouch 490 has been formed, at least most of each arm 46 is therefore disposed inside the pouch. As also described hereinabove, sheet 440 is stitched to arms 46. Once pouch 490 has been formed, the pouch (i.e., the part of the pouch defined by sheet 440) is therefore stitched to arms 46.
For some applications, a circumferential stitch line 445 is used to stitch sheet 440 to sheet 450 at a radius smaller than the overall radius of upstream support portion 40 (i.e., radially inward from the tips of arms 46), typically sandwiching arms 46 between these two sheets. Stitch line 445 is typically radially aligned with region 154 and/or wide (and flexible) portion 46c of arm 46. This typically creates a region 484 in which the portions of sheets 440 and 450 that are disposed radially outward from stitch line 445 are isolated from pouch 490. For such applications, the ends of arms 46 are therefore typically disposed in region 484, and are isolated from pouch 490.
For some applications, and as shown, sheet 450 is sufficiently baggy that the sheet (e.g., pouch 490) may extend radially outward beyond arms 46, particularly if uninhibited by tissue of the native valve. This may be achieved by radial dimension d21 of sheet 450 being greater than distance d22 between the ends arms 46 and clefts 250. For some applications, dimension d21 is more than 30 percent greater (e.g., more than 50 percent greater) than distance d22. For example, dimension d21 may be 30-100 percent greater (e.g., 30-80 percent greater, e.g., 40-80 percent greater, such as 50-70 percent greater) than distance d22. As shown, pouch 490 may extend radially outward beyond arms 46 irrespective of the presence of stitch line 445, which is disposed radially-inward from the ends of arms 46.
Regarding the axial position (i.e., the position along the longitudinal axis of implant 420) of pouch 490 and windows 482. For some applications, pouch 490 extends, with respect to the longitudinal axis of implant 420, further upstream than the leaflets. That is, for some applications, upstream regions of pouch 490 (e.g., those closest to prosthetic valve support 40) are situated further upstream than even the apex of curved edge 456 of leaflets 58. For some applications, and as shown, each of leaflets 58 is attached to liner 427 upstream of windows 482. That is, at least the apex of curved edge 456 of leaflets 58 is disposed upstream of windows 482. Free edge 458 of each leaflet 58 is typically disposed downstream of the third axial level—i.e., the axial level at which perimeter 452 of sheet 450 is attached to frame assembly 222. That is, leaflets 58 typically extend further downstream than pouch 490. For some applications, and as shown, the third axial level (i.e., the axial level at which perimeter 452 of sheet 450 is attached to frame assembly 222) is upstream of the second axial level (i.e., the axial level at which legs 50 are attached to the valve body).
It is to be noted that, whereas liner 427 is disposed on the inside of valve body 32, sheet 450 and belt 462 are disposed on the outside of the valve body. Axially downstream of windows 482, valve body 32 is typically not lined—i.e., no liner is typically disposed between leaflets 58 and frame 30. However, belt 462 circumscribes valve body 32 and serves a similar function to a liner—channeling fluid through the lumen of the valve body.
It is to be noted that projections 246 are not visible in
Reference is made to
Typically, and as shown, arms 46 and legs 50 alternate circumferentially. That is, when viewed from above, an arm 46 is disposed circumferentially on either side of each leg 50, and a leg is disposed circumferentially on either side of each arm. This is illustrated for implant 22 in
It is to be noted that narrowed portion 510 is therefore formed without pouch 490 being sandwiched directly between arms 46 and legs 50. It is also to be noted that, at narrowed portion 510, pouch 490 is stitched to arms 46 but not to legs 50. For some applications, at narrowed portion 510, legs 50 extend in an upstream direction past arms 46. (This can be understood from
It is to be noted that the configuration described hereinabove exists in implant 420 even prior to implantation—i.e., even in the absence of tissue captured between arms 46 and flanges 54.
For some applications of the invention, narrowed portion 510 impedes fluid communication between outer portion 504 and inner portion 502 (and thereby between the outer portion and the lumen of the implant). It is hypothesized by the inventors that, for some such applications, this advantageously inhibits blood that has entered outer portion 504, from exiting the outer portion. During ventricular systole, ventricular pressure forces blood through windows 482 into pouch 490 (i.e., inner portion 502 thereof). At least some of this blood typically enters outer portion 504, e.g., due to the relatively high ventricular pressure. It is hypothesized by the inventors that, at least in part due to narrowed portion 510, during ventricular diastole, pressure in the opposite direction is insufficient to force as much blood back out of outer portion 504. It is further hypothesized by the inventors that, for some applications, this results in a net increase in the volume of blood within outer portion 504 during each cardiac cycle, e.g., until resistance inhibits further inflation of outer portion 504. This is illustrated by the sequence of frames A-F in
It is hypothesized by the inventors that such a configuration of pouch 490 further improves paravalvular sealing provided by the pouch. It is further hypothesized by the inventors that, for some applications of the invention, such a configuration of pouch 490 facilitates the pouch (e.g., outer portion 504 thereof) conforming to the tissue surrounding implant 420, and therefore further facilitating sealing. For example,
For some applications, at least one coagulation component 530 is disposed within outer portion 504, and is configured to promote blood coagulation within the outer portion. For some applications, coagulation component 530 is annular and, within outer portion 504, circumscribes the longitudinal axis of the implant. For some applications, coagulation component 530 comprises a fabric (e.g., comprising polyethylene terephthalate). For some applications, coagulation component 530 comprises polytetrafluoroethylene (e.g., expanded polytetrafluoroethylene), e.g., in the form of a membrane or ribbon. For some applications, coagulation component 530 comprises a metallic (e.g., nitinol or stainless steel) wire, membrane, or mesh, covered by a fabric or expanded polytetrafluoroethylene. For applications, coagulation component comprises a coagulation-inducing drug coated thereon or embedded therein (e.g., within a fabric). For some applications, coagulation component 530 comprises pericardial tissue (e.g., bovine or porcine).
For some applications of the invention, the scope of the invention includes using one or more of the apparatus and techniques described in this patent application in combination with one or more of the apparatus and techniques described in one or more of the following documents, each of which is incorporated herein by reference:
(Some elements in the present patent application are also described in U.S. 62/560,384, U.S. Ser. No. 16/135,969, or U.S. Ser. No. 16/135,979, but are named differently. For the sake of clarity, element names used in the present application supersede those used in U.S. 62/560,384, U.S. Ser. No. 16/135,969, or U.S. Ser. No. 16/135,979.)
It will be appreciated by persons skilled in the art that the present invention is not limited to what has been particularly shown and described hereinabove. Rather, the scope of the present invention includes both combinations and subcombinations of the various features described hereinabove, as well as variations and modifications thereof that are not in the prior art, which would occur to persons skilled in the art upon reading the foregoing description.
The present application is a Continuation application of U.S. patent application Ser. No. 18/090,058 to Hariton et al., filed Dec. 28, 2022, which published as US 2023/0137909 and which is a Continuation application of U.S. patent application Ser. No. 17/101,787 to Hariton et al., filed Nov. 23, 2020, and entitled “Prosthetic valve with appendages” (now U.S. Pat. No. 11,571,298), which is: (1) a Continuation application of U.S. patent application Ser. No. 16/269,328 to Hariton et al., filed Feb. 6, 2019, and entitled “Prosthetic heart valve with pouch” (now U.S. Pat. No. 10,888,421), which is a Continuation-In-Part of: International patent application PCT/IL2018/050725 to Hariton et al., filed Jul. 4, 2018, and entitled “Prosthetic heart valve,” which published as WO 2019/026059, and which is a Continuation-In-Part of U.S. patent application Ser. No. 15/956,956 to Iamberger et al., filed Apr. 19, 2018, and entitled “Prosthetic heart valve” (now U.S. Pat. No. 10,575,948);U.S. patent application Ser. No. 16/135,969 to Hariton et al., filed Sep. 19, 2018, and entitled “Prosthetic valve with inflatable cuff configured for radial extension,” which published as US 2019/0083248 (now U.S. Pat. No. 11,819,405) and which claims benefit of U.S. provisional patent application 62/560,384 to Hariton et al., filed Sep. 19, 2017, and entitled “Prosthetic valve and methods of use;” andU.S. patent application Ser. No. 16/135,979 to Hariton et al., filed Sep. 19, 2018, and entitled “Prosthetic valve with inflatable cuff configured to fill a volume between atrial and ventricular tissue anchors” (now U.S. Pat. No. 11,304,805), which claims benefit of U.S. provisional patent application 62/560,384 to Hariton et al., filed Sep. 19, 2017, and entitled “Prosthetic valve and methods of use,” and(2) a Continuation-In-Part of U.S. patent application Ser. No. 16/776,581 to Hariton et al., filed Jan. 30, 2020, entitled, “Prosthetic heart valve,” which published as US 2020/0163761 (now U.S. Pat. No. 11,793,633) and which is a Continuation of International Patent Application PCT/IL2018/050725 to Hariton et al., filed Jul. 4, 2018, and entitled “Prosthetic heart valve,” which published as WO 2019/026059, and which:(a) claims priority from: U.S. patent application Ser. No. 15/668,559 to Iamberger et al., filed Aug. 3, 2017, and entitled “Prosthetic heart valve” (now U.S. Pat. No. 10,537,426),U.S. provisional patent application 62/560,384 to Hariton et al., filed Sep. 19, 2017, and entitled “Prosthetic valve and methods of use,” andU.S. patent application Ser. No. 15/956,956 to Iamberger et al., filed Apr. 19, 2018, and entitled “Prosthetic heart valve” (now U.S. Pat. No. 10,575,948); and(b) is a Continuation-In-Part of U.S. patent application Ser. No. 15/956,956 to Iamberger et al., filed Apr. 19, 2018, and entitled “Prosthetic heart valve,” (now U.S. Pat. No. 10,575,948) which is a Continuation-In-Part of U.S. patent application Ser. No. 15/668,559 to Iamberger et al., filed Aug. 3, 2017, and entitled “Prosthetic heart valve” (now U.S. Pat. No. 10,537,426). All of the above applications are incorporated herein by reference.
| Number | Name | Date | Kind |
|---|---|---|---|
| 3604488 | Wishart et al. | Sep 1971 | A |
| 3656185 | Carpentier | Apr 1972 | A |
| 3840018 | Heifetz | Oct 1974 | A |
| 3874388 | King et al. | Apr 1975 | A |
| 3898701 | La Russa | Aug 1975 | A |
| 4042979 | Angell | Aug 1977 | A |
| 4118805 | Reimels | Oct 1978 | A |
| 4214349 | Munch | Jul 1980 | A |
| 4222126 | Boretos et al. | Sep 1980 | A |
| 4261342 | Aranguren | Apr 1981 | A |
| 4275469 | Gabbay | Jun 1981 | A |
| 4340091 | Skelton et al. | Jul 1982 | A |
| 4423525 | Vallana et al. | Jan 1984 | A |
| 4434828 | Trincia | Mar 1984 | A |
| 4473928 | Johnson | Oct 1984 | A |
| 4602911 | Ahmadi et al. | Jul 1986 | A |
| 4625727 | Leiboff | Dec 1986 | A |
| 4712549 | Peters et al. | Dec 1987 | A |
| 4778468 | Hunt et al. | Oct 1988 | A |
| 4853986 | Allen | Aug 1989 | A |
| 4892541 | Alonso | Jan 1990 | A |
| 4917698 | Carpenter et al. | Apr 1990 | A |
| 4961738 | Mackin | Oct 1990 | A |
| 4972494 | White et al. | Nov 1990 | A |
| 4994077 | Dobben | Feb 1991 | A |
| 5061277 | Carpentier et al. | Oct 1991 | A |
| 5078739 | Martin | Jan 1992 | A |
| 5104407 | Lam et al. | Apr 1992 | A |
| 5108420 | Marks | Apr 1992 | A |
| 5201757 | Heyn et al. | Apr 1993 | A |
| 5201880 | Wright | Apr 1993 | A |
| 5258008 | Wilk | Nov 1993 | A |
| 5300034 | Behnke | Apr 1994 | A |
| 5306296 | Wright et al. | Apr 1994 | A |
| 5314473 | Godin | May 1994 | A |
| 5325845 | Adair | Jul 1994 | A |
| 5332402 | Teitelbaum | Jul 1994 | A |
| 5397351 | Pavcnik et al. | Mar 1995 | A |
| 5405378 | Strecker | Apr 1995 | A |
| 5443500 | Sigwart | Aug 1995 | A |
| 5450860 | O'Connor | Sep 1995 | A |
| 5473812 | Morris et al. | Dec 1995 | A |
| 5477856 | Lundquist | Dec 1995 | A |
| 5601572 | Middleman et al. | Feb 1997 | A |
| 5607444 | Lam | Mar 1997 | A |
| 5607470 | Milo | Mar 1997 | A |
| 5626609 | Zvenyatsky et al. | May 1997 | A |
| 5647857 | Anderson et al. | Jul 1997 | A |
| 5669919 | Sanders et al. | Sep 1997 | A |
| 5674279 | Wright et al. | Oct 1997 | A |
| 5683402 | Cosgrove et al. | Nov 1997 | A |
| 5702397 | Goble et al. | Dec 1997 | A |
| 5702398 | Tarabishy | Dec 1997 | A |
| 5709695 | Northrup, III | Jan 1998 | A |
| 5713948 | Uflacker | Feb 1998 | A |
| 5716370 | Williamson et al. | Feb 1998 | A |
| 5716397 | Myers | Feb 1998 | A |
| 5716417 | Girard et al. | Feb 1998 | A |
| 5728116 | Rosenman | Mar 1998 | A |
| 5730150 | Peppel et al. | Mar 1998 | A |
| 5741297 | Simon | Apr 1998 | A |
| 5749371 | Zadini et al. | May 1998 | A |
| 5765682 | Bley et al. | Jun 1998 | A |
| 5776140 | Cottone | Jul 1998 | A |
| 5810882 | Bolduc | Sep 1998 | A |
| 5824066 | Gross | Oct 1998 | A |
| 5830221 | Stein et al. | Nov 1998 | A |
| 5843120 | Israel et al. | Dec 1998 | A |
| 5855614 | Stevens et al. | Jan 1999 | A |
| 5868777 | Lam | Feb 1999 | A |
| 5873906 | Lau et al. | Feb 1999 | A |
| 5876373 | Giba et al. | Mar 1999 | A |
| 5935098 | Blaisdell et al. | Aug 1999 | A |
| 5954766 | Zadno-Azizi et al. | Sep 1999 | A |
| 5957949 | Leonhardt et al. | Sep 1999 | A |
| 5957953 | DiPoto et al. | Sep 1999 | A |
| 5961440 | Schweich et al. | Oct 1999 | A |
| 5961539 | Northrup, III et al. | Oct 1999 | A |
| 5961549 | Nguyen et al. | Oct 1999 | A |
| 5980565 | Jayaraman | Nov 1999 | A |
| 5984959 | Robertson | Nov 1999 | A |
| 6010530 | Goicoechea | Jan 2000 | A |
| 6019787 | Richard et al. | Feb 2000 | A |
| 6042554 | Rosenman | Mar 2000 | A |
| 6042607 | Williamson, IV | Mar 2000 | A |
| 6045497 | Schweich et al. | Apr 2000 | A |
| 6050936 | Schweich et al. | Apr 2000 | A |
| 6059715 | Schweich et al. | May 2000 | A |
| 6059827 | Fenton | May 2000 | A |
| 6074401 | Gardiner et al. | Jun 2000 | A |
| 6074417 | Peredo | Jun 2000 | A |
| 6102945 | Campbell | Aug 2000 | A |
| 6106550 | Magovern | Aug 2000 | A |
| 6110200 | Hinnenkamp | Aug 2000 | A |
| 6113612 | Swanson et al. | Sep 2000 | A |
| 6120534 | Ruiz | Sep 2000 | A |
| 6126686 | Badylak et al. | Oct 2000 | A |
| 6143024 | Campbell et al. | Nov 2000 | A |
| 6152937 | Peterson et al. | Nov 2000 | A |
| 6159240 | Sparer | Dec 2000 | A |
| 6165119 | Schweich et al. | Dec 2000 | A |
| 6165183 | Kuehn et al. | Dec 2000 | A |
| 6165210 | Lau et al. | Dec 2000 | A |
| 6174332 | Loch | Jan 2001 | B1 |
| 6183411 | Mortier et al. | Feb 2001 | B1 |
| 6187020 | Zegdi et al. | Feb 2001 | B1 |
| 6187040 | Wright | Feb 2001 | B1 |
| 6193686 | Estrada et al. | Feb 2001 | B1 |
| 6193745 | Fogarty et al. | Feb 2001 | B1 |
| 6315784 | Djurovic | Feb 2001 | B1 |
| 6217610 | Carpentier et al. | Apr 2001 | B1 |
| 6231602 | Carpentier et al. | May 2001 | B1 |
| 6251092 | Qin et al. | Jun 2001 | B1 |
| 6254609 | Vrba et al. | Jul 2001 | B1 |
| 6264700 | Kilcoyne et al. | Jul 2001 | B1 |
| 6287339 | Vasquez et al. | Sep 2001 | B1 |
| 6296656 | Bodluc et al. | Oct 2001 | B1 |
| 6312465 | Griffin et al. | Nov 2001 | B1 |
| 6319281 | Patel | Nov 2001 | B1 |
| 6332893 | Mortier et al. | Dec 2001 | B1 |
| 6334873 | Lane et al. | Jan 2002 | B1 |
| 6346074 | Roth | Feb 2002 | B1 |
| 6350278 | Lenker et al. | Feb 2002 | B1 |
| 6352561 | Leopold et al. | Mar 2002 | B1 |
| 6391036 | Berg et al. | May 2002 | B1 |
| 6402780 | Williamson, IV | Jun 2002 | B2 |
| 6406420 | McCarthy et al. | Jun 2002 | B1 |
| 6406493 | Tu et al. | Jun 2002 | B1 |
| 6409755 | Vrba | Jun 2002 | B1 |
| 6419696 | Ortiz et al. | Jul 2002 | B1 |
| 6428550 | Vargas et al. | Aug 2002 | B1 |
| 6440164 | Dimatteo et al. | Aug 2002 | B1 |
| 6451054 | Stevens | Sep 2002 | B1 |
| 6454799 | Schreck | Sep 2002 | B1 |
| 6458153 | Bailey et al. | Oct 2002 | B1 |
| 6461366 | Seguin | Oct 2002 | B1 |
| 6470892 | Forsell | Oct 2002 | B1 |
| 6478807 | Foreman et al. | Nov 2002 | B1 |
| 6482228 | Norred | Nov 2002 | B1 |
| 6491711 | Durcan | Dec 2002 | B1 |
| 6503274 | Howanec et al. | Jan 2003 | B1 |
| 6511491 | Grudem et al. | Jan 2003 | B2 |
| 6524338 | Gundry | Feb 2003 | B1 |
| 6530952 | Vesely | Mar 2003 | B2 |
| 6533772 | Sherts et al. | Mar 2003 | B1 |
| 6537314 | Langberg et al. | Mar 2003 | B2 |
| 6540782 | Snyders | Apr 2003 | B1 |
| 6547801 | Dargent et al. | Apr 2003 | B1 |
| 6551350 | Thornton et al. | Apr 2003 | B1 |
| 6554845 | Fleenor et al. | Apr 2003 | B1 |
| 6558396 | Inoue | May 2003 | B1 |
| 6558418 | Carpentier et al. | May 2003 | B2 |
| 6564805 | Garrison et al. | May 2003 | B2 |
| 6565603 | Cox | May 2003 | B2 |
| 6569196 | Vesely | May 2003 | B1 |
| 6569198 | Wilson et al. | May 2003 | B1 |
| 6579297 | Bicek et al. | Jun 2003 | B2 |
| 6582464 | Gabbay | Jun 2003 | B2 |
| 6589160 | Schweich et al. | Jul 2003 | B2 |
| 6602263 | Swanson et al. | Aug 2003 | B1 |
| 6602288 | Cosgrove et al. | Aug 2003 | B1 |
| 6602289 | Colvin et al. | Aug 2003 | B1 |
| 6613078 | Barone | Sep 2003 | B1 |
| 6613079 | Wolinsky et al. | Sep 2003 | B1 |
| 6616675 | Evard et al. | Sep 2003 | B1 |
| 6619291 | Hlavka et al. | Sep 2003 | B2 |
| 6626899 | Houser et al. | Sep 2003 | B2 |
| 6626917 | Craig | Sep 2003 | B1 |
| 6626930 | Allen et al. | Sep 2003 | B1 |
| 6629534 | St. Goar et al. | Oct 2003 | B1 |
| 6629921 | Schweich et al. | Oct 2003 | B1 |
| 6651671 | Donlon et al. | Nov 2003 | B1 |
| 6652556 | VanTassel et al. | Nov 2003 | B1 |
| 6669724 | Park et al. | Dec 2003 | B2 |
| 6682558 | Tu et al. | Jan 2004 | B2 |
| 6689125 | Keith et al. | Feb 2004 | B1 |
| 6689164 | Seguin | Feb 2004 | B1 |
| 6695866 | Kuehn et al. | Feb 2004 | B1 |
| 6699256 | Logan et al. | Mar 2004 | B1 |
| 6702826 | Liddicoat et al. | Mar 2004 | B2 |
| 6702846 | Mikus et al. | Mar 2004 | B2 |
| 6706065 | Langberg et al. | Mar 2004 | B2 |
| 6709456 | Langberg et al. | Mar 2004 | B2 |
| 6711444 | Koblish | Mar 2004 | B2 |
| 6716244 | Klaco | Apr 2004 | B2 |
| 6718985 | Hlavka et al. | Apr 2004 | B2 |
| 6719781 | Kim | Apr 2004 | B1 |
| 6719786 | Ryan et al. | Apr 2004 | B2 |
| 6719788 | Cox | Apr 2004 | B2 |
| 6723038 | Schroeder et al. | Apr 2004 | B1 |
| 6726716 | Marquez | Apr 2004 | B2 |
| 6726717 | Alfieri et al. | Apr 2004 | B2 |
| 6730118 | Spenser et al. | May 2004 | B2 |
| 6730121 | Ortiz et al. | May 2004 | B2 |
| 6733525 | Yang et al. | May 2004 | B2 |
| 6749630 | McCarthy et al. | Jun 2004 | B2 |
| 6752813 | Goldfarb et al. | Jun 2004 | B2 |
| 6755857 | Peterson et al. | Jun 2004 | B2 |
| 6764310 | Ichihashi et al. | Jul 2004 | B1 |
| 6764510 | Vidlund et al. | Jul 2004 | B2 |
| 6764514 | Li et al. | Jul 2004 | B1 |
| 6764518 | Godin | Jul 2004 | B2 |
| 6767362 | Schreck | Jul 2004 | B2 |
| 6770083 | Seguin | Aug 2004 | B2 |
| 6786924 | Ryan et al. | Sep 2004 | B2 |
| 6786925 | Schoon et al. | Sep 2004 | B1 |
| 6790231 | Liddicoat et al. | Sep 2004 | B2 |
| 6797001 | Mathis et al. | Sep 2004 | B2 |
| 6797002 | Spence et al. | Sep 2004 | B2 |
| 6802319 | Stevens et al. | Oct 2004 | B2 |
| 6805710 | Bolling et al. | Oct 2004 | B2 |
| 6805711 | Quijano et al. | Oct 2004 | B2 |
| 6821297 | Snyders | Nov 2004 | B2 |
| 6830585 | Artof et al. | Dec 2004 | B1 |
| 6830638 | Boylan et al. | Dec 2004 | B2 |
| 6855126 | Flinchbaugh | Feb 2005 | B2 |
| 6858039 | McCarthy | Feb 2005 | B2 |
| 6884250 | Monassevitch et al. | Apr 2005 | B2 |
| 6884257 | Cox | Apr 2005 | B1 |
| 6893459 | Macoviak | May 2005 | B1 |
| 6893460 | Spenser et al. | May 2005 | B2 |
| 6908482 | McCarthy et al. | Jun 2005 | B2 |
| 6918917 | Nguyen et al. | Jul 2005 | B1 |
| 6926715 | Hauck et al. | Aug 2005 | B1 |
| 6926730 | Nguyen et al. | Aug 2005 | B1 |
| 6939370 | Hartley et al. | Sep 2005 | B2 |
| 6951571 | Srivastava | Oct 2005 | B1 |
| 6960217 | Bolduc | Nov 2005 | B2 |
| 6964684 | Ortiz et al. | Nov 2005 | B2 |
| 6964686 | Gordon | Nov 2005 | B2 |
| 6974476 | McGuckin et al. | Dec 2005 | B2 |
| 6976995 | Mathis et al. | Dec 2005 | B2 |
| 6986775 | Morales et al. | Jan 2006 | B2 |
| 6989028 | Lashinski et al. | Jan 2006 | B2 |
| 6997951 | Solem et al. | Feb 2006 | B2 |
| 7004176 | Lau | Feb 2006 | B2 |
| 7011669 | Kimblad | Mar 2006 | B2 |
| 7011681 | Vesely | Mar 2006 | B2 |
| 7011682 | Lashinski et al. | Mar 2006 | B2 |
| 7018406 | Seguin et al. | Mar 2006 | B2 |
| 7037334 | Hlavka et al. | May 2006 | B1 |
| 7041132 | Quijano et al. | May 2006 | B2 |
| 7074236 | Rabkin et al. | Jul 2006 | B2 |
| 7077850 | Kortenbach | Jul 2006 | B2 |
| 7077861 | Spence | Jul 2006 | B2 |
| 7077862 | Vidlund et al. | Jul 2006 | B2 |
| 7087064 | Hyde | Aug 2006 | B1 |
| 7101395 | Tremulis et al. | Sep 2006 | B2 |
| 7101396 | Artof et al. | Sep 2006 | B2 |
| 7112207 | Allen et al. | Sep 2006 | B2 |
| 7118595 | Ryan et al. | Oct 2006 | B2 |
| 7125421 | Tremulis et al. | Oct 2006 | B2 |
| 7137184 | Schreck | Nov 2006 | B2 |
| 7150737 | Purdy et al. | Dec 2006 | B2 |
| 7159593 | McCarthy et al. | Jan 2007 | B2 |
| 7166127 | Spence et al. | Jan 2007 | B2 |
| 7169187 | Datta et al. | Jan 2007 | B2 |
| 7172625 | Shu et al. | Feb 2007 | B2 |
| 7175656 | Khairkhahan | Feb 2007 | B2 |
| 7175660 | Cartledge et al. | Feb 2007 | B2 |
| 7186262 | Saadat | Mar 2007 | B2 |
| 7186264 | Liddicoat et al. | Mar 2007 | B2 |
| 7189199 | McCarthy et al. | Mar 2007 | B2 |
| 7192443 | Solem et al. | Mar 2007 | B2 |
| 7198646 | Figulla et al. | Apr 2007 | B2 |
| 7201772 | Schwammenthal | Apr 2007 | B2 |
| 7220277 | Arru et al. | May 2007 | B2 |
| 7226467 | Lucatero et al. | Jun 2007 | B2 |
| 7226477 | Cox | Jun 2007 | B2 |
| 7226647 | Kasperchik et al. | Jun 2007 | B2 |
| 7229452 | Kayan | Jun 2007 | B2 |
| 7238191 | Bachmann | Jul 2007 | B2 |
| 7261686 | Couvillon, Jr. | Aug 2007 | B2 |
| 7288097 | Seguin | Oct 2007 | B2 |
| 7288111 | Holloway et al. | Oct 2007 | B1 |
| 7294148 | McCarthy | Nov 2007 | B2 |
| 7297150 | Cartledge et al. | Nov 2007 | B2 |
| 7311728 | Solem et al. | Dec 2007 | B2 |
| 7311729 | Mathis et al. | Dec 2007 | B2 |
| 7314485 | Mathis | Jan 2008 | B2 |
| 7316710 | Cheng et al. | Jan 2008 | B1 |
| 7316716 | Egan | Jan 2008 | B2 |
| 7329279 | Haug et al. | Feb 2008 | B2 |
| 7329280 | Bolling et al. | Feb 2008 | B2 |
| 7335213 | Hyde et al. | Feb 2008 | B1 |
| 7351256 | Hojeibane et al. | Apr 2008 | B2 |
| 7361190 | Shoulian et al. | Apr 2008 | B2 |
| 7364588 | Mathis et al. | Apr 2008 | B2 |
| 7374571 | Pease et al. | May 2008 | B2 |
| 7374573 | Gabbay | May 2008 | B2 |
| 7377938 | Sarac et al. | May 2008 | B2 |
| 7377941 | Rhee et al. | May 2008 | B2 |
| 7381218 | Schreck | Jun 2008 | B2 |
| 7381219 | Salahieh et al. | Jun 2008 | B2 |
| 7390329 | Westra et al. | Jun 2008 | B2 |
| 7404824 | Webler et al. | Jul 2008 | B1 |
| 7422603 | Lane | Sep 2008 | B2 |
| 7429269 | Schwammenthal | Sep 2008 | B2 |
| 7431692 | Zollinger et al. | Oct 2008 | B2 |
| 7442204 | Schwammenthal | Oct 2008 | B2 |
| 7442207 | Rafiee | Oct 2008 | B2 |
| 7445630 | Lashinski et al. | Nov 2008 | B2 |
| 7452376 | Lim et al. | Nov 2008 | B2 |
| 7455677 | Vargas et al. | Nov 2008 | B2 |
| 7455688 | Furst et al. | Nov 2008 | B2 |
| 7455690 | Cartledge et al. | Nov 2008 | B2 |
| 7462162 | Phan et al. | Dec 2008 | B2 |
| 7481838 | Carpentier et al. | Jan 2009 | B2 |
| 7485142 | Milo | Feb 2009 | B2 |
| 7500989 | Solem et al. | Mar 2009 | B2 |
| 7507252 | Lashinski et al. | Mar 2009 | B2 |
| 7510575 | Spenser et al. | Mar 2009 | B2 |
| 7510577 | Moaddeb et al. | Mar 2009 | B2 |
| 7513909 | Lane et al. | Apr 2009 | B2 |
| 7524331 | Birdsall | Apr 2009 | B2 |
| 7527646 | Rahdert et al. | May 2009 | B2 |
| 7527647 | Spence | May 2009 | B2 |
| 7530995 | Quijano et al. | May 2009 | B2 |
| 7549983 | Roue et al. | Jun 2009 | B2 |
| 7556632 | Zadno | Jul 2009 | B2 |
| 7556646 | Yang et al. | Jul 2009 | B2 |
| 7559936 | Levine | Jul 2009 | B2 |
| 7562660 | Saadat | Jul 2009 | B2 |
| 7563267 | Goldfarb et al. | Jul 2009 | B2 |
| 7563273 | Goldfarb et al. | Jul 2009 | B2 |
| 7569062 | Kuehn et al. | Aug 2009 | B1 |
| 7582111 | Krolik et al. | Sep 2009 | B2 |
| 7585321 | Cribier | Sep 2009 | B2 |
| 7588582 | Starksen et al. | Sep 2009 | B2 |
| 7591826 | Alferness et al. | Sep 2009 | B2 |
| 7597711 | Drews et al. | Oct 2009 | B2 |
| 7604646 | Goldfarb et al. | Oct 2009 | B2 |
| 7608091 | Goldfarb et al. | Oct 2009 | B2 |
| 7608103 | McCarthy | Oct 2009 | B2 |
| 7611534 | Kapadia et al. | Nov 2009 | B2 |
| 7618449 | Tremulis et al. | Nov 2009 | B2 |
| 7621948 | Hermann et al. | Nov 2009 | B2 |
| 7625403 | Krivoruchko | Dec 2009 | B2 |
| 7632302 | Vreeman et al. | Dec 2009 | B2 |
| 7632303 | Stalker et al. | Dec 2009 | B1 |
| 7635329 | Goldfarb et al. | Dec 2009 | B2 |
| 7635386 | Gammie | Dec 2009 | B1 |
| 7648528 | Styrc | Jan 2010 | B2 |
| 7655015 | Goldfarb et al. | Feb 2010 | B2 |
| 7666204 | Thornton et al. | Feb 2010 | B2 |
| 7682319 | Martin | Mar 2010 | B2 |
| 7682369 | Seguin | Mar 2010 | B2 |
| 7682380 | Thornton et al. | Mar 2010 | B2 |
| 7686822 | Shayani | Mar 2010 | B2 |
| 7699892 | Rafiee et al. | Apr 2010 | B2 |
| 7704269 | St. Goar et al. | Apr 2010 | B2 |
| 7704277 | Zakay et al. | Apr 2010 | B2 |
| 7708775 | Rowe et al. | May 2010 | B2 |
| 7717952 | Case et al. | May 2010 | B2 |
| 7717955 | Lane et al. | May 2010 | B2 |
| 7722666 | Lafontaine | May 2010 | B2 |
| 7731741 | Eidenschink | Jun 2010 | B2 |
| 7731742 | Schlick et al. | Jun 2010 | B2 |
| 7736388 | Goldfarb et al. | Jun 2010 | B2 |
| 7748389 | Salahieh et al. | Jul 2010 | B2 |
| 7753922 | Starksen | Jul 2010 | B2 |
| 7753924 | Starksen et al. | Jul 2010 | B2 |
| 7753949 | Lamphere et al. | Jul 2010 | B2 |
| 7758595 | Allen et al. | Jul 2010 | B2 |
| 7758632 | Hojeibane et al. | Jul 2010 | B2 |
| 7758640 | Vesely | Jul 2010 | B2 |
| 7771467 | Svensson | Aug 2010 | B2 |
| 7771469 | Liddicoat | Aug 2010 | B2 |
| 7776080 | Bei et al. | Aug 2010 | B2 |
| 7776083 | Vesely | Aug 2010 | B2 |
| 7780726 | Seguin | Aug 2010 | B2 |
| 7785341 | Forster et al. | Aug 2010 | B2 |
| 7799069 | Bailey et al. | Sep 2010 | B2 |
| 7803181 | Furst et al. | Sep 2010 | B2 |
| 7811296 | Goldfarb et al. | Oct 2010 | B2 |
| 7811316 | Kalmann et al. | Oct 2010 | B2 |
| 7824442 | Salahieh et al. | Nov 2010 | B2 |
| 7837645 | Bessler et al. | Nov 2010 | B2 |
| 7837727 | Goetz et al. | Nov 2010 | B2 |
| 7842081 | Yadin | Nov 2010 | B2 |
| 7850725 | Vardi et al. | Dec 2010 | B2 |
| 7871368 | Zollinger et al. | Jan 2011 | B2 |
| 7871432 | Bergin | Jan 2011 | B2 |
| 7871433 | Lattouf | Jan 2011 | B2 |
| 7871436 | Ryan et al. | Jan 2011 | B2 |
| 7887583 | Macoviak | Feb 2011 | B2 |
| 7892281 | Seguin et al. | Feb 2011 | B2 |
| 7896915 | Guyenot et al. | Mar 2011 | B2 |
| 7914544 | Nguyen et al. | Mar 2011 | B2 |
| 7914569 | Nguyen et al. | Mar 2011 | B2 |
| 7927370 | Webler et al. | Apr 2011 | B2 |
| 7927371 | Navia et al. | Apr 2011 | B2 |
| 7942927 | Kaye et al. | May 2011 | B2 |
| 7947072 | Yang et al. | May 2011 | B2 |
| 7947075 | Goetz et al. | May 2011 | B2 |
| 7951195 | Antonsson et al. | May 2011 | B2 |
| 7955375 | Agnew | Jun 2011 | B2 |
| 7955377 | Melsheimer | Jun 2011 | B2 |
| 7955384 | Rafiee et al. | Jun 2011 | B2 |
| 7959666 | Salahieh et al. | Jun 2011 | B2 |
| 7959672 | Salahieh et al. | Jun 2011 | B2 |
| 7967833 | Sterman et al. | Jun 2011 | B2 |
| 7967857 | Lane | Jun 2011 | B2 |
| 7981151 | Rowe | Jul 2011 | B2 |
| 7981153 | Fogarty et al. | Jul 2011 | B2 |
| 7988725 | Gross et al. | Aug 2011 | B2 |
| 7992567 | Hirotsuka et al. | Aug 2011 | B2 |
| 7993368 | Gambale et al. | Aug 2011 | B2 |
| 7993393 | Carpentier et al. | Aug 2011 | B2 |
| 7993397 | Lashinski | Aug 2011 | B2 |
| 8002825 | Letac et al. | Aug 2011 | B2 |
| 8002826 | Seguin | Aug 2011 | B2 |
| 8012201 | Lashinski et al. | Sep 2011 | B2 |
| 8016877 | Seguin et al. | Sep 2011 | B2 |
| 8016882 | Macoviak | Sep 2011 | B2 |
| 8021420 | Dolan | Sep 2011 | B2 |
| 8021421 | Fogarty et al. | Sep 2011 | B2 |
| 8025695 | Fogarty et al. | Sep 2011 | B2 |
| 8029518 | Goldfarb et al. | Oct 2011 | B2 |
| 8029557 | Sobrino-Serrano et al. | Oct 2011 | B2 |
| 8029564 | Johnson et al. | Oct 2011 | B2 |
| 8034103 | Burriesci | Oct 2011 | B2 |
| 8034104 | Carpentier et al. | Oct 2011 | B2 |
| 8038720 | Wallace et al. | Oct 2011 | B2 |
| 8043360 | McNamara et al. | Oct 2011 | B2 |
| 8048138 | Sulivan et al. | Nov 2011 | B2 |
| 8048140 | Purdy | Nov 2011 | B2 |
| 8048153 | Salahieh et al. | Nov 2011 | B2 |
| 8052592 | Goldfarb et al. | Nov 2011 | B2 |
| 8052741 | Bruszewski et al. | Nov 2011 | B2 |
| 8052749 | Salahieh et al. | Nov 2011 | B2 |
| 8057493 | Goldfarb et al. | Nov 2011 | B2 |
| 8057532 | Hoffman | Nov 2011 | B2 |
| 8057540 | Letac et al. | Nov 2011 | B2 |
| 8062355 | Figulla et al. | Nov 2011 | B2 |
| 8062359 | Marquez et al. | Nov 2011 | B2 |
| 8070708 | Rottenberg et al. | Dec 2011 | B2 |
| 8070800 | Lock et al. | Dec 2011 | B2 |
| 8070802 | Lamphere et al. | Dec 2011 | B2 |
| 8070804 | Hyde | Dec 2011 | B2 |
| 8070805 | Vidlund | Dec 2011 | B2 |
| 8075611 | Milwee et al. | Dec 2011 | B2 |
| 8075616 | Solem | Dec 2011 | B2 |
| 8080054 | Rowe | Dec 2011 | B2 |
| 8083793 | Lane et al. | Dec 2011 | B2 |
| D652927 | Braido et al. | Jan 2012 | S |
| D653341 | Braido et al. | Jan 2012 | S |
| 8092518 | Schreck | Jan 2012 | B2 |
| 8092520 | Quadri | Jan 2012 | B2 |
| 8092521 | Figulla et al. | Jan 2012 | B2 |
| 8100964 | Spence | Jan 2012 | B2 |
| 8105377 | Liddicoat | Jan 2012 | B2 |
| 8109996 | Stacchino et al. | Feb 2012 | B2 |
| 8118866 | Herrmann et al. | Feb 2012 | B2 |
| 8123800 | McCarthy | Feb 2012 | B2 |
| 8123801 | Milo | Feb 2012 | B2 |
| 8323334 | Deem et al. | Feb 2012 | B2 |
| 8133270 | Kheradvar et al. | Mar 2012 | B2 |
| 8136218 | Millwee et al. | Mar 2012 | B2 |
| 8137398 | Tuval et al. | Mar 2012 | B2 |
| 8142492 | Forster et al. | Mar 2012 | B2 |
| 8142493 | Spence et al. | Mar 2012 | B2 |
| 8142494 | Rahdert et al. | Mar 2012 | B2 |
| 8142495 | Hasenkam et al. | Mar 2012 | B2 |
| 8142496 | Berreklouw | Mar 2012 | B2 |
| 8142497 | Friedman | Mar 2012 | B2 |
| 8147504 | Ino et al. | Apr 2012 | B2 |
| 8147542 | Maisano et al. | Apr 2012 | B2 |
| 8152844 | Rao | Apr 2012 | B2 |
| 8157852 | Bloom et al. | Apr 2012 | B2 |
| 8157853 | Laske et al. | Apr 2012 | B2 |
| 8157860 | McNamara et al. | Apr 2012 | B2 |
| 8163008 | Wilson et al. | Apr 2012 | B2 |
| 8163013 | Machold et al. | Apr 2012 | B2 |
| 8163014 | Lane et al. | Apr 2012 | B2 |
| D660433 | Braido et al. | May 2012 | S |
| D660967 | Braido et al. | May 2012 | S |
| 8167894 | Miles et al. | May 2012 | B2 |
| 8167932 | Bourang et al. | May 2012 | B2 |
| 8167935 | McGuckin, Jr. et al. | May 2012 | B2 |
| 8172896 | McNamara et al. | May 2012 | B2 |
| 8172898 | Alferness et al. | May 2012 | B2 |
| 8177836 | Lee et al. | May 2012 | B2 |
| 8182528 | Salahieh et al. | May 2012 | B2 |
| 8187299 | Goldfarb et al. | May 2012 | B2 |
| 8187324 | Webler et al. | May 2012 | B2 |
| 8202315 | Hlavka et al. | Jun 2012 | B2 |
| 8206439 | Gomez-Duran | Jun 2012 | B2 |
| 8211169 | Lane et al. | Jul 2012 | B2 |
| 8216256 | Raschdorf, Jr. et al. | Jul 2012 | B2 |
| 8216301 | Bonhoeffer et al. | Jul 2012 | B2 |
| 8221492 | Case et al. | Jul 2012 | B2 |
| 8221493 | Boyle et al. | Jul 2012 | B2 |
| 8226710 | Nguyen et al. | Jul 2012 | B2 |
| 8226711 | Mortier et al. | Jul 2012 | B2 |
| 8231670 | Salahieh et al. | Jul 2012 | B2 |
| 8231671 | Kim | Jul 2012 | B2 |
| 8236045 | Benichou et al. | Aug 2012 | B2 |
| 8236049 | Rowe et al. | Aug 2012 | B2 |
| 8241351 | Cabiri | Aug 2012 | B2 |
| 8252042 | McNamara et al. | Aug 2012 | B2 |
| 8252050 | Maisano et al. | Aug 2012 | B2 |
| 8252051 | Chau et al. | Aug 2012 | B2 |
| 8252052 | Salahieh et al. | Aug 2012 | B2 |
| 8257390 | Carley et al. | Sep 2012 | B2 |
| 8262725 | Subramanian | Sep 2012 | B2 |
| 8267988 | Hamer et al. | Sep 2012 | B2 |
| 8277501 | Chalekian et al. | Oct 2012 | B2 |
| 8277502 | Miller et al. | Oct 2012 | B2 |
| 8287584 | Salahieh et al. | Oct 2012 | B2 |
| 8287591 | Keidar et al. | Oct 2012 | B2 |
| 8298280 | Yadin et al. | Oct 2012 | B2 |
| 8303608 | Goldfarb et al. | Nov 2012 | B2 |
| 8303653 | Bonhoeffer et al. | Nov 2012 | B2 |
| 8308798 | Pintor et al. | Nov 2012 | B2 |
| 8313525 | Tuval et al. | Nov 2012 | B2 |
| 8317853 | Agnew | Nov 2012 | B2 |
| 8317855 | Gregorich et al. | Nov 2012 | B2 |
| 8323335 | Rowe et al. | Dec 2012 | B2 |
| 8328868 | Paul et al. | Dec 2012 | B2 |
| 8333777 | Schaller et al. | Dec 2012 | B2 |
| 8337541 | Quadri et al. | Dec 2012 | B2 |
| 8343173 | Starksen et al. | Jan 2013 | B2 |
| 8343174 | Goldfarb et al. | Jan 2013 | B2 |
| 8343213 | Salahieh et al. | Jan 2013 | B2 |
| 8348999 | Kheradvar et al. | Jan 2013 | B2 |
| 8349002 | Milo | Jan 2013 | B2 |
| 8353956 | Miller et al. | Jan 2013 | B2 |
| 8357195 | Kuehn | Jan 2013 | B2 |
| 8361144 | Fish et al. | Jan 2013 | B2 |
| 8366767 | Zhang | Feb 2013 | B2 |
| 8372140 | Hoffman et al. | Feb 2013 | B2 |
| 8377119 | Drews et al. | Feb 2013 | B2 |
| 8382829 | Call et al. | Feb 2013 | B1 |
| 8388680 | Starksen et al. | Mar 2013 | B2 |
| 8393517 | Milo | Mar 2013 | B2 |
| 8398708 | Meiri et al. | Mar 2013 | B2 |
| 8403981 | Forster et al. | Mar 2013 | B2 |
| 8403983 | Quadri et al. | Mar 2013 | B2 |
| 8408214 | Spenser | Apr 2013 | B2 |
| 8414644 | Quadri et al. | Apr 2013 | B2 |
| 8425593 | Braido et al. | Apr 2013 | B2 |
| 8430926 | Kirson | Apr 2013 | B2 |
| 8430934 | Das | Apr 2013 | B2 |
| 8444689 | Zhang | May 2013 | B2 |
| 8449599 | Chau et al. | May 2013 | B2 |
| 8449625 | Campbell et al. | May 2013 | B2 |
| 8454686 | Alkhatib | Jun 2013 | B2 |
| 8460365 | Haverkost et al. | Jun 2013 | B2 |
| 8460370 | Zakay et al. | Jun 2013 | B2 |
| 8460371 | Hlavka et al. | Jun 2013 | B2 |
| 8474460 | Barrett et al. | Jul 2013 | B2 |
| 8475491 | Milo | Jul 2013 | B2 |
| 8480732 | Subramanian | Jul 2013 | B2 |
| 8500800 | Maisano et al. | Aug 2013 | B2 |
| 8500821 | Sobrino-Serrano et al. | Aug 2013 | B2 |
| 8512400 | Tran et al. | Aug 2013 | B2 |
| 8518107 | Tsukashima et al. | Aug 2013 | B2 |
| 8523881 | Cabiri et al. | Sep 2013 | B2 |
| 8523940 | Richardson et al. | Sep 2013 | B2 |
| 8529431 | Baker et al. | Sep 2013 | B2 |
| 8539662 | Stacchino et al. | Sep 2013 | B2 |
| 8540767 | Zhang | Sep 2013 | B2 |
| 8545544 | Spenser et al. | Oct 2013 | B2 |
| 8545553 | Zipory et al. | Oct 2013 | B2 |
| 8551160 | Figulla et al. | Oct 2013 | B2 |
| 8551161 | Dolan | Oct 2013 | B2 |
| 8562672 | Bonhoeffer et al. | Oct 2013 | B2 |
| 8568475 | Nguyen et al. | Oct 2013 | B2 |
| 8579964 | Lane et al. | Nov 2013 | B2 |
| 8579965 | Bonhoeffer et al. | Nov 2013 | B2 |
| 8585755 | Chau et al. | Nov 2013 | B2 |
| 8585756 | Bonhoeffer et al. | Nov 2013 | B2 |
| 8591460 | Wilson et al. | Nov 2013 | B2 |
| 8591570 | Revuelta et al. | Nov 2013 | B2 |
| 8591576 | Hasenkam et al. | Nov 2013 | B2 |
| 8608797 | Gross et al. | Dec 2013 | B2 |
| 8623075 | Murray et al. | Jan 2014 | B2 |
| 8623080 | Fogarty et al. | Jan 2014 | B2 |
| 8628569 | Benichou et al. | Jan 2014 | B2 |
| 8628570 | Seguin | Jan 2014 | B2 |
| 8628571 | Hacohen et al. | Jan 2014 | B1 |
| 8641727 | Starksen et al. | Feb 2014 | B2 |
| 8652202 | Alon et al. | Feb 2014 | B2 |
| 8652203 | Quadri et al. | Feb 2014 | B2 |
| 8652204 | Quill et al. | Feb 2014 | B2 |
| 8657872 | Seguin | Feb 2014 | B2 |
| 8663322 | Keranen | Mar 2014 | B2 |
| 8673020 | Sobrino-Serrano et al. | Mar 2014 | B2 |
| 8679174 | Ottma et al. | Mar 2014 | B2 |
| 8685086 | Navia et al. | Apr 2014 | B2 |
| 8690939 | Miller et al. | Apr 2014 | B2 |
| 8696742 | Pintor et al. | Apr 2014 | B2 |
| 8715342 | Zipory et al. | May 2014 | B2 |
| 8728097 | Sugimoto et al. | May 2014 | B1 |
| 8728155 | Montorfano et al. | May 2014 | B2 |
| 8734467 | Miller et al. | May 2014 | B2 |
| 8734507 | Keranen | May 2014 | B2 |
| 8740920 | Goldfarb et al. | Jun 2014 | B2 |
| 8747460 | Tuval et al. | Jun 2014 | B2 |
| 8771345 | Tuval et al. | Jul 2014 | B2 |
| 8778021 | Cartledge | Jul 2014 | B2 |
| 8784472 | Eidenschink | Jul 2014 | B2 |
| 8784479 | Antonsson et al. | Jul 2014 | B2 |
| 8784481 | Alkhatib et al. | Jul 2014 | B2 |
| 8790367 | Nguyen et al. | Jul 2014 | B2 |
| 8790394 | Miller et al. | Jul 2014 | B2 |
| 8795298 | Hernlund et al. | Aug 2014 | B2 |
| 8795355 | Alkhatib | Aug 2014 | B2 |
| 8795356 | Quadri et al. | Aug 2014 | B2 |
| 8795357 | Yohanan et al. | Aug 2014 | B2 |
| 8801776 | House et al. | Aug 2014 | B2 |
| 8808366 | Braido et al. | Aug 2014 | B2 |
| 8808368 | Maisano et al. | Aug 2014 | B2 |
| 8808371 | Cartledge | Aug 2014 | B2 |
| 8840663 | Salahieh et al. | Sep 2014 | B2 |
| 8840664 | Karapetian et al. | Sep 2014 | B2 |
| 8845717 | Khairkhahan et al. | Sep 2014 | B2 |
| 8845722 | Gabbay | Sep 2014 | B2 |
| 8845723 | Spence et al. | Sep 2014 | B2 |
| 8852261 | White | Oct 2014 | B2 |
| 8852272 | Gross et al. | Oct 2014 | B2 |
| 8858623 | Miller et al. | Oct 2014 | B2 |
| 8864822 | Spence et al. | Oct 2014 | B2 |
| 8870948 | Erzberger et al. | Oct 2014 | B1 |
| 8870949 | Rowe | Oct 2014 | B2 |
| 8870950 | Hacohen | Oct 2014 | B2 |
| 8876800 | Behan | Nov 2014 | B2 |
| 8888843 | Khairkhahan et al. | Nov 2014 | B2 |
| 8894702 | Quadri et al. | Nov 2014 | B2 |
| 8900294 | Paniagua et al. | Dec 2014 | B2 |
| 8900295 | Migliazza et al. | Dec 2014 | B2 |
| 8906083 | Obermiller et al. | Dec 2014 | B2 |
| 8911455 | Quadri et al. | Dec 2014 | B2 |
| 8911461 | Traynor et al. | Dec 2014 | B2 |
| 8911489 | Ben-Muvhar | Dec 2014 | B2 |
| 8911493 | Rowe et al. | Dec 2014 | B2 |
| 8911494 | Hammer et al. | Dec 2014 | B2 |
| 8926695 | Gross et al. | Jan 2015 | B2 |
| 8926696 | Cabiri et al. | Jan 2015 | B2 |
| 8926697 | Gross et al. | Jan 2015 | B2 |
| 8932343 | Alkhatib et al. | Jan 2015 | B2 |
| 8932348 | Solem et al. | Jan 2015 | B2 |
| 8940042 | Miller et al. | Jan 2015 | B2 |
| 8940044 | Hammer et al. | Jan 2015 | B2 |
| 8945177 | Dell et al. | Feb 2015 | B2 |
| 8945211 | Sugimoto | Feb 2015 | B2 |
| 8951285 | Sugimoto et al. | Feb 2015 | B2 |
| 8951286 | Sugimoto et al. | Feb 2015 | B2 |
| 8961595 | Alkhatib | Feb 2015 | B2 |
| 8979922 | Jayasinghe et al. | Mar 2015 | B2 |
| 8986370 | Annest | Mar 2015 | B2 |
| 8986373 | Chau et al. | Mar 2015 | B2 |
| 8986375 | Garde et al. | Mar 2015 | B2 |
| 8992599 | Thubrikar et al. | Mar 2015 | B2 |
| 8992604 | Gross et al. | Mar 2015 | B2 |
| 8992608 | Haug et al. | Mar 2015 | B2 |
| 8998982 | Richter et al. | Apr 2015 | B2 |
| 9005273 | Salahieh et al. | Apr 2015 | B2 |
| 9011468 | Ketai et al. | Apr 2015 | B2 |
| 9011520 | Miller et al. | Apr 2015 | B2 |
| 9011527 | Li et al. | Apr 2015 | B2 |
| 9011530 | Reich et al. | Apr 2015 | B2 |
| 9017399 | Gross et al. | Apr 2015 | B2 |
| D730520 | Braido et al. | May 2015 | S |
| D730521 | Braido et al. | May 2015 | S |
| 9023100 | Quadri et al. | May 2015 | B2 |
| 9034032 | McLean et al. | May 2015 | B2 |
| 9034033 | McLean et al. | May 2015 | B2 |
| 9039757 | McLean et al. | May 2015 | B2 |
| D732666 | Nguyen et al. | Jun 2015 | S |
| 9050188 | Schweich et al. | Jun 2015 | B2 |
| 9060858 | Thornton et al. | Jun 2015 | B2 |
| 9072603 | Tuval et al. | Jul 2015 | B2 |
| 9084676 | Chau et al. | Jul 2015 | B2 |
| 9095434 | Rowe | Aug 2015 | B2 |
| 9119719 | Zipory et al. | Sep 2015 | B2 |
| 9125632 | Loulmet et al. | Sep 2015 | B2 |
| 9125738 | Figulla et al. | Sep 2015 | B2 |
| 9125740 | Morriss et al. | Sep 2015 | B2 |
| 9132006 | Spenser et al. | Sep 2015 | B2 |
| 9132009 | Hacohen et al. | Sep 2015 | B2 |
| 9138312 | Tuval et al. | Sep 2015 | B2 |
| 9155619 | Liu et al. | Oct 2015 | B2 |
| 9173646 | Fabro | Nov 2015 | B2 |
| 9173659 | Bodewadt et al. | Nov 2015 | B2 |
| 9173738 | Murray et al. | Nov 2015 | B2 |
| 9180005 | Lashinski et al. | Nov 2015 | B1 |
| 9180009 | Majkrzak et al. | Nov 2015 | B2 |
| 9192472 | Gross et al. | Nov 2015 | B2 |
| 9220594 | Braido et al. | Dec 2015 | B2 |
| 9226820 | Braido et al. | Jan 2016 | B2 |
| 9226825 | Starksen et al. | Jan 2016 | B2 |
| 9226839 | Kariniemi et al. | Jan 2016 | B1 |
| 9232995 | Kovalsky et al. | Jan 2016 | B2 |
| 9241790 | Lane et al. | Jan 2016 | B2 |
| 9241791 | Braido et al. | Jan 2016 | B2 |
| 9241792 | Benichou et al. | Jan 2016 | B2 |
| 9241794 | Braido et al. | Jan 2016 | B2 |
| 9248014 | Lane et al. | Feb 2016 | B2 |
| 9265608 | Miller et al. | Feb 2016 | B2 |
| 9277994 | Miller et al. | Mar 2016 | B2 |
| 9289290 | Alkhatib et al. | Mar 2016 | B2 |
| 9289291 | Gorman et al. | Mar 2016 | B2 |
| 9295550 | Nguyen et al. | Mar 2016 | B2 |
| 9295551 | Straubinger et al. | Mar 2016 | B2 |
| 9295552 | McLean et al. | Mar 2016 | B2 |
| 9301836 | Buchbinder et al. | Apr 2016 | B2 |
| 9308087 | Lane et al. | Apr 2016 | B2 |
| 9320591 | Bolduc | Apr 2016 | B2 |
| D755384 | Pesce et al. | May 2016 | S |
| 9326852 | Spenser | May 2016 | B2 |
| 9326876 | Acosta et al. | May 2016 | B2 |
| 9345573 | Nyuli et al. | May 2016 | B2 |
| 9351830 | Gross et al. | May 2016 | B2 |
| 9358107 | Nguyen et al. | Jun 2016 | B2 |
| 9387078 | Gross et al. | Jul 2016 | B2 |
| 9393110 | Levi et al. | Jul 2016 | B2 |
| 9421098 | Gifford et al. | Aug 2016 | B2 |
| 9427303 | Liddy et al. | Aug 2016 | B2 |
| 9427316 | Schweich, Jr. et al. | Aug 2016 | B2 |
| 9439757 | Wallace et al. | Sep 2016 | B2 |
| 9445893 | Vaturi | Sep 2016 | B2 |
| 9463102 | Kelly | Oct 2016 | B2 |
| 9474599 | Keränen | Oct 2016 | B2 |
| 9474638 | Robinson et al. | Oct 2016 | B2 |
| 9480559 | Vidlund et al. | Nov 2016 | B2 |
| 9492273 | Wallace et al. | Nov 2016 | B2 |
| 9498314 | Behan | Nov 2016 | B2 |
| 9498332 | Hacohen et al. | Nov 2016 | B2 |
| 9510947 | Straubinger et al. | Dec 2016 | B2 |
| 9532870 | Cooper et al. | Jan 2017 | B2 |
| 9554897 | Lane et al. | Jan 2017 | B2 |
| 9554899 | Granada et al. | Jan 2017 | B2 |
| 9561103 | Granada et al. | Feb 2017 | B2 |
| 9566152 | Schweich et al. | Feb 2017 | B2 |
| 9572665 | Lane et al. | Feb 2017 | B2 |
| 9597182 | Straubinger et al. | Mar 2017 | B2 |
| 9629716 | Seguin | Apr 2017 | B2 |
| 9662203 | Sheahan et al. | May 2017 | B2 |
| 9681952 | Hacohen et al. | Jun 2017 | B2 |
| 9717591 | Chau et al. | Aug 2017 | B2 |
| 9743932 | Amplatz et al. | Aug 2017 | B2 |
| 9763657 | Hacohen et al. | Sep 2017 | B2 |
| 9763817 | Roeder | Sep 2017 | B2 |
| 9770256 | Cohen et al. | Sep 2017 | B2 |
| D800908 | Hariton et al. | Oct 2017 | S |
| 9788941 | Hacohen | Oct 2017 | B2 |
| 9895226 | Harari et al. | Feb 2018 | B1 |
| 9974651 | Hariton et al. | May 2018 | B2 |
| 9987132 | Hariton et al. | Jun 2018 | B1 |
| 9993360 | Shalev et al. | Jun 2018 | B2 |
| 10010414 | Cooper et al. | Jul 2018 | B2 |
| 10045845 | Hacohen et al. | Aug 2018 | B2 |
| 10076415 | Metchik et al. | Sep 2018 | B1 |
| 10098732 | Hariton et al. | Oct 2018 | B1 |
| 10105222 | Metchik et al. | Oct 2018 | B1 |
| 10111751 | Metchik et al. | Oct 2018 | B1 |
| 10123873 | Metchik et al. | Nov 2018 | B1 |
| 10130475 | Metchik et al. | Nov 2018 | B1 |
| 10136993 | Metchik et al. | Nov 2018 | B1 |
| 10143552 | Wallace et al. | Dec 2018 | B2 |
| 10149761 | Granada et al. | Dec 2018 | B2 |
| 10154903 | Albitov et al. | Dec 2018 | B2 |
| 10154906 | Granada et al. | Dec 2018 | B2 |
| 10159570 | Metchik et al. | Dec 2018 | B1 |
| 10182908 | Tubishevitz et al. | Jan 2019 | B2 |
| 10206668 | Mcgoldrick et al. | Feb 2019 | B2 |
| 10226341 | Gross et al. | Mar 2019 | B2 |
| 10231831 | Hacohen | Mar 2019 | B2 |
| 10231837 | Metchik et al. | Mar 2019 | B1 |
| 10238493 | Metchik et al. | Mar 2019 | B1 |
| 10245143 | Gross et al. | Apr 2019 | B2 |
| 10245144 | Metchik et al. | Apr 2019 | B1 |
| 10258471 | Lutter et al. | Apr 2019 | B2 |
| 10292816 | Raanani et al. | May 2019 | B2 |
| 10299927 | McLean et al. | May 2019 | B2 |
| 10321995 | Christianson et al. | Jun 2019 | B1 |
| 10322020 | Lam et al. | Jun 2019 | B2 |
| 10327895 | Lozonschi et al. | Jun 2019 | B2 |
| 10335278 | McLean et al. | Jul 2019 | B2 |
| 10357360 | Hariton et al. | Jul 2019 | B2 |
| 10376361 | Gross et al. | Aug 2019 | B2 |
| 10390952 | Hariton et al. | Aug 2019 | B2 |
| 10426610 | Hariton et al. | Oct 2019 | B2 |
| 10426614 | Hariton et al. | Oct 2019 | B2 |
| 10449047 | Hariton et al. | Oct 2019 | B2 |
| 10456256 | Braido et al. | Oct 2019 | B2 |
| 10463487 | Hariton et al. | Nov 2019 | B2 |
| 10463488 | Hariton et al. | Nov 2019 | B2 |
| 10492908 | Hammer et al. | Dec 2019 | B2 |
| 10507105 | Hariton et al. | Dec 2019 | B2 |
| 10507108 | Delgado et al. | Dec 2019 | B2 |
| 10507109 | Metchik et al. | Dec 2019 | B2 |
| 10512456 | Hacohen et al. | Dec 2019 | B2 |
| 10517719 | Miller et al. | Dec 2019 | B2 |
| 10524792 | Hernandez et al. | Jan 2020 | B2 |
| 10524903 | Hariton et al. | Jan 2020 | B2 |
| 10524910 | Hammer et al. | Jan 2020 | B2 |
| 10531866 | Hariton et al. | Jan 2020 | B2 |
| 10531872 | Hacohen et al. | Jan 2020 | B2 |
| 10537426 | Iamberger et al. | Jan 2020 | B2 |
| 10548726 | Hacohen et al. | Feb 2020 | B2 |
| 10548731 | Lashinski et al. | Feb 2020 | B2 |
| 10575948 | Iamberger et al. | Mar 2020 | B2 |
| 10595992 | Chambers | Mar 2020 | B2 |
| 10595997 | Metchik et al. | Mar 2020 | B2 |
| 10610358 | Vidlund et al. | Apr 2020 | B2 |
| 10610359 | Hacohen | Apr 2020 | B2 |
| 10631871 | Goldfarb et al. | Apr 2020 | B2 |
| 10631982 | Hammer et al. | Apr 2020 | B2 |
| 10646342 | Marr et al. | May 2020 | B1 |
| 10660751 | Hacohen | May 2020 | B2 |
| 10667908 | Hariton et al. | Jun 2020 | B2 |
| 10667912 | Dixon et al. | Jun 2020 | B2 |
| 10682227 | Hariton et al. | Jun 2020 | B2 |
| 10695177 | Hariton et al. | Jun 2020 | B2 |
| 10702380 | Morriss et al. | Jul 2020 | B2 |
| 10702385 | Hacohen | Jul 2020 | B2 |
| 10722360 | Hariton et al. | Jul 2020 | B2 |
| 10736742 | Hariton et al. | Aug 2020 | B2 |
| 10758342 | Chau et al. | Sep 2020 | B2 |
| 10758344 | Hariton et al. | Sep 2020 | B2 |
| 10779939 | Hariton et al. | Sep 2020 | B2 |
| 10799345 | Hariton et al. | Oct 2020 | B2 |
| 10813760 | Metchik et al. | Oct 2020 | B2 |
| 10820998 | Marr et al. | Nov 2020 | B2 |
| 10842627 | Delgado et al. | Nov 2020 | B2 |
| 10849748 | Hariton et al. | Dec 2020 | B2 |
| 10856972 | Hariton et al. | Dec 2020 | B2 |
| 10856975 | Hariton et al. | Dec 2020 | B2 |
| 10856978 | Straubinger et al. | Dec 2020 | B2 |
| 10864078 | Hariton et al. | Dec 2020 | B2 |
| 10874514 | Dixon et al. | Dec 2020 | B2 |
| 10881511 | Hariton et al. | Jan 2021 | B2 |
| 10888421 | Hariton et al. | Jan 2021 | B2 |
| 10888422 | Hariton et al. | Jan 2021 | B2 |
| 10888425 | Delgado et al. | Jan 2021 | B2 |
| 10888644 | Ratz et al. | Jan 2021 | B2 |
| 10905548 | Hariton et al. | Feb 2021 | B2 |
| 10905549 | Hariton et al. | Feb 2021 | B2 |
| 10905552 | Dixon et al. | Feb 2021 | B2 |
| 10905554 | Cao | Feb 2021 | B2 |
| 10918481 | Hariton et al. | Feb 2021 | B2 |
| 10918483 | Metchik et al. | Feb 2021 | B2 |
| 10925595 | Hacohen et al. | Feb 2021 | B2 |
| 10925732 | Delgado et al. | Feb 2021 | B2 |
| 10945843 | Delgado et al. | Mar 2021 | B2 |
| 10945844 | McCann et al. | Mar 2021 | B2 |
| 10952850 | Hariton et al. | Mar 2021 | B2 |
| 10959846 | Marr et al. | Mar 2021 | B2 |
| 10973636 | Hariton et al. | Apr 2021 | B2 |
| 10993809 | McCann et al. | May 2021 | B2 |
| 11065114 | Raanani et al. | Jul 2021 | B2 |
| 11083582 | McCann et al. | Aug 2021 | B2 |
| 11147672 | McCann et al. | Oct 2021 | B2 |
| 11179240 | Delgado et al. | Nov 2021 | B2 |
| 11291545 | Hacohen | Apr 2022 | B2 |
| 11291546 | Gross et al. | Apr 2022 | B2 |
| 11291547 | Gross et al. | Apr 2022 | B2 |
| 11291844 | Gross | Apr 2022 | B2 |
| 11304805 | Hariton et al. | Apr 2022 | B2 |
| 11304806 | Hariton et al. | Apr 2022 | B2 |
| 11389297 | Franklin et al. | Jul 2022 | B2 |
| 11426155 | Hacohen et al. | Aug 2022 | B2 |
| 11517429 | Gross et al. | Dec 2022 | B2 |
| 11517436 | Hacohen | Dec 2022 | B2 |
| 11571298 | Hariton et al. | Feb 2023 | B2 |
| 20010002445 | Vesely | May 2001 | A1 |
| 20010005787 | Oz et al. | Jun 2001 | A1 |
| 20010021872 | Bailey et al. | Sep 2001 | A1 |
| 20010021874 | Carpentier et al. | Sep 2001 | A1 |
| 20010044656 | Williamson et al. | Nov 2001 | A1 |
| 20010056295 | Solem | Dec 2001 | A1 |
| 20020013571 | Goldfarb et al. | Jan 2002 | A1 |
| 20020022862 | Grafton et al. | Feb 2002 | A1 |
| 20020029080 | Mortier et al. | Mar 2002 | A1 |
| 20020032481 | Gabbay | Mar 2002 | A1 |
| 20020042621 | Liddicoat et al. | Apr 2002 | A1 |
| 20020082525 | Oslund et al. | Jun 2002 | A1 |
| 20020087048 | Brock et al. | Jul 2002 | A1 |
| 20020099436 | Thornton et al. | Jul 2002 | A1 |
| 20020103532 | Langberg et al. | Aug 2002 | A1 |
| 20020151916 | Muramatsu et al. | Oct 2002 | A1 |
| 20020151961 | Lashinski et al. | Oct 2002 | A1 |
| 20020151970 | Garrison et al. | Oct 2002 | A1 |
| 20020169358 | Mortier et al. | Nov 2002 | A1 |
| 20020173841 | Ortiz et al. | Nov 2002 | A1 |
| 20020177894 | Acosta et al. | Nov 2002 | A1 |
| 20020177904 | Huxel et al. | Nov 2002 | A1 |
| 20020198586 | Inoue | Dec 2002 | A1 |
| 20030009236 | Godin | Jan 2003 | A1 |
| 20030018358 | Saadat | Jan 2003 | A1 |
| 20030036791 | Philipp et al. | Feb 2003 | A1 |
| 20030050693 | Quijano et al. | Mar 2003 | A1 |
| 20030050694 | Yang et al. | Mar 2003 | A1 |
| 20030060846 | Egnelov et al. | Mar 2003 | A1 |
| 20030060875 | Wittens | Mar 2003 | A1 |
| 20030069635 | Cartledge | Apr 2003 | A1 |
| 20030074052 | Besselink | Apr 2003 | A1 |
| 20030074059 | Nguyen et al. | Apr 2003 | A1 |
| 20030078465 | Pai et al. | Apr 2003 | A1 |
| 20030078653 | Vesely et al. | Apr 2003 | A1 |
| 20030083742 | Spence et al. | May 2003 | A1 |
| 20030100943 | Bolduc | May 2003 | A1 |
| 20030105519 | Fasol et al. | Jun 2003 | A1 |
| 20030114901 | Loeb et al. | Jun 2003 | A1 |
| 20030130731 | Vidlund et al. | Jul 2003 | A1 |
| 20030158578 | Pantages et al. | Aug 2003 | A1 |
| 20030167062 | Gambale et al. | Sep 2003 | A1 |
| 20030171760 | Gambale | Sep 2003 | A1 |
| 20030191528 | Quijano et al. | Oct 2003 | A1 |
| 20030199974 | Lee et al. | Oct 2003 | A1 |
| 20030204195 | Keane et al. | Oct 2003 | A1 |
| 20030229350 | Kay | Dec 2003 | A1 |
| 20030229395 | Cox | Dec 2003 | A1 |
| 20030233142 | Morales et al. | Dec 2003 | A1 |
| 20040010272 | Manetakis et al. | Jan 2004 | A1 |
| 20040019377 | Taylor et al. | Jan 2004 | A1 |
| 20040024451 | Johnson et al. | Feb 2004 | A1 |
| 20040030382 | St. Goar et al. | Feb 2004 | A1 |
| 20040039414 | Carley et al. | Feb 2004 | A1 |
| 20040039436 | Spenser et al. | Feb 2004 | A1 |
| 20040039442 | St. Goar et al. | Feb 2004 | A1 |
| 20040049207 | Goldfarb et al. | Mar 2004 | A1 |
| 20040059413 | Argento | Mar 2004 | A1 |
| 20040092962 | Thornton et al. | May 2004 | A1 |
| 20040093060 | Seguin et al. | May 2004 | A1 |
| 20040122448 | Levine | Jun 2004 | A1 |
| 20040122503 | Campbell et al. | Jun 2004 | A1 |
| 20040122514 | Fogarty et al. | Jun 2004 | A1 |
| 20040127982 | Machold et al. | Jul 2004 | A1 |
| 20040127983 | Mortier et al. | Jul 2004 | A1 |
| 20040133220 | Lashinski et al. | Jul 2004 | A1 |
| 20040133267 | Lane | Jul 2004 | A1 |
| 20040133274 | Webler et al. | Jul 2004 | A1 |
| 20040133374 | Kattan | Jul 2004 | A1 |
| 20040138744 | Lashinski et al. | Jul 2004 | A1 |
| 20040138745 | Macoviak et al. | Jul 2004 | A1 |
| 20040143315 | Bruun et al. | Jul 2004 | A1 |
| 20040148019 | Vidlund et al. | Jul 2004 | A1 |
| 20040148020 | Vidlund et al. | Jul 2004 | A1 |
| 20040148021 | Cartledge et al. | Jul 2004 | A1 |
| 20040153146 | Lashinski et al. | Aug 2004 | A1 |
| 20040172046 | Hlavka et al. | Sep 2004 | A1 |
| 20040176788 | Opolski | Sep 2004 | A1 |
| 20040176839 | Huynh et al. | Sep 2004 | A1 |
| 20040181287 | Gellman | Sep 2004 | A1 |
| 20040186558 | Pavcnik et al. | Sep 2004 | A1 |
| 20040186565 | Schreck | Sep 2004 | A1 |
| 20040186566 | Hindrichs et al. | Sep 2004 | A1 |
| 20040210244 | Vargas et al. | Oct 2004 | A1 |
| 20040210304 | Seguin et al. | Oct 2004 | A1 |
| 20040220593 | Greenhalgh | Nov 2004 | A1 |
| 20040225354 | Allen et al. | Nov 2004 | A1 |
| 20040236354 | Seguin | Nov 2004 | A1 |
| 20040236419 | Milo | Nov 2004 | A1 |
| 20040249433 | Freitag | Dec 2004 | A1 |
| 20040249453 | Cartledge et al. | Dec 2004 | A1 |
| 20040260317 | Bloom et al. | Dec 2004 | A1 |
| 20040260389 | Case et al. | Dec 2004 | A1 |
| 20040260393 | Rahdert et al. | Dec 2004 | A1 |
| 20040260394 | Douk et al. | Dec 2004 | A1 |
| 20040267358 | Reitan | Dec 2004 | A1 |
| 20050004668 | Aklog et al. | Jan 2005 | A1 |
| 20050010287 | Macoviak et al. | Jan 2005 | A1 |
| 20050010787 | Tarbouriech | Jan 2005 | A1 |
| 20050016560 | Voughlohn | Jan 2005 | A1 |
| 20050021056 | St. Goar et al. | Jan 2005 | A1 |
| 20050027305 | Shiu et al. | Feb 2005 | A1 |
| 20050027348 | Case et al. | Feb 2005 | A1 |
| 20050038494 | Eidenschink | Feb 2005 | A1 |
| 20050055038 | Kelleher et al. | Mar 2005 | A1 |
| 20050055086 | Stobie | Mar 2005 | A1 |
| 20050055087 | Starksen | Mar 2005 | A1 |
| 20050060030 | Lashinski et al. | Mar 2005 | A1 |
| 20050065601 | Lee et al. | Mar 2005 | A1 |
| 20050070999 | Spence | Mar 2005 | A1 |
| 20050075726 | Svanidze et al. | Apr 2005 | A1 |
| 20050075727 | Wheatley | Apr 2005 | A1 |
| 20050075731 | Artof et al. | Apr 2005 | A1 |
| 20050080430 | Wright et al. | Apr 2005 | A1 |
| 20050080474 | Andreas et al. | Apr 2005 | A1 |
| 20050085900 | Case et al. | Apr 2005 | A1 |
| 20050085903 | Lau | Apr 2005 | A1 |
| 20050090827 | Gedebou | Apr 2005 | A1 |
| 20050096740 | Langberg et al. | May 2005 | A1 |
| 20050107871 | Realyvasquez et al. | May 2005 | A1 |
| 20050119734 | Spence et al. | Jun 2005 | A1 |
| 20050125002 | Baran et al. | Jun 2005 | A1 |
| 20050125011 | Spence et al. | Jun 2005 | A1 |
| 20050131533 | Alfieri et al. | Jun 2005 | A1 |
| 20050137681 | Shoemaker et al. | Jun 2005 | A1 |
| 20050137686 | Salahieh et al. | Jun 2005 | A1 |
| 20050137688 | Salahieh et al. | Jun 2005 | A1 |
| 20050137689 | Salahieh et al. | Jun 2005 | A1 |
| 20050137690 | Salahieh et al. | Jun 2005 | A1 |
| 20050137691 | Salahieh et al. | Jun 2005 | A1 |
| 20050137692 | Haug et al. | Jun 2005 | A1 |
| 20050137693 | Haug et al. | Jun 2005 | A1 |
| 20050137695 | Salahieh et al. | Jun 2005 | A1 |
| 20050137697 | Salahieh et al. | Jun 2005 | A1 |
| 20050137699 | Salahieh et al. | Jun 2005 | A1 |
| 20050143809 | Salahieh et al. | Jun 2005 | A1 |
| 20050149160 | McFerran | Jul 2005 | A1 |
| 20050154443 | Linder et al. | Jul 2005 | A1 |
| 20050159728 | Armour et al. | Jul 2005 | A1 |
| 20050171601 | Cosgrove et al. | Aug 2005 | A1 |
| 20050177180 | Kaganov et al. | Aug 2005 | A1 |
| 20050177228 | Solem et al. | Aug 2005 | A1 |
| 20050182483 | Osborne et al. | Aug 2005 | A1 |
| 20050182486 | Gabbay | Aug 2005 | A1 |
| 20050187613 | Bolduc et al. | Aug 2005 | A1 |
| 20050192596 | Jugenheimer et al. | Sep 2005 | A1 |
| 20050197695 | Stacchino et al. | Sep 2005 | A1 |
| 20050197696 | Gomez Duran | Sep 2005 | A1 |
| 20050203549 | Realyvasquez | Sep 2005 | A1 |
| 20050203606 | VanCamp | Sep 2005 | A1 |
| 20050203618 | Sharkawy et al. | Sep 2005 | A1 |
| 20050216039 | Lederman | Sep 2005 | A1 |
| 20050216079 | MaCoviak | Sep 2005 | A1 |
| 20050222665 | Aranyi | Oct 2005 | A1 |
| 20050222678 | Lashinski et al. | Oct 2005 | A1 |
| 20050234508 | Cummins et al. | Oct 2005 | A1 |
| 20050240200 | Bergheim | Oct 2005 | A1 |
| 20050251251 | Cribier | Nov 2005 | A1 |
| 20050256532 | Nayak et al. | Nov 2005 | A1 |
| 20050256566 | Gabbay | Nov 2005 | A1 |
| 20050267478 | Corradi et al. | Dec 2005 | A1 |
| 20050267573 | Macoviak et al. | Dec 2005 | A9 |
| 20050273138 | To et al. | Dec 2005 | A1 |
| 20050288776 | Shaoulian et al. | Dec 2005 | A1 |
| 20050288778 | Shaoulian et al. | Dec 2005 | A1 |
| 20050288781 | Moaddeb et al. | Dec 2005 | A1 |
| 20060004439 | Spenser et al. | Jan 2006 | A1 |
| 20060004442 | Spenser et al. | Jan 2006 | A1 |
| 20060004443 | Liddicoat et al. | Jan 2006 | A1 |
| 20060004469 | Sokel | Jan 2006 | A1 |
| 20060015171 | Armstrong | Jan 2006 | A1 |
| 20060020275 | Goldfarb et al. | Jan 2006 | A1 |
| 20060020326 | Bolduc et al. | Jan 2006 | A9 |
| 20060020327 | Lashinski et al. | Jan 2006 | A1 |
| 20060020333 | Lashinski et al. | Jan 2006 | A1 |
| 20060020336 | Liddicoat | Jan 2006 | A1 |
| 20060025787 | Morales et al. | Feb 2006 | A1 |
| 20060025855 | Lashinski et al. | Feb 2006 | A1 |
| 20060025858 | Alameddine | Feb 2006 | A1 |
| 20060030885 | Hyde | Feb 2006 | A1 |
| 20060041189 | Vancaillie | Feb 2006 | A1 |
| 20060041319 | Taylor et al. | Feb 2006 | A1 |
| 20060052867 | Revuelta et al. | Mar 2006 | A1 |
| 20060052868 | Mortier | Mar 2006 | A1 |
| 20060058871 | Zakay et al. | Mar 2006 | A1 |
| 20060069429 | Spence et al. | Mar 2006 | A1 |
| 20060074486 | Liddicoat et al. | Apr 2006 | A1 |
| 20060085012 | Dolan | Apr 2006 | A1 |
| 20060089627 | Burnett et al. | Apr 2006 | A1 |
| 20060095009 | Lampropoulos et al. | May 2006 | A1 |
| 20060106423 | Weisel et al. | May 2006 | A1 |
| 20060111773 | Rittgers et al. | May 2006 | A1 |
| 20060116750 | Herbert et al. | Jun 2006 | A1 |
| 20060116757 | Lashinski et al. | Jun 2006 | A1 |
| 20060122692 | Gilad et al. | Jun 2006 | A1 |
| 20060129166 | Lavelle | Jun 2006 | A1 |
| 20060135964 | Vesley | Jun 2006 | A1 |
| 20060149280 | Harvine et al. | Jul 2006 | A1 |
| 20060149368 | Spence | Jul 2006 | A1 |
| 20060155357 | Melsheimer | Jul 2006 | A1 |
| 20060161250 | Shaw | Jul 2006 | A1 |
| 20060161265 | Levine et al. | Jul 2006 | A1 |
| 20060047297 | Case | Aug 2006 | A1 |
| 20060178700 | Quinn | Aug 2006 | A1 |
| 20060178740 | Stacchino et al. | Aug 2006 | A1 |
| 20060184203 | Martin et al. | Aug 2006 | A1 |
| 20060184240 | Jimenez et al. | Aug 2006 | A1 |
| 20060184242 | Lichtenstein | Aug 2006 | A1 |
| 20060190036 | Wendel et al. | Aug 2006 | A1 |
| 20060190038 | Carley et al. | Aug 2006 | A1 |
| 20060195134 | Crittenden | Aug 2006 | A1 |
| 20060195183 | Navia et al. | Aug 2006 | A1 |
| 20060195184 | Lane et al. | Aug 2006 | A1 |
| 20060201519 | Frazier et al. | Sep 2006 | A1 |
| 20060212111 | Case et al. | Sep 2006 | A1 |
| 20060216404 | Seyler et al. | Sep 2006 | A1 |
| 20060229708 | Powell et al. | Oct 2006 | A1 |
| 20060241622 | Zergiebel | Oct 2006 | A1 |
| 20060241656 | Starksen et al. | Oct 2006 | A1 |
| 20060241745 | Solem | Oct 2006 | A1 |
| 20060241748 | Lee et al. | Oct 2006 | A1 |
| 20060247680 | Amplatz et al. | Nov 2006 | A1 |
| 20060247763 | Slater | Nov 2006 | A1 |
| 20060253191 | Salahieh et al. | Nov 2006 | A1 |
| 20060259135 | Navia et al. | Nov 2006 | A1 |
| 20060259136 | Nguyen et al. | Nov 2006 | A1 |
| 20060259137 | Artof et al. | Nov 2006 | A1 |
| 20060271166 | Thill et al. | Nov 2006 | A1 |
| 20060271171 | McQuinn et al. | Nov 2006 | A1 |
| 20060271175 | Woolfson | Nov 2006 | A1 |
| 20060282150 | Olson et al. | Dec 2006 | A1 |
| 20060282161 | Huyn et al. | Dec 2006 | A1 |
| 20060287661 | Bolduc et al. | Dec 2006 | A1 |
| 20060287716 | Banbury et al. | Dec 2006 | A1 |
| 20060287719 | Rowe et al. | Dec 2006 | A1 |
| 20070001627 | Lin et al. | Jan 2007 | A1 |
| 20070008018 | Nagashima et al. | Jan 2007 | A1 |
| 20070016286 | Herrmann et al. | Jan 2007 | A1 |
| 20070016287 | Cartledge et al. | Jan 2007 | A1 |
| 20070016288 | Gurskis et al. | Jan 2007 | A1 |
| 20070021781 | Jervis et al. | Jan 2007 | A1 |
| 20070027528 | Agnew | Feb 2007 | A1 |
| 20070027533 | Douk | Feb 2007 | A1 |
| 20070027536 | Mihaljevic et al. | Feb 2007 | A1 |
| 20070027549 | Godin | Feb 2007 | A1 |
| 20070038221 | Fine et al. | Feb 2007 | A1 |
| 20070038293 | St. Goar et al. | Feb 2007 | A1 |
| 20070038295 | Case et al. | Feb 2007 | A1 |
| 20070043435 | Seguin et al. | Feb 2007 | A1 |
| 20070049942 | Hindrichs et al. | Mar 2007 | A1 |
| 20070049970 | Belef et al. | Mar 2007 | A1 |
| 20070051377 | Douk et al. | Mar 2007 | A1 |
| 20070055206 | To et al. | Mar 2007 | A1 |
| 20070055340 | Pryor | Mar 2007 | A1 |
| 20070056346 | Spenser et al. | Mar 2007 | A1 |
| 20070061010 | Hauser et al. | Mar 2007 | A1 |
| 20070066863 | Rafiee et al. | Mar 2007 | A1 |
| 20070078297 | Rafiee et al. | Apr 2007 | A1 |
| 20070078510 | Ryan | Apr 2007 | A1 |
| 20070080188 | Spence et al. | Apr 2007 | A1 |
| 20070083168 | Whiting et al. | Apr 2007 | A1 |
| 20070106328 | Wardle et al. | May 2007 | A1 |
| 20070112359 | Kimura et al. | May 2007 | A1 |
| 20070112422 | Dehdashtian | May 2007 | A1 |
| 20070112425 | Schaller et al. | May 2007 | A1 |
| 20070118151 | Davidson | May 2007 | A1 |
| 20070118154 | Crabtree | May 2007 | A1 |
| 20070118213 | Loulmet | May 2007 | A1 |
| 20070118215 | Moaddeb | May 2007 | A1 |
| 20070142907 | Moaddeb et al. | Jun 2007 | A1 |
| 20070162103 | Case et al. | Jul 2007 | A1 |
| 20070162107 | Haug et al. | Jul 2007 | A1 |
| 20070162111 | Fukamachi et al. | Jul 2007 | A1 |
| 20070173932 | Cali et al. | Jul 2007 | A1 |
| 20070197858 | Goldfarb et al. | Aug 2007 | A1 |
| 20070198077 | Cully et al. | Aug 2007 | A1 |
| 20070198082 | Kapadia et al. | Aug 2007 | A1 |
| 20070198097 | Zegdi | Aug 2007 | A1 |
| 20070208550 | Cao et al. | Sep 2007 | A1 |
| 20070213582 | Zollinger et al. | Sep 2007 | A1 |
| 20070213810 | Newhauser et al. | Sep 2007 | A1 |
| 20070213813 | Von Segesser et al. | Sep 2007 | A1 |
| 20070219558 | Deutsch | Sep 2007 | A1 |
| 20070219630 | Chu | Sep 2007 | A1 |
| 20070225759 | Thommen et al. | Sep 2007 | A1 |
| 20070225760 | Moszner et al. | Sep 2007 | A1 |
| 20070233186 | Meng | Oct 2007 | A1 |
| 20070233237 | Krivoruchko | Oct 2007 | A1 |
| 20070233239 | Navia et al. | Oct 2007 | A1 |
| 20070239208 | Crawford | Oct 2007 | A1 |
| 20070239272 | Navia et al. | Oct 2007 | A1 |
| 20070239273 | Allen | Oct 2007 | A1 |
| 20070244546 | Francis | Oct 2007 | A1 |
| 20070244555 | Rafiee et al. | Oct 2007 | A1 |
| 20070244556 | Rafiee et al. | Oct 2007 | A1 |
| 20070244557 | Rafiee et al. | Oct 2007 | A1 |
| 20070250160 | Rafiee | Oct 2007 | A1 |
| 20070255397 | Ryan et al. | Nov 2007 | A1 |
| 20070255400 | Parravicini et al. | Nov 2007 | A1 |
| 20070270755 | Von Oepen et al. | Nov 2007 | A1 |
| 20070270943 | Solem et al. | Nov 2007 | A1 |
| 20070276437 | Call et al. | Nov 2007 | A1 |
| 20070282375 | Hindrichs et al. | Dec 2007 | A1 |
| 20070282429 | Hauser et al. | Dec 2007 | A1 |
| 20070295172 | Swartz | Dec 2007 | A1 |
| 20070299424 | Cumming et al. | Dec 2007 | A1 |
| 20080004688 | Spenser et al. | Jan 2008 | A1 |
| 20080004697 | Lichtenstein et al. | Jan 2008 | A1 |
| 20080027483 | Cartledge et al. | Jan 2008 | A1 |
| 20080027555 | Hawkins | Jan 2008 | A1 |
| 20080035160 | Woodson et al. | Feb 2008 | A1 |
| 20080039935 | Buch | Feb 2008 | A1 |
| 20080051703 | Thornton et al. | Feb 2008 | A1 |
| 20080058595 | Snoke et al. | Mar 2008 | A1 |
| 20080065011 | Marchand et al. | Mar 2008 | A1 |
| 20080065204 | Mackoviak et al. | Mar 2008 | A1 |
| 20080071361 | Tuval et al. | Mar 2008 | A1 |
| 20080071363 | Tuval et al. | Mar 2008 | A1 |
| 20080071366 | Tuval et al. | Mar 2008 | A1 |
| 20080071369 | Tuval et al. | Mar 2008 | A1 |
| 20080077235 | Kirson | Mar 2008 | A1 |
| 20080082083 | Forde et al. | Apr 2008 | A1 |
| 20080082159 | Tseng et al. | Apr 2008 | A1 |
| 20080082166 | Styrc et al. | Apr 2008 | A1 |
| 20080086138 | Stone et al. | Apr 2008 | A1 |
| 20080086164 | Rowe et al. | Apr 2008 | A1 |
| 20080086203 | Roberts | Apr 2008 | A1 |
| 20080086204 | Rankin | Apr 2008 | A1 |
| 20080091257 | Andreas et al. | Apr 2008 | A1 |
| 20080091261 | Long et al. | Apr 2008 | A1 |
| 20080097523 | Bolduc et al. | Apr 2008 | A1 |
| 20080097595 | Gabbay | Apr 2008 | A1 |
| 20080132989 | Snow et al. | Jun 2008 | A1 |
| 20080140003 | Bei et al. | Jun 2008 | A1 |
| 20080140116 | Bonutti | Jun 2008 | A1 |
| 20080147182 | Righini et al. | Jun 2008 | A1 |
| 20080161910 | Revuelta et al. | Jul 2008 | A1 |
| 20080167705 | Agnew | Jul 2008 | A1 |
| 20080167714 | St. Goar et al. | Jul 2008 | A1 |
| 20080188929 | Schreck | Aug 2008 | A1 |
| 20080195126 | Solem | Aug 2008 | A1 |
| 20080195200 | Vidlund et al. | Aug 2008 | A1 |
| 20080200980 | Robin et al. | Aug 2008 | A1 |
| 20080208265 | Frazier et al. | Aug 2008 | A1 |
| 20080208328 | Antocci et al. | Aug 2008 | A1 |
| 20080208330 | Keranen | Aug 2008 | A1 |
| 20080208332 | Lamphere et al. | Aug 2008 | A1 |
| 20080221672 | Lamphere et al. | Sep 2008 | A1 |
| 20080234813 | Heuser | Sep 2008 | A1 |
| 20080234814 | Salahieh et al. | Sep 2008 | A1 |
| 20080243245 | Thambar et al. | Oct 2008 | A1 |
| 20080255580 | Hoffman et al. | Oct 2008 | A1 |
| 20080262609 | Gross et al. | Oct 2008 | A1 |
| 20080269879 | Sathe et al. | Oct 2008 | A1 |
| 20080275300 | Rothe et al. | Nov 2008 | A1 |
| 20080275469 | Fanton et al. | Nov 2008 | A1 |
| 20080275551 | Alfieri | Nov 2008 | A1 |
| 20080281411 | Berreklouw | Nov 2008 | A1 |
| 20080288044 | Osborne | Nov 2008 | A1 |
| 20080288062 | Andrieu et al. | Nov 2008 | A1 |
| 20080294234 | Hartley et al. | Nov 2008 | A1 |
| 20080294248 | Yang et al. | Nov 2008 | A1 |
| 20080300629 | Surti | Dec 2008 | A1 |
| 20090005863 | Goetz et al. | Jan 2009 | A1 |
| 20090036966 | O'Connor et al. | Feb 2009 | A1 |
| 20090043153 | Zollinger et al. | Feb 2009 | A1 |
| 20090043381 | Macoviak et al. | Feb 2009 | A1 |
| 20090054969 | Salahieh et al. | Feb 2009 | A1 |
| 20090062866 | Jackson | Mar 2009 | A1 |
| 20090076586 | Hauser et al. | Mar 2009 | A1 |
| 20090076600 | Quinn | Mar 2009 | A1 |
| 20090082844 | Zacharias et al. | Mar 2009 | A1 |
| 20090088836 | Bishop et al. | Apr 2009 | A1 |
| 20090088837 | Gillinov et al. | Apr 2009 | A1 |
| 20090099554 | Forster et al. | Apr 2009 | A1 |
| 20090099650 | Bolduc et al. | Apr 2009 | A1 |
| 20090105794 | Ziarno et al. | Apr 2009 | A1 |
| 20090105816 | Olsen et al. | Apr 2009 | A1 |
| 20090112159 | Slattery et al. | Apr 2009 | A1 |
| 20090125098 | Chuter | May 2009 | A1 |
| 20090125102 | Cartledge | May 2009 | A1 |
| 20090149872 | Gross et al. | Jun 2009 | A1 |
| 20090157175 | Benichou | Jun 2009 | A1 |
| 20090163934 | Raschdorf, Jr. et al. | Jun 2009 | A1 |
| 20090177274 | Scorsin et al. | Jun 2009 | A1 |
| 20090171363 | Chocron | Jul 2009 | A1 |
| 20090171439 | Nissl | Jul 2009 | A1 |
| 20090177266 | Powell et al. | Jul 2009 | A1 |
| 20090177277 | Milo | Jul 2009 | A1 |
| 20090177278 | Spence | Jul 2009 | A1 |
| 20090192601 | Rafiee et al. | Jul 2009 | A1 |
| 20090210052 | Forster et al. | Aug 2009 | A1 |
| 20090222081 | Linder et al. | Sep 2009 | A1 |
| 20090240320 | Tuval et al. | Sep 2009 | A1 |
| 20090241656 | Jacquemin | Oct 2009 | A1 |
| 20090248143 | Laham | Oct 2009 | A1 |
| 20090248148 | Shaolian et al. | Oct 2009 | A1 |
| 20090254103 | Deustch | Oct 2009 | A1 |
| 20090259306 | Rowe | Oct 2009 | A1 |
| 20090259307 | Gross et al. | Oct 2009 | A1 |
| 20090264859 | Mas | Oct 2009 | A1 |
| 20090264994 | Saadat | Oct 2009 | A1 |
| 20090264995 | Subramanian | Oct 2009 | A1 |
| 20090276040 | Rowe et al. | Nov 2009 | A1 |
| 20090281619 | Le et al. | Nov 2009 | A1 |
| 20090287299 | Tabor et al. | Nov 2009 | A1 |
| 20090287304 | Dahlgren et al. | Nov 2009 | A1 |
| 20090299409 | Coe et al. | Dec 2009 | A1 |
| 20090299449 | Styrc | Dec 2009 | A1 |
| 20090306768 | Quardi | Dec 2009 | A1 |
| 20090319037 | Rowe et al. | Dec 2009 | A1 |
| 20090326648 | Machold et al. | Dec 2009 | A1 |
| 20100001038 | Levin et al. | Jan 2010 | A1 |
| 20100010538 | Juravic et al. | Jan 2010 | A1 |
| 20100022823 | Goldfarb et al. | Jan 2010 | A1 |
| 20100023117 | Yoganathan et al. | Jan 2010 | A1 |
| 20100023118 | Medlock et al. | Jan 2010 | A1 |
| 20100023120 | Holecek et al. | Jan 2010 | A1 |
| 20100030014 | Ferrazzi | Feb 2010 | A1 |
| 20100036479 | Hill et al. | Feb 2010 | A1 |
| 20100036484 | Hariton et al. | Feb 2010 | A1 |
| 20100042147 | Janovsky et al. | Feb 2010 | A1 |
| 20100049306 | House et al. | Feb 2010 | A1 |
| 20100049313 | Alon et al. | Feb 2010 | A1 |
| 20100063542 | Van der Burg et al. | Mar 2010 | A1 |
| 20100063550 | Felix et al. | Mar 2010 | A1 |
| 20100063586 | Hasenkam et al. | Mar 2010 | A1 |
| 20100069852 | Kelley | Mar 2010 | A1 |
| 20100076499 | McNamara et al. | Mar 2010 | A1 |
| 20100076548 | Konno | Mar 2010 | A1 |
| 20100082094 | Quadri et al. | Apr 2010 | A1 |
| 20100094248 | Nguyen et al. | Apr 2010 | A1 |
| 20100100167 | Bortlein et al. | Apr 2010 | A1 |
| 20100114180 | Rock | May 2010 | A1 |
| 20100114299 | Ben-Muvhar et al. | May 2010 | A1 |
| 20100121349 | Meier | May 2010 | A1 |
| 20100130992 | Machold et al. | May 2010 | A1 |
| 20100131054 | Tuval et al. | May 2010 | A1 |
| 20100137979 | Tuval et al. | Jun 2010 | A1 |
| 20100152845 | Bloom et al. | Jun 2010 | A1 |
| 20100160958 | Clark | Jun 2010 | A1 |
| 20100161036 | Pintor et al. | Jun 2010 | A1 |
| 20100161041 | Maisano et al. | Jun 2010 | A1 |
| 20100161042 | Maisano et al. | Jun 2010 | A1 |
| 20100161043 | Maisano et al. | Jun 2010 | A1 |
| 20100161047 | Cabiri | Jun 2010 | A1 |
| 20100168845 | Wright | Jul 2010 | A1 |
| 20100174358 | Rabkin et al. | Jul 2010 | A1 |
| 20100174363 | Castro | Jul 2010 | A1 |
| 20100179574 | Longoria et al. | Jul 2010 | A1 |
| 20100179643 | Shalev | Jul 2010 | A1 |
| 20100179648 | Richter et al. | Jul 2010 | A1 |
| 20100179649 | Richter et al. | Jul 2010 | A1 |
| 20100185277 | Braido et al. | Jul 2010 | A1 |
| 20100198347 | Zakay et al. | Aug 2010 | A1 |
| 20100217382 | Chau et al. | Aug 2010 | A1 |
| 20100222810 | DeBeer et al. | Sep 2010 | A1 |
| 20100228285 | Miles et al. | Sep 2010 | A1 |
| 20100234935 | Bashiri et al. | Sep 2010 | A1 |
| 20100234940 | Dolan | Sep 2010 | A1 |
| 20100249908 | Chau et al. | Sep 2010 | A1 |
| 20100249915 | Zhang | Sep 2010 | A1 |
| 20100249917 | Zhang | Sep 2010 | A1 |
| 20100249920 | Bolling et al. | Sep 2010 | A1 |
| 20100256737 | Pollock et al. | Oct 2010 | A1 |
| 20100262232 | Annest | Oct 2010 | A1 |
| 20100262233 | He | Oct 2010 | A1 |
| 20100280603 | Maisano et al. | Nov 2010 | A1 |
| 20100280604 | Zipory et al. | Nov 2010 | A1 |
| 20100280605 | Hammer et al. | Nov 2010 | A1 |
| 20100280606 | Naor | Nov 2010 | A1 |
| 20100286628 | Gross | Nov 2010 | A1 |
| 20100286767 | Zipory et al. | Nov 2010 | A1 |
| 20100305475 | Hinchliffe et al. | Dec 2010 | A1 |
| 20100312333 | Navia et al. | Dec 2010 | A1 |
| 20100324595 | Linder et al. | Dec 2010 | A1 |
| 20100331971 | Keränen et al. | Dec 2010 | A1 |
| 20110004210 | Johnson et al. | Jan 2011 | A1 |
| 20110004227 | Goldfarb et al. | Jan 2011 | A1 |
| 20110004296 | Lutter et al. | Jan 2011 | A1 |
| 20110004298 | Lee et al. | Jan 2011 | A1 |
| 20110004299 | Navia et al. | Jan 2011 | A1 |
| 20110011917 | Loulmet | Jan 2011 | A1 |
| 20110015729 | Jimenez et al. | Jan 2011 | A1 |
| 20110015731 | Carpentier et al. | Jan 2011 | A1 |
| 20110015739 | Cheung et al. | Jan 2011 | A1 |
| 20110021985 | Spargias | Jan 2011 | A1 |
| 20110022165 | Oba et al. | Jan 2011 | A1 |
| 20110178597 | Navia et al. | Jan 2011 | A9 |
| 20110026208 | Otsuro et al. | Feb 2011 | A1 |
| 20110029066 | Gilad et al. | Feb 2011 | A1 |
| 20110029067 | Mcguckin, Jr. et al. | Feb 2011 | A1 |
| 20110029072 | Gabbay | Feb 2011 | A1 |
| 20110035000 | Nieminen et al. | Feb 2011 | A1 |
| 20110040374 | Goetz et al. | Feb 2011 | A1 |
| 20110040375 | Letac et al. | Feb 2011 | A1 |
| 20110046662 | Moszner et al. | Feb 2011 | A1 |
| 20110054466 | Rothstein et al. | Mar 2011 | A1 |
| 20110054596 | Taylor | Mar 2011 | A1 |
| 20110054598 | Johnson | Mar 2011 | A1 |
| 20110066231 | Cartledge et al. | Mar 2011 | A1 |
| 20110066233 | Thornton et al. | Mar 2011 | A1 |
| 20110067770 | Pederson et al. | Mar 2011 | A1 |
| 20110071626 | Wright et al. | Mar 2011 | A1 |
| 20110077730 | Fentster | Mar 2011 | A1 |
| 20110082538 | Dahlgren et al. | Apr 2011 | A1 |
| 20110087146 | Ryan et al. | Apr 2011 | A1 |
| 20110087322 | Letac et al. | Apr 2011 | A1 |
| 20110093002 | Rucker et al. | Apr 2011 | A1 |
| 20110093063 | Schreck | Apr 2011 | A1 |
| 20110098525 | Kermode et al. | Apr 2011 | A1 |
| 20110098802 | Braido et al. | Apr 2011 | A1 |
| 20110106245 | Miller et al. | May 2011 | A1 |
| 20110106247 | Miller et al. | May 2011 | A1 |
| 20110112625 | Ben-Muvhar et al. | May 2011 | A1 |
| 20110112632 | Chau et al. | May 2011 | A1 |
| 20110113768 | Bauer et al. | May 2011 | A1 |
| 20110118830 | Liddicoat et al. | May 2011 | A1 |
| 20110118832 | Punjabi | May 2011 | A1 |
| 20110125257 | Seguin et al. | May 2011 | A1 |
| 20110125258 | Centola | May 2011 | A1 |
| 20110137326 | Bachman | Jun 2011 | A1 |
| 20110137397 | Chau et al. | Jun 2011 | A1 |
| 20110137409 | Yang et al. | Jun 2011 | A1 |
| 20110137410 | Hacohen | Jun 2011 | A1 |
| 20110144703 | Krause et al. | Jun 2011 | A1 |
| 20110144742 | Madrid et al. | Jun 2011 | A1 |
| 20110166636 | Rowe | Jul 2011 | A1 |
| 20110166649 | Gross et al. | Jul 2011 | A1 |
| 20110172784 | Richter | Jul 2011 | A1 |
| 20110184510 | Maisano et al. | Jul 2011 | A1 |
| 20110190877 | Lane et al. | Aug 2011 | A1 |
| 20110190879 | Bobo et al. | Aug 2011 | A1 |
| 20110202076 | Richter | Aug 2011 | A1 |
| 20110202130 | Cartledge et al. | Aug 2011 | A1 |
| 20110208283 | Rust | Aug 2011 | A1 |
| 20110208293 | Tabor | Aug 2011 | A1 |
| 20110208298 | Tuval et al. | Aug 2011 | A1 |
| 20110213459 | Garrison et al. | Sep 2011 | A1 |
| 20110213461 | Seguin et al. | Sep 2011 | A1 |
| 20110218619 | Benichou et al. | Sep 2011 | A1 |
| 20110218620 | Meiri et al. | Sep 2011 | A1 |
| 20110224785 | Hacohen | Sep 2011 | A1 |
| 20110230941 | Markus | Sep 2011 | A1 |
| 20110230961 | Langer et al. | Sep 2011 | A1 |
| 20110238088 | Bodluc et al. | Sep 2011 | A1 |
| 20110238094 | Thomas et al. | Sep 2011 | A1 |
| 20110238159 | Guyenot et al. | Sep 2011 | A1 |
| 20110245911 | Quill et al. | Oct 2011 | A1 |
| 20110245917 | Savage et al. | Oct 2011 | A1 |
| 20110251675 | Dwork | Oct 2011 | A1 |
| 20110251676 | Sweeney et al. | Oct 2011 | A1 |
| 20110251678 | Eidenschink et al. | Oct 2011 | A1 |
| 20110251679 | Weimeyer et al. | Oct 2011 | A1 |
| 20110251680 | Tran et al. | Oct 2011 | A1 |
| 20110251682 | Murray, III et al. | Oct 2011 | A1 |
| 20110251683 | Tabor | Oct 2011 | A1 |
| 20110257433 | Walker | Oct 2011 | A1 |
| 20110257633 | Cartledge et al. | Oct 2011 | A1 |
| 20110257721 | Tabor | Oct 2011 | A1 |
| 20110257728 | Kuehn | Oct 2011 | A1 |
| 20110257729 | Spenser et al. | Oct 2011 | A1 |
| 20110257736 | Marquez et al. | Oct 2011 | A1 |
| 20110257737 | Fogarty et al. | Oct 2011 | A1 |
| 20110264191 | Rothstein | Oct 2011 | A1 |
| 20110264196 | Savage et al. | Oct 2011 | A1 |
| 20110264198 | Murray, III et al. | Oct 2011 | A1 |
| 20110264199 | Tran et al. | Oct 2011 | A1 |
| 20110264200 | Tran et al. | Oct 2011 | A1 |
| 20110264201 | Yeung | Oct 2011 | A1 |
| 20110264202 | Murray, III et al. | Oct 2011 | A1 |
| 20110264203 | Dwork et al. | Oct 2011 | A1 |
| 20110264206 | Tabor | Oct 2011 | A1 |
| 20110264208 | Duffy | Oct 2011 | A1 |
| 20110270276 | Rothstein et al. | Nov 2011 | A1 |
| 20110271967 | Mortier et al. | Nov 2011 | A1 |
| 20110276062 | Bolduc | Nov 2011 | A1 |
| 20110276128 | Cao et al. | Nov 2011 | A1 |
| 20110282361 | Miller et al. | Nov 2011 | A1 |
| 20110282438 | Drews et al. | Nov 2011 | A1 |
| 20110282439 | Thill et al. | Nov 2011 | A1 |
| 20110282440 | Cao | Nov 2011 | A1 |
| 20110283514 | Fogarty et al. | Nov 2011 | A1 |
| 20110288435 | Christy et al. | Nov 2011 | A1 |
| 20110288632 | White | Nov 2011 | A1 |
| 20110288634 | Tuval et al. | Nov 2011 | A1 |
| 20110288635 | Miller et al. | Nov 2011 | A1 |
| 20110295354 | Bueche et al. | Dec 2011 | A1 |
| 20110295363 | Girard et al. | Dec 2011 | A1 |
| 20110301498 | Maenhout et al. | Dec 2011 | A1 |
| 20110301688 | Dolan | Dec 2011 | A1 |
| 20110301698 | Miller et al. | Dec 2011 | A1 |
| 20110301701 | Padala et al. | Dec 2011 | A1 |
| 20110301702 | Rust et al. | Dec 2011 | A1 |
| 20110306916 | Nitzan et al. | Dec 2011 | A1 |
| 20110307049 | Kao | Dec 2011 | A1 |
| 20110313452 | Carley et al. | Dec 2011 | A1 |
| 20110313515 | Quadri et al. | Dec 2011 | A1 |
| 20110319988 | Schankereli et al. | Dec 2011 | A1 |
| 20110319989 | Lane et al. | Dec 2011 | A1 |
| 20110319991 | Hariton et al. | Dec 2011 | A1 |
| 20120010694 | Lutter et al. | Jan 2012 | A1 |
| 20120016468 | Robin et al. | Jan 2012 | A1 |
| 20120022557 | Cabiri et al. | Jan 2012 | A1 |
| 20120022629 | Perera et al. | Jan 2012 | A1 |
| 20120022633 | Olson et al. | Jan 2012 | A1 |
| 20120022637 | Ben-Movhar et al. | Jan 2012 | A1 |
| 20120022639 | Hacohen et al. | Jan 2012 | A1 |
| 20120022640 | Gross et al. | Jan 2012 | A1 |
| 20120022644 | Reich et al. | Jan 2012 | A1 |
| 20120035703 | Lutter et al. | Feb 2012 | A1 |
| 20120035712 | Maisano et al. | Feb 2012 | A1 |
| 20120035713 | Lutter et al. | Feb 2012 | A1 |
| 20120035722 | Tuval et al. | Feb 2012 | A1 |
| 20120041547 | Duffy et al. | Feb 2012 | A1 |
| 20120041551 | Spenser et al. | Feb 2012 | A1 |
| 20120046738 | Lau et al. | Feb 2012 | A1 |
| 20120046742 | Tuval et al. | Feb 2012 | A1 |
| 20120053676 | Ku et al. | Mar 2012 | A1 |
| 20120053680 | Bolling et al. | Mar 2012 | A1 |
| 20120053682 | Kovalsky et al. | Mar 2012 | A1 |
| 20120053688 | Fogarty et al. | Mar 2012 | A1 |
| 20120059337 | Eilat | Mar 2012 | A1 |
| 20120059454 | Millwee et al. | Mar 2012 | A1 |
| 20120059458 | Buchbinder et al. | Mar 2012 | A1 |
| 20120065464 | Ellis et al. | Mar 2012 | A1 |
| 20120078237 | Wang et al. | Mar 2012 | A1 |
| 20120078353 | Quadri et al. | Mar 2012 | A1 |
| 20120078355 | Zipory et al. | Mar 2012 | A1 |
| 20120078357 | Conklin | Mar 2012 | A1 |
| 20120078359 | Li et al. | Mar 2012 | A1 |
| 20120083832 | Delaloye et al. | Apr 2012 | A1 |
| 20120083839 | Letac et al. | Apr 2012 | A1 |
| 20120083879 | Eberhardt et al. | Apr 2012 | A1 |
| 20120089022 | House et al. | Apr 2012 | A1 |
| 20120089223 | Nguyen et al. | Apr 2012 | A1 |
| 20120095552 | Spence et al. | Apr 2012 | A1 |
| 20120101570 | Tuval et al. | Apr 2012 | A1 |
| 20120101571 | Thambar et al. | Apr 2012 | A1 |
| 20120101572 | Kovalsky et al. | Apr 2012 | A1 |
| 20120109155 | Robinson et al. | May 2012 | A1 |
| 20120123511 | Brown | May 2012 | A1 |
| 20120123529 | Levi et al. | May 2012 | A1 |
| 20120123530 | Carpentier et al. | May 2012 | A1 |
| 20120130473 | Norris et al. | May 2012 | A1 |
| 20120130474 | Buckley | May 2012 | A1 |
| 20120130475 | Shaw | May 2012 | A1 |
| 20120136434 | Carpentier et al. | May 2012 | A1 |
| 20120136436 | Cabiri et al. | May 2012 | A1 |
| 20120143323 | Hasenkam et al. | Jun 2012 | A1 |
| 20120150218 | Sandgren et al. | Jun 2012 | A1 |
| 20120150290 | Gabbay | Jun 2012 | A1 |
| 20120158021 | Morrill | Jun 2012 | A1 |
| 20120165915 | Melsheimer et al. | Jun 2012 | A1 |
| 20120165930 | Gifford, III et al. | Jun 2012 | A1 |
| 20120179086 | Shank et al. | Jul 2012 | A1 |
| 20120179244 | Schankereli et al. | Jul 2012 | A1 |
| 20120191182 | Hauser et al. | Jul 2012 | A1 |
| 20120197292 | Chin-Chen et al. | Aug 2012 | A1 |
| 20120197388 | Khairkhahan et al. | Aug 2012 | A1 |
| 20120215303 | Quadri et al. | Aug 2012 | A1 |
| 20120239142 | Liu et al. | Sep 2012 | A1 |
| 20120245604 | Tegzes | Sep 2012 | A1 |
| 20120271198 | Whittaker et al. | Oct 2012 | A1 |
| 20120277845 | Bowe | Nov 2012 | A1 |
| 20120283757 | Miller et al. | Nov 2012 | A1 |
| 20120283824 | Lutter et al. | Nov 2012 | A1 |
| 20120290062 | McNamara et al. | Nov 2012 | A1 |
| 20120296349 | Smith et al. | Nov 2012 | A1 |
| 20120296360 | Norris et al. | Nov 2012 | A1 |
| 20120296417 | Hill et al. | Nov 2012 | A1 |
| 20120296418 | Bonyuet et al. | Nov 2012 | A1 |
| 20120296419 | Richardson | Nov 2012 | A1 |
| 20120300063 | Majkrzak et al. | Nov 2012 | A1 |
| 20120123531 | Tsukashima et al. | Dec 2012 | A1 |
| 20120310328 | Olson et al. | Dec 2012 | A1 |
| 20120310330 | Buchbinder et al. | Dec 2012 | A1 |
| 20120323313 | Seguin | Dec 2012 | A1 |
| 20120323316 | Chau et al. | Dec 2012 | A1 |
| 20120330408 | Hillukka et al. | Dec 2012 | A1 |
| 20120330410 | Hammer et al. | Dec 2012 | A1 |
| 20120330411 | Gross et al. | Dec 2012 | A1 |
| 20130006347 | McHugo | Jan 2013 | A1 |
| 20130018450 | Hunt | Jan 2013 | A1 |
| 20130018458 | Yohanan et al. | Jan 2013 | A1 |
| 20130023758 | Fabro | Jan 2013 | A1 |
| 20130030519 | Tran et al. | Jan 2013 | A1 |
| 20130030522 | Rowe et al. | Jan 2013 | A1 |
| 20130035759 | Gross et al. | Feb 2013 | A1 |
| 20130041204 | Heilman et al. | Feb 2013 | A1 |
| 20130041451 | Patterson et al. | Feb 2013 | A1 |
| 20130046373 | Cartledge et al. | Feb 2013 | A1 |
| 20130066341 | Ketai et al. | Mar 2013 | A1 |
| 20130066342 | Dell et al. | Mar 2013 | A1 |
| 20130079872 | Gallagher | Mar 2013 | A1 |
| 20130079873 | Migliazza et al. | Mar 2013 | A1 |
| 20130085529 | Housman | Apr 2013 | A1 |
| 20130090724 | Subramanian et al. | Apr 2013 | A1 |
| 20130096673 | Hill et al. | Apr 2013 | A1 |
| 20130116776 | Gross et al. | May 2013 | A1 |
| 20130116779 | Weber | May 2013 | A1 |
| 20130116780 | Miller et al. | May 2013 | A1 |
| 20130123896 | Bloss et al. | May 2013 | A1 |
| 20130123900 | Eblacas et al. | May 2013 | A1 |
| 20130123910 | Cartledge et al. | May 2013 | A1 |
| 20130131791 | Hlavka et al. | May 2013 | A1 |
| 20130131792 | Miller et al. | May 2013 | A1 |
| 20130144381 | Quadri et al. | Jun 2013 | A1 |
| 20130150945 | Crawford et al. | Jun 2013 | A1 |
| 20130150956 | Yohanan et al. | Jun 2013 | A1 |
| 20130158647 | Norris et al. | Jun 2013 | A1 |
| 20130166017 | Cartledge et al. | Jun 2013 | A1 |
| 20130166022 | Conklin | Jun 2013 | A1 |
| 20130172978 | Vidlund et al. | Jul 2013 | A1 |
| 20130172992 | Gross et al. | Jul 2013 | A1 |
| 20130178930 | Straubinger et al. | Jul 2013 | A1 |
| 20130190857 | Mitra et al. | Jul 2013 | A1 |
| 20130190861 | Chau et al. | Jul 2013 | A1 |
| 20130190863 | Call et al. | Jul 2013 | A1 |
| 20130190866 | Zipory et al. | Jul 2013 | A1 |
| 20130197632 | Kovach et al. | Aug 2013 | A1 |
| 20130204361 | Adams et al. | Aug 2013 | A1 |
| 20130211501 | Buckley et al. | Aug 2013 | A1 |
| 20130211508 | Lane et al. | Aug 2013 | A1 |
| 20130226289 | Shaolian et al. | Aug 2013 | A1 |
| 20130226290 | Yellin et al. | Aug 2013 | A1 |
| 20130231735 | Deem et al. | Sep 2013 | A1 |
| 20130245742 | Norris | Sep 2013 | A1 |
| 20130253643 | Rolando et al. | Sep 2013 | A1 |
| 20130261737 | Costello | Oct 2013 | A1 |
| 20130261738 | Clague et al. | Oct 2013 | A1 |
| 20130268069 | Zakai et al. | Oct 2013 | A1 |
| 20130274870 | Lombardi et al. | Oct 2013 | A1 |
| 20130282059 | Ketai et al. | Oct 2013 | A1 |
| 20130289711 | Liddy et al. | Oct 2013 | A1 |
| 20130289718 | Tsukashima et al. | Oct 2013 | A1 |
| 20130289740 | Liddy et al. | Oct 2013 | A1 |
| 20130297013 | Klima et al. | Nov 2013 | A1 |
| 20130304093 | Serina et al. | Nov 2013 | A1 |
| 20130304197 | Buchbinder et al. | Nov 2013 | A1 |
| 20130304200 | McLean et al. | Nov 2013 | A1 |
| 20130310928 | Morriss et al. | Nov 2013 | A1 |
| 20130325114 | McLean et al. | Dec 2013 | A1 |
| 20130325118 | Cartledge | Dec 2013 | A1 |
| 20130331929 | Mitra et al. | Dec 2013 | A1 |
| 20140000112 | Braido et al. | Jan 2014 | A1 |
| 20140005767 | Glazier et al. | Jan 2014 | A1 |
| 20140005778 | Buchbinder et al. | Jan 2014 | A1 |
| 20140018911 | Zhou et al. | Jan 2014 | A1 |
| 20140018914 | Zipory et al. | Jan 2014 | A1 |
| 20140018915 | Biadillah et al. | Jan 2014 | A1 |
| 20140031928 | Murphy et al. | Jan 2014 | A1 |
| 20140046430 | Shaw | Feb 2014 | A1 |
| 20140052237 | Lane et al. | Feb 2014 | A1 |
| 20140067050 | Costello et al. | Mar 2014 | A1 |
| 20140067054 | Chau et al. | Mar 2014 | A1 |
| 20140081376 | Burkart et al. | Mar 2014 | A1 |
| 20140088368 | Park | Mar 2014 | A1 |
| 20140094826 | Sutherland et al. | Apr 2014 | A1 |
| 20140094903 | Miller et al. | Apr 2014 | A1 |
| 20140094906 | Spence et al. | Apr 2014 | A1 |
| 20140099726 | Heller | Apr 2014 | A1 |
| 20140106951 | Brandon | Apr 2014 | A1 |
| 20140120287 | Jacoby et al. | May 2014 | A1 |
| 20140121749 | Roeder | May 2014 | A1 |
| 20140121763 | Duffy et al. | May 2014 | A1 |
| 20140135799 | Henderson | May 2014 | A1 |
| 20140135894 | Norris et al. | May 2014 | A1 |
| 20140135895 | Andress et al. | May 2014 | A1 |
| 20140142619 | Serina et al. | May 2014 | A1 |
| 20140142681 | Norris | May 2014 | A1 |
| 20140142688 | Duffy et al. | May 2014 | A1 |
| 20140142695 | Gross et al. | May 2014 | A1 |
| 20140148849 | Serina et al. | May 2014 | A1 |
| 20140148891 | Johnson | May 2014 | A1 |
| 20140148898 | Gross et al. | May 2014 | A1 |
| 20140155783 | Starksen et al. | Jun 2014 | A1 |
| 20140163670 | Alon et al. | Jun 2014 | A1 |
| 20140163690 | White | Jun 2014 | A1 |
| 20140172069 | Roeder et al. | Jun 2014 | A1 |
| 20140172077 | Bruchman et al. | Jun 2014 | A1 |
| 20140172082 | Bruchman et al. | Jun 2014 | A1 |
| 20140188108 | Goodine et al. | Jul 2014 | A1 |
| 20140188140 | Meier et al. | Jul 2014 | A1 |
| 20140188210 | Beard et al. | Jul 2014 | A1 |
| 20140188215 | Hlavka et al. | Jul 2014 | A1 |
| 20140188221 | Chung et al. | Jul 2014 | A1 |
| 20140194970 | Chobotov et al. | Jul 2014 | A1 |
| 20140194976 | Starksen et al. | Jul 2014 | A1 |
| 20140194981 | Menk et al. | Jul 2014 | A1 |
| 20140194983 | Kovalsky et al. | Jul 2014 | A1 |
| 20140207231 | Hacohen et al. | Jul 2014 | A1 |
| 20140214157 | Börtlein et al. | Jul 2014 | A1 |
| 20140214159 | Vidlund et al. | Jul 2014 | A1 |
| 20140222136 | Geist et al. | Aug 2014 | A1 |
| 20140222137 | Miller et al. | Aug 2014 | A1 |
| 20140222142 | Kovalsky et al. | Aug 2014 | A1 |
| 20140236287 | Clague et al. | Aug 2014 | A1 |
| 20140236289 | Alkhatib | Aug 2014 | A1 |
| 20140243859 | Robinson | Aug 2014 | A1 |
| 20140243894 | Groothuis et al. | Aug 2014 | A1 |
| 20140243963 | Sheps et al. | Aug 2014 | A1 |
| 20140249622 | Carmi et al. | Sep 2014 | A1 |
| 20140257461 | Robinson et al. | Sep 2014 | A1 |
| 20140257467 | Lane et al. | Sep 2014 | A1 |
| 20140257475 | Gross et al. | Sep 2014 | A1 |
| 20140257476 | Montorfano et al. | Sep 2014 | A1 |
| 20140275757 | Goodwin et al. | Sep 2014 | A1 |
| 20140276648 | Hammer et al. | Sep 2014 | A1 |
| 20140277358 | Slazas | Sep 2014 | A1 |
| 20140277409 | Börtlein et al. | Sep 2014 | A1 |
| 20140277411 | Börtlein et al. | Sep 2014 | A1 |
| 20140277412 | Börtlein et al. | Sep 2014 | A1 |
| 20140277418 | Miller | Sep 2014 | A1 |
| 20140277419 | Garde et al. | Sep 2014 | A1 |
| 20140277422 | Ratz et al. | Sep 2014 | A1 |
| 20140277427 | Ratz et al. | Sep 2014 | A1 |
| 20140296962 | Cartledge et al. | Oct 2014 | A1 |
| 20140296969 | Tegels et al. | Oct 2014 | A1 |
| 20140303649 | Nguyen et al. | Oct 2014 | A1 |
| 20140303720 | Sugimoto et al. | Oct 2014 | A1 |
| 20140309661 | Sheps et al. | Oct 2014 | A1 |
| 20140309730 | Alon et al. | Oct 2014 | A1 |
| 20140324164 | Gross et al. | Oct 2014 | A1 |
| 20140329225 | Morin | Nov 2014 | A1 |
| 20140330371 | Gloss et al. | Nov 2014 | A1 |
| 20140331475 | Duffy et al. | Nov 2014 | A1 |
| 20140336744 | Tani et al. | Nov 2014 | A1 |
| 20140343668 | Zipory et al. | Nov 2014 | A1 |
| 20140343670 | Bakis et al. | Nov 2014 | A1 |
| 20140350662 | Vaturi | Nov 2014 | A1 |
| 20140350670 | Keränen | Nov 2014 | A1 |
| 20140358222 | Gorman, III et al. | Dec 2014 | A1 |
| 20140358224 | Tegels et al. | Dec 2014 | A1 |
| 20140378331 | Morin | Dec 2014 | A1 |
| 20140379006 | Sutherland et al. | Dec 2014 | A1 |
| 20140379065 | Johnson et al. | Dec 2014 | A1 |
| 20140379074 | Spence et al. | Dec 2014 | A1 |
| 20140379076 | Vidlund et al. | Dec 2014 | A1 |
| 20150012087 | Miller et al. | Jan 2015 | A1 |
| 20150018940 | Quill et al. | Jan 2015 | A1 |
| 20150018944 | O'connell et al. | Jan 2015 | A1 |
| 20150032205 | Matheny | Jan 2015 | A1 |
| 20150045880 | Hacohen | Feb 2015 | A1 |
| 20150045881 | Lim | Feb 2015 | A1 |
| 20150051697 | Spence et al. | Feb 2015 | A1 |
| 20150081014 | Gross et al. | Mar 2015 | A1 |
| 20150094802 | Buchbinder et al. | Apr 2015 | A1 |
| 20150105855 | Cabiri et al. | Apr 2015 | A1 |
| 20150119970 | Nakayama et al. | Apr 2015 | A1 |
| 20150127097 | Neumann et al. | May 2015 | A1 |
| 20150142100 | Morriss et al. | May 2015 | A1 |
| 20150142103 | Vidlund | May 2015 | A1 |
| 20150148894 | Damm et al. | May 2015 | A1 |
| 20150157457 | Hacohen | Jun 2015 | A1 |
| 20150157458 | Thambar et al. | Jun 2015 | A1 |
| 20150164640 | McLean et al. | Jun 2015 | A1 |
| 20150173896 | Richter et al. | Jun 2015 | A1 |
| 20150173897 | Raanani et al. | Jun 2015 | A1 |
| 20150182336 | Zipory et al. | Jul 2015 | A1 |
| 20150196390 | Ma et al. | Jul 2015 | A1 |
| 20150196393 | Vidlund et al. | Jul 2015 | A1 |
| 20150216661 | Hacohen et al. | Aug 2015 | A1 |
| 20150230923 | Tamir | Aug 2015 | A1 |
| 20150230924 | Miller et al. | Aug 2015 | A1 |
| 20150238313 | Spence et al. | Aug 2015 | A1 |
| 20150245934 | Lombardi et al. | Sep 2015 | A1 |
| 20150250588 | Yang et al. | Sep 2015 | A1 |
| 20150272730 | Melnick et al. | Oct 2015 | A1 |
| 20150272731 | Racchini et al. | Oct 2015 | A1 |
| 20150272734 | Sheps et al. | Oct 2015 | A1 |
| 20150282964 | Beard et al. | Oct 2015 | A1 |
| 20150320556 | Levi et al. | Nov 2015 | A1 |
| 20150327994 | Morriss et al. | Nov 2015 | A1 |
| 20150328000 | Ratz et al. | Nov 2015 | A1 |
| 20150335429 | Morriss et al. | Nov 2015 | A1 |
| 20150342736 | Rabito et al. | Dec 2015 | A1 |
| 20150351903 | Morriss et al. | Dec 2015 | A1 |
| 20150351904 | Cooper et al. | Dec 2015 | A1 |
| 20150351906 | Hammer et al. | Dec 2015 | A1 |
| 20150359629 | Ganesan et al. | Dec 2015 | A1 |
| 20150359631 | Sheahan et al. | Dec 2015 | A1 |
| 20160008129 | Siegel | Jan 2016 | A1 |
| 20160030169 | Shahriari | Feb 2016 | A1 |
| 20160030171 | Quijano et al. | Feb 2016 | A1 |
| 20160089482 | Siegenthaler | Mar 2016 | A1 |
| 20160095700 | Righini | Apr 2016 | A1 |
| 20160100939 | Armstrong et al. | Apr 2016 | A1 |
| 20160106539 | Buchbinder et al. | Apr 2016 | A1 |
| 20160113765 | Ganesan et al. | Apr 2016 | A1 |
| 20160113766 | Ganesan et al. | Apr 2016 | A1 |
| 20160113768 | Ganesan et al. | Apr 2016 | A1 |
| 20160125160 | Heneghan et al. | May 2016 | A1 |
| 20160175095 | Dienno et al. | Jun 2016 | A1 |
| 20160184098 | Vaturi | Jun 2016 | A1 |
| 20160200773 | Morin | Jul 2016 | A1 |
| 20160213473 | Hacohen et al. | Jul 2016 | A1 |
| 20160220367 | Barrett | Aug 2016 | A1 |
| 20160228247 | Maimon et al. | Aug 2016 | A1 |
| 20160242902 | Morriss et al. | Aug 2016 | A1 |
| 20160245802 | Morin et al. | Aug 2016 | A1 |
| 20160258939 | Morin et al. | Sep 2016 | A1 |
| 20160262885 | Sandstrom et al. | Sep 2016 | A1 |
| 20160266089 | Morin et al. | Sep 2016 | A1 |
| 20160270911 | Ganesan et al. | Sep 2016 | A1 |
| 20160296330 | Hacohen | Oct 2016 | A1 |
| 20160310268 | Oba et al. | Oct 2016 | A1 |
| 20160310274 | Gross et al. | Oct 2016 | A1 |
| 20160317301 | Quadri et al. | Nov 2016 | A1 |
| 20160317305 | Pelled et al. | Nov 2016 | A1 |
| 20160324633 | Gross et al. | Nov 2016 | A1 |
| 20160324635 | Vidlund et al. | Nov 2016 | A1 |
| 20160324640 | Gifford et al. | Nov 2016 | A1 |
| 20160331525 | Straubinger et al. | Nov 2016 | A1 |
| 20160331526 | Schweich et al. | Nov 2016 | A1 |
| 20160331527 | Vidlund et al. | Nov 2016 | A1 |
| 20160338706 | Rowe | Nov 2016 | A1 |
| 20160367360 | Cartledge et al. | Dec 2016 | A1 |
| 20160367368 | Vidlund et al. | Dec 2016 | A1 |
| 20160374801 | Jimenez et al. | Dec 2016 | A1 |
| 20160374802 | Levi et al. | Dec 2016 | A1 |
| 20170042678 | Ganesan et al. | Feb 2017 | A1 |
| 20170049435 | Sauer et al. | Feb 2017 | A1 |
| 20170056166 | Ratz et al. | Mar 2017 | A1 |
| 20170056171 | Cooper et al. | Mar 2017 | A1 |
| 20170065407 | Hacohen et al. | Mar 2017 | A1 |
| 20170065411 | Grundeman et al. | Mar 2017 | A1 |
| 20170074855 | Morin et al. | Mar 2017 | A1 |
| 20170100236 | Robertson et al. | Apr 2017 | A1 |
| 20170128205 | Tamir et al. | May 2017 | A1 |
| 20170135816 | Lashinski et al. | May 2017 | A1 |
| 20170165054 | Benson | Jun 2017 | A1 |
| 20170189174 | Braido et al. | Jul 2017 | A1 |
| 20170196688 | Christianson et al. | Jul 2017 | A1 |
| 20170196692 | Kirk et al. | Jul 2017 | A1 |
| 20170209264 | Chau et al. | Jul 2017 | A1 |
| 20170216026 | Quill et al. | Aug 2017 | A1 |
| 20170224323 | Rowe et al. | Aug 2017 | A1 |
| 20170231757 | Gassler | Aug 2017 | A1 |
| 20170231759 | Geist et al. | Aug 2017 | A1 |
| 20170231760 | Lane et al. | Aug 2017 | A1 |
| 20170231766 | Hariton et al. | Aug 2017 | A1 |
| 20170234850 | Morin | Aug 2017 | A1 |
| 20170239048 | Goldfarb et al. | Aug 2017 | A1 |
| 20170252159 | Hacohen et al. | Sep 2017 | A1 |
| 20170266003 | Hammer et al. | Sep 2017 | A1 |
| 20170281337 | Campbell | Oct 2017 | A1 |
| 20170325948 | Wallace et al. | Nov 2017 | A1 |
| 20170333183 | Backus | Nov 2017 | A1 |
| 20170333187 | Hariton et al. | Nov 2017 | A1 |
| 20170349940 | Morin et al. | Dec 2017 | A1 |
| 20170360426 | Hacohen et al. | Dec 2017 | A1 |
| 20170367823 | Hariton et al. | Dec 2017 | A1 |
| 20180000580 | Wallace et al. | Jan 2018 | A1 |
| 20180014930 | Hariton et al. | Jan 2018 | A1 |
| 20180014932 | Hammer et al. | Jan 2018 | A1 |
| 20180021129 | Peterson et al. | Jan 2018 | A1 |
| 20180023114 | Morin et al. | Jan 2018 | A1 |
| 20180023115 | Morin et al. | Jan 2018 | A1 |
| 20180028215 | Cohen | Feb 2018 | A1 |
| 20180028311 | Hacohen | Feb 2018 | A1 |
| 20180049873 | Manash et al. | Feb 2018 | A1 |
| 20180055628 | Patel et al. | Mar 2018 | A1 |
| 20180055629 | Oba et al. | Mar 2018 | A1 |
| 20180055630 | Patel et al. | Mar 2018 | A1 |
| 20180098850 | Rafiee et al. | Apr 2018 | A1 |
| 20180116790 | Ratz et al. | May 2018 | A1 |
| 20180116843 | Schreck et al. | May 2018 | A1 |
| 20180125644 | Conklin | May 2018 | A1 |
| 20180132999 | Perouse | May 2018 | A1 |
| 20180133003 | Levi | May 2018 | A1 |
| 20180147059 | Hammer et al. | May 2018 | A1 |
| 20180153687 | Hariton et al. | Jun 2018 | A1 |
| 20180153689 | Maimon et al. | Jun 2018 | A1 |
| 20180153695 | Cunningham et al. | Jun 2018 | A1 |
| 20180153696 | Albitov et al. | Jun 2018 | A1 |
| 20180161159 | Lee et al. | Jun 2018 | A1 |
| 20180177593 | Hariton et al. | Jun 2018 | A1 |
| 20180177594 | Patel et al. | Jun 2018 | A1 |
| 20180185148 | Hariton et al. | Jul 2018 | A1 |
| 20180206982 | Haivatov et al. | Jul 2018 | A1 |
| 20180206983 | Noe et al. | Jul 2018 | A1 |
| 20180214263 | Rolando et al. | Aug 2018 | A1 |
| 20180243086 | Barbarino et al. | Aug 2018 | A1 |
| 20180250126 | O'connor et al. | Sep 2018 | A1 |
| 20180250130 | Hariton et al. | Sep 2018 | A1 |
| 20180250147 | Syed | Sep 2018 | A1 |
| 20180271654 | Hariton et al. | Sep 2018 | A1 |
| 20180280136 | Hariton et al. | Oct 2018 | A1 |
| 20180296333 | Dixon et al. | Oct 2018 | A1 |
| 20180296336 | Cooper et al. | Oct 2018 | A1 |
| 20180296341 | Noe et al. | Oct 2018 | A1 |
| 20180325671 | Abunassar et al. | Nov 2018 | A1 |
| 20180344457 | Gross et al. | Dec 2018 | A1 |
| 20180344490 | Fox et al. | Dec 2018 | A1 |
| 20180353294 | Calomeni et al. | Dec 2018 | A1 |
| 20180360457 | Ellis et al. | Dec 2018 | A1 |
| 20190000613 | Delgado et al. | Jan 2019 | A1 |
| 20190015200 | Delgado et al. | Jan 2019 | A1 |
| 20190021852 | Delgado et al. | Jan 2019 | A1 |
| 20190021857 | Hacohen et al. | Jan 2019 | A1 |
| 20190038404 | Iamberger et al. | Feb 2019 | A1 |
| 20190038405 | Iamberger et al. | Feb 2019 | A1 |
| 20190053896 | Adamek-bowers et al. | Feb 2019 | A1 |
| 20190060060 | Chau et al. | Feb 2019 | A1 |
| 20190060068 | Cope et al. | Feb 2019 | A1 |
| 20190060070 | Groothuis et al. | Feb 2019 | A1 |
| 20190069997 | Ratz et al. | Mar 2019 | A1 |
| 20190069998 | Hacohen | Mar 2019 | A1 |
| 20190083248 | Hariton et al. | Mar 2019 | A1 |
| 20190083249 | Hariton et al. | Mar 2019 | A1 |
| 20190083261 | Perszyk et al. | Mar 2019 | A1 |
| 20190083262 | Hariton et al. | Mar 2019 | A1 |
| 20190105153 | Barash et al. | Apr 2019 | A1 |
| 20190117391 | Humair | Apr 2019 | A1 |
| 20190167423 | Hariton et al. | Jun 2019 | A1 |
| 20190175339 | Vidlund | Jun 2019 | A1 |
| 20190175342 | Hariton et al. | Jun 2019 | A1 |
| 20190183639 | Moore | Jun 2019 | A1 |
| 20190192295 | Spence et al. | Jun 2019 | A1 |
| 20190216602 | Lozonschi | Jul 2019 | A1 |
| 20190224008 | Bressloff et al. | Jul 2019 | A1 |
| 20190231525 | Hariton et al. | Aug 2019 | A1 |
| 20190240010 | Hacohen | Aug 2019 | A1 |
| 20190262507 | Adamek-bowers et al. | Aug 2019 | A1 |
| 20190336280 | Naor | Nov 2019 | A1 |
| 20190350701 | Adamek-bowers et al. | Nov 2019 | A1 |
| 20190365530 | Hoang et al. | Dec 2019 | A1 |
| 20190388218 | Vidlund et al. | Dec 2019 | A1 |
| 20190388220 | Vidlund et al. | Dec 2019 | A1 |
| 20200000449 | Goldfarb et al. | Jan 2020 | A1 |
| 20200000579 | Manash et al. | Jan 2020 | A1 |
| 20200000580 | Hacohen | Jan 2020 | A1 |
| 20200015964 | Noe et al. | Jan 2020 | A1 |
| 20200030098 | Delgado et al. | Jan 2020 | A1 |
| 20200038181 | Hariton et al. | Feb 2020 | A1 |
| 20200046496 | Hammer et al. | Feb 2020 | A1 |
| 20200054335 | Hernandez et al. | Feb 2020 | A1 |
| 20200060818 | Geist et al. | Feb 2020 | A1 |
| 20200069417 | Morin et al. | Mar 2020 | A1 |
| 20200113677 | McCann et al. | Apr 2020 | A1 |
| 20200113689 | McCann et al. | Apr 2020 | A1 |
| 20200113692 | McCann et al. | Apr 2020 | A1 |
| 20200138567 | Marr et al. | May 2020 | A1 |
| 20200146671 | Hacohen et al. | May 2020 | A1 |
| 20200146824 | Hammer et al. | May 2020 | A1 |
| 20200163760 | Hariton et al. | May 2020 | A1 |
| 20200163761 | Hariton et al. | May 2020 | A1 |
| 20200205969 | Hacohen | Jul 2020 | A1 |
| 20200214832 | Metchik et al. | Jul 2020 | A1 |
| 20200237512 | McCann et al. | Jul 2020 | A1 |
| 20200246136 | Marr et al. | Aug 2020 | A1 |
| 20200246140 | Hariton et al. | Aug 2020 | A1 |
| 20200253600 | Darabian | Aug 2020 | A1 |
| 20200261094 | Goldfarb et al. | Aug 2020 | A1 |
| 20200306037 | Siegel et al. | Oct 2020 | A1 |
| 20200315786 | Metchik et al. | Oct 2020 | A1 |
| 20200337842 | Metchik et al. | Oct 2020 | A1 |
| 20200360139 | Hammer et al. | Nov 2020 | A1 |
| 20200390546 | Hariton et al. | Dec 2020 | A1 |
| 20200390548 | Hariton et al. | Dec 2020 | A1 |
| 20210085455 | Bateman et al. | Mar 2021 | A1 |
| 20210093449 | Hariton et al. | Apr 2021 | A1 |
| 20210106419 | Abunassar | Apr 2021 | A1 |
| 20210113331 | Quadri et al. | Apr 2021 | A1 |
| 20210137680 | Kizuka et al. | May 2021 | A1 |
| 20210259835 | Tyler, II et al. | Aug 2021 | A1 |
| 20210361422 | Gross et al. | Nov 2021 | A1 |
| 20210401573 | Gross et al. | Dec 2021 | A1 |
| 20220000612 | Hacohen | Jan 2022 | A1 |
| 20220023036 | Levi et al. | Jan 2022 | A1 |
| 20220061984 | Humair et al. | Mar 2022 | A1 |
| 20220105238 | Reimer et al. | Apr 2022 | A1 |
| 20220151779 | Pintor | May 2022 | A1 |
| 20230137909 | Hariton et al. | May 2023 | A1 |
| Number | Date | Country |
|---|---|---|
| 2822801 | Aug 2006 | CA |
| 2671966 | Jun 2008 | CA |
| 101653365 | Feb 2010 | CN |
| 202313807 | Jul 2012 | CN |
| 103974674 | Aug 2014 | CN |
| 103997990 | Aug 2014 | CN |
| 105324091 | Feb 2016 | CN |
| 112603598 | Apr 2021 | CN |
| 0170262 | Feb 1986 | EP |
| 0614342 | Sep 1994 | EP |
| 1006905 | Jun 2000 | EP |
| 0954257 | Aug 2000 | EP |
| 1258437 | Nov 2002 | EP |
| 1264582 | Dec 2002 | EP |
| 0871417 | Oct 2003 | EP |
| 1266641 | Oct 2004 | EP |
| 1034753 | Feb 2005 | EP |
| 1637092 | Mar 2006 | EP |
| 1990014 | Nov 2008 | EP |
| 1562522 | Dec 2008 | EP |
| 1258232 | Jan 2009 | EP |
| 1420723 | Jan 2009 | EP |
| 1903991 | Sep 2009 | EP |
| 1418865 | Oct 2009 | EP |
| 2119399 | Nov 2009 | EP |
| 1531762 | Apr 2010 | EP |
| 1450733 | Feb 2011 | EP |
| 2446915 | May 2012 | EP |
| 2088965 | Nov 2012 | EP |
| 2641569 | Sep 2013 | EP |
| 1768630 | Jan 2015 | EP |
| 1861045 | Mar 2015 | EP |
| 1465555 | May 2015 | EP |
| 2219558 | Aug 2015 | EP |
| 2349124 | Oct 2018 | EP |
| 2739214 | Oct 2018 | EP |
| 3417813 | Dec 2018 | EP |
| 3583922 | Dec 2019 | EP |
| 3270825 | Apr 2020 | EP |
| 2485795 | Sep 2020 | EP |
| 223448 | Dec 2012 | IL |
| S53152790 | Dec 1978 | JP |
| 20010046894 | Jun 2001 | KR |
| 9205093 | Apr 1992 | WO |
| 9310714 | Jun 1993 | WO |
| 9639963 | Dec 1996 | WO |
| 9640344 | Dec 1996 | WO |
| 9701369 | Jan 1997 | WO |
| 9846149 | Oct 1998 | WO |
| 1998043557 | Oct 1998 | WO |
| 1999030647 | Jun 1999 | WO |
| 0022981 | Apr 2000 | WO |
| 2000-047139 | Aug 2000 | WO |
| 0126586 | Apr 2001 | WO |
| 0156457 | Aug 2001 | WO |
| 2001-062189 | Aug 2001 | WO |
| 0182832 | Nov 2001 | WO |
| 02085250 | Oct 2002 | WO |
| 02085251 | Oct 2002 | WO |
| 02085252 | Oct 2002 | WO |
| 2003020179 | Mar 2003 | WO |
| 2003028558 | Apr 2003 | WO |
| 03047467 | Jun 2003 | WO |
| 2003049647 | Jun 2003 | WO |
| 2003105667 | Dec 2003 | WO |
| 2004028399 | Apr 2004 | WO |
| 04103434 | Dec 2004 | WO |
| 2004108191 | Dec 2004 | WO |
| 05021063 | Mar 2005 | WO |
| 05046488 | May 2005 | WO |
| 2005062931 | Jul 2005 | WO |
| 2005107650 | Nov 2005 | WO |
| 2006007389 | Jan 2006 | WO |
| 2006007401 | Jan 2006 | WO |
| 06012013 | Feb 2006 | WO |
| 06012038 | Feb 2006 | WO |
| 06054930 | May 2006 | WO |
| 2006065212 | Jun 2006 | WO |
| 2006070372 | Jul 2006 | WO |
| 06086434 | Aug 2006 | WO |
| 2006089236 | Aug 2006 | WO |
| 2006091163 | Aug 2006 | WO |
| 06097931 | Sep 2006 | WO |
| 06105084 | Oct 2006 | WO |
| 2006113906 | Oct 2006 | WO |
| 06116558 | Nov 2006 | WO |
| 2006128193 | Nov 2006 | WO |
| 07011799 | Jan 2007 | WO |
| 2007030063 | Mar 2007 | WO |
| 2007047488 | Apr 2007 | WO |
| 2007059252 | May 2007 | WO |
| 07121314 | Oct 2007 | WO |
| 07136783 | Nov 2007 | WO |
| 07136981 | Nov 2007 | WO |
| 08013915 | Jan 2008 | WO |
| 2008014144 | Jan 2008 | WO |
| 2008029296 | Mar 2008 | WO |
| 2008031103 | Mar 2008 | WO |
| 2008058940 | May 2008 | WO |
| 08068756 | Jun 2008 | WO |
| 2008070797 | Jun 2008 | WO |
| 2008103722 | Aug 2008 | WO |
| 2009026563 | Feb 2009 | WO |
| 09033469 | Mar 2009 | WO |
| 09053497 | Apr 2009 | WO |
| 2009080801 | Jul 2009 | WO |
| 2009091509 | Jul 2009 | WO |
| 2009130631 | Oct 2009 | WO |
| 10004546 | Jan 2010 | WO |
| 2010000454 | Jan 2010 | WO |
| 2010005827 | Jan 2010 | WO |
| 2010006627 | Jan 2010 | WO |
| 2010006905 | Jan 2010 | WO |
| 2010027485 | Mar 2010 | WO |
| 2010037141 | Apr 2010 | WO |
| 2010044851 | Apr 2010 | WO |
| 2010045297 | Apr 2010 | WO |
| 2010057262 | May 2010 | WO |
| 2010073246 | Jul 2010 | WO |
| 2010081033 | Jul 2010 | WO |
| 2010085649 | Jul 2010 | WO |
| 2010121076 | Oct 2010 | WO |
| 2010128502 | Nov 2010 | WO |
| 2010128503 | Nov 2010 | WO |
| 2010150178 | Dec 2010 | WO |
| 2011025972 | Mar 2011 | WO |
| 2011051942 | May 2011 | WO |
| 2011057087 | May 2011 | WO |
| 2011067770 | Jun 2011 | WO |
| 2011069048 | Jun 2011 | WO |
| 2011072084 | Jun 2011 | WO |
| 2011089401 | Jul 2011 | WO |
| 2011089601 | Jul 2011 | WO |
| 2011106137 | Sep 2011 | WO |
| 2011111047 | Sep 2011 | WO |
| 0187190 | Nov 2011 | WO |
| 2011137531 | Nov 2011 | WO |
| 2011-143263 | Nov 2011 | WO |
| 2011144351 | Nov 2011 | WO |
| 2011148374 | Dec 2011 | WO |
| 2011154942 | Dec 2011 | WO |
| 2012011108 | Jan 2012 | WO |
| 2012014201 | Feb 2012 | WO |
| 2012024428 | Feb 2012 | WO |
| 2012036740 | Mar 2012 | WO |
| 2012048035 | Apr 2012 | WO |
| 2012068541 | May 2012 | WO |
| 2012127309 | Sep 2012 | WO |
| 2012176195 | Dec 2012 | WO |
| 2012177942 | Dec 2012 | WO |
| 2012178115 | Dec 2012 | WO |
| 2013021374 | Feb 2013 | WO |
| 2013021375 | Feb 2013 | WO |
| 2013021384 | Feb 2013 | WO |
| 2013028387 | Feb 2013 | WO |
| 2013059743 | Apr 2013 | WO |
| 2013059747 | Apr 2013 | WO |
| 2013069019 | May 2013 | WO |
| 2013072496 | May 2013 | WO |
| 2013078497 | Jun 2013 | WO |
| 2013088327 | Jun 2013 | WO |
| 2013114214 | Aug 2013 | WO |
| 2013128436 | Sep 2013 | WO |
| 2013175468 | Nov 2013 | WO |
| 2014022124 | Feb 2014 | WO |
| 2014064694 | May 2014 | WO |
| 2014064695 | May 2014 | WO |
| 2014076696 | May 2014 | WO |
| 2014087402 | Jun 2014 | WO |
| 2014115149 | Jul 2014 | WO |
| 2014121275 | Aug 2014 | WO |
| 2014121280 | Aug 2014 | WO |
| 2014144937 | Sep 2014 | WO |
| 2014145338 | Sep 2014 | WO |
| 2014164364 | Oct 2014 | WO |
| 2014194178 | Dec 2014 | WO |
| 2014195786 | Dec 2014 | WO |
| 2015059699 | Apr 2015 | WO |
| 2015173794 | Nov 2015 | WO |
| 2015191923 | Dec 2015 | WO |
| 2016016899 | Feb 2016 | WO |
| 2016093877 | Jun 2016 | WO |
| 2016098104 | Jun 2016 | WO |
| 2016125160 | Aug 2016 | WO |
| 2016150806 | Sep 2016 | WO |
| WO-2016183526 | Nov 2016 | WO |
| 2017223486 | Dec 2017 | WO |
| 2018025260 | Feb 2018 | WO |
| 2018025263 | Feb 2018 | WO |
| 2018029680 | Feb 2018 | WO |
| 2018039631 | Mar 2018 | WO |
| 2018106837 | Jun 2018 | WO |
| 2018112429 | Jun 2018 | WO |
| 2018118717 | Jun 2018 | WO |
| 2018131042 | Jul 2018 | WO |
| 2018131043 | Jul 2018 | WO |
| 2019026059 | Feb 2019 | WO |
| 2019027507 | Feb 2019 | WO |
| 2019030753 | Feb 2019 | WO |
| 2019077595 | Apr 2019 | WO |
| 2019086958 | May 2019 | WO |
| 2019116369 | Jun 2019 | WO |
| 2019138400 | Jul 2019 | WO |
| 2019195860 | Oct 2019 | WO |
| 2019202579 | Oct 2019 | WO |
| 2020058972 | Mar 2020 | WO |
| 2020167677 | Aug 2020 | WO |
| 2021156866 | Aug 2021 | WO |
| 2021178400 | Sep 2021 | WO |
| 2021186424 | Sep 2021 | WO |
| 2022046568 | Mar 2022 | WO |
| 2022061017 | Mar 2022 | WO |
| 2022118316 | Jun 2022 | WO |
| Entry |
|---|
| An Office Action dated Nov. 23, 2012, which issued during the prosecution of U.S. Appl. No. 13/033,852. |
| An Office Action dated Dec. 31, 2012, which issued during the prosecution of U.S. Appl. No. 13/044,694. |
| An Office Action dated Feb. 6, 2013, which issued during the prosecution of U.S. Appl. No. 13/412,814. |
| Langer F et al., “Ring plus String: Papillary muscle repositioning as an adjunctive repair technique for ischemic mitral regurgitation,” J Thorac Cardiovasc Surg 133:247-9, Jan. 2007. |
| Langer F et al., “Ring+String: Successful repair technique for ischemic mitral regurgitation with severe leaflet tethering,” Circulation 120[suppl 1]: S85-S91, Sep. 2009. |
| “Transcatheter Valve-in-Valve Implantation for Failed Bioprosthetic Heart Valves”, J Webb et al., Circulation. Apr. 2010; 121: 1848-1857. |
| Jansen, J., Willeke, S., Reul, H. and Rum, G. (1992), Detachable Shape-Memory Sewing Ring for Heart Valves. Artificial Organs, 16:294-297. 1992 (an abstract). |
| Alexander S. Geha, et al., Replacement of degenerated mitral and aortic bioprostheses without explanation Ann Thorac Surg. Jun. 2001; 72:1509-1514. |
| An International Search Report and a Written Opinion both dated Oct. 13, 2011 which issued during the prosecution of Applicant's PCT/IL11/00231. |
| An Office Action dated Jul. 1, 2016, which issued during the prosecution of U.S. Appl. No. 14/161,921. |
| An International Search Report and a Written Opinion both dated Dec. 5, 2011, which issued during the prosecution of Applicant's PCT/IL11/00582. |
| An Office Action dated May 29, 2012, which issued during the prosecution of U.S. Appl. No. 12/840,463. |
| U.S. Appl. No. 61/555,160, filed Nov. 3, 2011. |
| U.S. Appl. No. 61/525,281, filed Aug. 19, 2011. |
| U.S. Appl. No. 61/537,276, filed Sep. 21, 2011. |
| U.S. Appl. No. 61/515,372, filed Aug. 5, 2011. |
| U.S. Appl. No. 61/492,449, filed Jun. 2, 2011. |
| U.S. Appl. No. 61/588,892, filed Jan. 20, 2012. |
| An International Search Report and a Written Opinion both dated Feb. 6, 2013, which issued during the prosecution of Applicant's PCT/IL12/00292. |
| An International Search Report and a Written Opinion both dated Feb. 6, 2013, which issued during the prosecution of Applicant's PCT/IL12/00293. |
| An Office Action dated Nov. 28, 2012, which issued during the prosecution of U.S. Appl. No. 12/961,721. |
| An Office Action dated Feb. 15, 2013, which issued during the prosecution of U.S. Appl. No. 12/840,463. |
| An Office Action dated Feb. 10, 2014, which issued during the prosecution of U.S. Appl. No. 13/033,852. |
| An Office Action dated Sep. 19, 2014, which issued during the prosecution of U.S. Appl. No. 13/044,694. |
| An International Search Report and a Written Opinion both dated Sep. 4, 2014 which issued during the prosecution of Applicant's PCT/IL2014/050087. |
| Invitation to Pay Additional Fees dated Jun. 12, 2014 PCT/IL2014/050087. |
| An Office Action dated Jun. 17, 2014, which issued during the prosecution of U.S. Appl. No. 12/961,721. |
| An Office Action dated Jul. 3, 2014, which issued during the prosecution of U.S. Appl. No. 13/033,852. |
| An Office Action dated May 23, 2014, which issued during the prosecution of U.S. Appl. No. 13/412,814. |
| Dominique Himbert; Mitral Regurgitation and Stenosis from Bioprosthesis and Annuloplasty Failure: Transcatheter approaches and outcomes, 24 pages Oct. 28, 2013. |
| An International Search Report and a Written Opinion both dated Mar. 17, 2014 which issued during the prosecution of Applicant's PCT/IL2013/050937. |
| An International Preliminary Report dated Dec. 2, 2013, which issued during the prosecution of Applicant's PCT/IL11/00582. |
| An Office Action dated Sep. 12, 2013, which issued during the prosecution of U.S. Appl. No. 13/412,814. |
| An Office Action dated Aug. 2, 2013, which issued during the prosecution of U.S. Appl. No. 13/033,852. |
| An International Preliminary Report on patentabilty dated Sep. 11, 2012, which issued during the prosecution of Applicant's PCT/IL2011/000231. |
| An Office Action dated Jul. 2, 2014, which issued during the prosecution of U.S. Appl. No. 13/811,308. |
| An Office Action dated Jan. 20, 2016, which issued during the prosecution of U.S. Appl. No. 14/161,921. |
| An Office Action dated Jul. 23, 2013, which issued during the prosecution of U.S. Appl. No. 12/961,721. |
| An Office Action dated Jul. 18, 2013, which issued during the prosecution of U.S. Appl. No. 13/044,694. |
| An Office Action dated Nov. 8, 2013, which issued during the prosecution of U.S. Appl. No. 12/840,463. |
| An Office Action dated Jun. 4, 2014, which issued during the prosecution of U.S. Appl. No. 12/840,463. |
| An Office Action dated Aug. 13, 2012, which issued during the prosecution of U.S. Appl. No. 13/044,694. |
| An Office Action dated Jul. 2, 2012, which issued during the prosecution of U.S. Appl. No. 13/033,852. |
| An Office Action dated Feb. 3, 2014, which issued during the prosecution of U.S. Appl. No. 13/811,308. |
| An International Preliminary Report on patentabilty dated Feb. 11, 2014, which issued during the prosecution of Applicant's PCT/IL12/00292. |
| An International Preliminary Report on patentabilty dated Feb. 11, 2014, which issued during the prosecution of Applicant's PCT/IL12/00293. |
| A Notice of Allowance dated Aug. 15, 2014, which issued during the prosecution of U.S. Appl. No. 13/412,814. |
| An Office Action dated Aug. 14, 2012, which issued during the prosecution of U.S. Appl. No. 12/961,721. |
| U.S. Appl. No. 61/283,819, filed Dec. 8, 2009. |
| Notice of Allowance dated Apr. 8, 2016, which issued during the prosecution of U.S. Appl. No. 14/237,258. |
| U.S. Appl. No. 61/756,034, filed Jan. 24, 2013. |
| U.S. Appl. No. 61/756,049, filed Jan. 24, 2013. |
| An International Preliminary Report on Patentability dated Jan. 31, 2017, which issued during the prosecution of Applicant's PCT/IL2015/050792. |
| U.S. Appl. No. 62/372,861, filed Aug. 10, 2016. |
| Notice of Allowance dated Aug. 13, 2018, which issued during the prosecution of U.S. Appl. No. 15/995,597. |
| Notice of Allowance dated Apr. 20, 2018, which issued during the prosecution of U.S. Appl. No. 15/878,206. |
| An Office Action dated Dec. 10, 2015, which issued during the prosecution of U.S. Appl. No. 14/237,258. |
| An International Preliminary Report on Patentability dated Jul. 28, 2015, which issued during the prosecution of Applicant's PCT/IL2014/050087. |
| An Office Action dated Nov. 27, 2015, which issued during the prosecution of U.S. Appl. No. 14/626,267. |
| An Office Action dated Jan. 21, 2016, which issued during the prosecution of U.S. Appl. No. 14/237,264. |
| An Office Action dated Jan. 30, 2015, which issued during the prosecution of UK Patent Application No. 1413474.6. |
| An International Search Report and a Written Opinion both dated May 30, 2016, which issued during the prosecution of Applicant's PCT/IL2016/050125. |
| An Office Action dated Sep. 26, 2016, which issued during the prosecution of U.S. Appl. No. 14/763,004. |
| An Office Action dated Jan. 18, 2017, which issued during the prosecution of U.S. Appl. No. 14/626,267. |
| An Office Action dated Feb. 7, 2017, which issued during the prosecution of U.S. Appl. No. 14/689,608. |
| An Office Action dated Feb. 7, 2017, which issued during the prosecution of UK Patent Application No. 1613219.3. |
| An Office Action together dated Feb. 10, 2017, which issued during the prosecution of European Patent Application No. 12821522.5. |
| An International Search Report and a Written Opinion both dated Oct. 27, 2015, which issued during the prosecution of Applicant's PCT/IL2015/050792. |
| European Search Report dated Feb. 18, 2015, which issued during the prosecution of Applicant's European App No. 12821522.5. |
| Saturn Project—a novel solution for transcatheter heart valve replacement specifically designed to address clinical therapeutic needs on mitral valve: Dec. 2016. |
| Righini presentation EuroPCR May 2015 (Saturn)—(downloaded from: https://www.pcronline.com/Cases-resourcesimages/Resources/Course-videos-slides/2015/Cardiovascularinnovation-pipeline-Mitral-and-tricuspid-valve-interventions). |
| An Advisory Action dated Apr. 2, 2018, which issued during the prosecution of U.S. Appl. No. 14/763,004. |
| An Office Action dated Jul. 26, 2018, which issued during the prosecution of U.S. Appl. No. 15/872,501. |
| An Office Action dated May 4, 2018, which issued during the prosecution of U.S. Appl. No. 15/872,501. |
| An Office Action dated Apr. 20, 2018, which issued during the prosecution of U.S. Appl. No. 15/886,517. |
| An Office Action dated Aug. 9, 2018, which issued during the prosecution of U.S. Appl. No. 15/899,858. |
| An Office Action dated Aug. 9, 2018, which issued during the prosecution of U.S. Appl. No. 15/902,403. |
| An Office Action dated Jun. 28, 2018, which issued during the prosecution of Design U.S. Appl. No. 29/635,658. |
| An Office Action dated Jun. 28, 2018, which issued during the prosecution of Design U.S. Appl. No. 29/635,661. |
| Georg Lutter, MD, et al; “Percutaneous Valve Replacement: Current State and Future Prospects”, The Annals of Thoracic Surgery ; vol. 78, pp. 2199-2206; Dec. 2004. |
| An Office Action dated Jun. 6, 2018, which issued during the prosecution of UK Patent Application No. 1720803.4. |
| An International Search Report and a Written Opinion both dated Jun. 20, 2018, which issued during the prosecution of Applicant's PCT/IL2018/050024. |
| An Office Action dated Jun. 18, 2018, which issued during the prosecution of UK Patent Application No. 1800399.6. |
| An Office Action dated Oct. 23, 2017, which issued during the prosecution of U.S. Appl. No. 14/763,004. |
| An Office Action dated Dec. 7, 2017, which issued during the prosecution of U.S. Appl. No. 15/213,791. |
| Interview Summary dated Feb. 8, 2018, which issued during the prosecution of U.S. Appl. No. 15/213,791. |
| An Office Action dated Feb. 7, 2018, which issued during the prosecution of U.S. Appl. No. 15/197,069. |
| An International Search Report and a Written Opinion both dated Nov. 24, 2017, which issued during the prosecution of Applicant's PCT/IL2017/050873. |
| An Office Action dated Jan. 5, 2018, which issued during the prosecution of U.S. Appl. No. 15/541,783. |
| An Office Action dated Feb. 2, 2018, which issued during the prosecution of U.S. Appl. No. 15/329,920. |
| An Invitation to pay additional fees dated Jan. 2, 2018, which issued during the prosecution of Applicant's PCT/IL2017/050849. |
| An Invitation to pay additional fees dated Sep. 29, 2017, which issued during the prosecution of Applicant's PCT/IL2017/050873. |
| European Search Report dated Jun. 29, 2017, which issued during the prosecution of Applicant's European App No. 11809374.9. |
| An Invitation to pay additional fees dated Oct. 11. 2018, which issued during the prosecution of Applicant's PCT/IL2018/050725. |
| An Office Action dated Dec. 4, 2018, which issued during the prosecution of U.S. Appl. No. 16/045,059. |
| An Office Action together with the English translation dated Nov. 5, 2018 which issued during the prosecution of Chinese Patent Application No. 201680008328.5. |
| Notice of Allowance dated Sep. 25, 2018, which issued during the prosecution of U.S. Appl. No. 15/188,507. |
| European Search Report dated Sep. 26, 2018 which issued during the prosecution of Applicant's European App No. 18186784.7. |
| An Office Action dated Jun. 30, 2015, which issued during the prosecution of U.S. Appl. No. 14/522,987. |
| Notice of Allowance dated Dec. 13, 2013, which issued during the prosecution of U.S. Appl. No. 13/675,119. |
| An International Preliminary Report on Patentability dated Aug. 8, 2017, which issued during the prosecution of Applicant's PCT/IL2016/050125. |
| An Office Action dated Jan. 17, 2018, which issued during the prosecution of U.S. Appl. No. 14/763,004. |
| An Office Action dated Mar. 25, 2015, which issued during the prosecution of U.S. Appl. No. 12/840,463. |
| An Office Action dated Feb. 25, 2016, which issued during the prosecution of U.S. Appl. No. 14/522,987. |
| An Office Action dated Apr. 13, 2016, which issued during the prosecution of U.S. Appl. No. 14/626,267. |
| An Office Action dated Aug. 28, 2015, which issued during the prosecution of U.S. Appl. No. 14/237,264. |
| Maisano (2015) TCR presentation re Cardiovalve. |
| Notice of Allowance dated Sep. 29, 2016, which issued during the prosecution of U.S. Appl. No. 14/442,541. |
| Notice of Allowance dated May 10, 2016, which issued during the prosecution of U.S. Appl. No. 14/237,258. |
| Notice of Allowance dated May 20, 2016, which issued during the prosecution of U.S. Appl. No. 14/237,258. |
| An International Preliminary Report on Patentability dated May 19, 2015, which issued during the prosecution of Applicant's PCT/IL2013/050937. |
| Dusan Pavcnik, MD, PhD2, et al; “Development and Initial Experimental Evaluation of a Prosthetic Aortic Valve for Transcatheter Placement”, Cardiovascular Radiology. Radiology Apr. 1992, vol. 183, pp. 151-154. |
| Notice of Allowance dated Oct. 16, 2013, which issued during the prosecution of U.S. Appl. No. 13/675,119. |
| Notice of Allowance dated Feb. 11, 2015, which issued during the prosecution of U.S. Appl. No. 13/033,852. |
| Notice of Allowance dated May 5, 2015, which issued during the prosecution of U.S. Appl. No. 12/840,463. |
| Notice of Allowance dated Mar. 10, 2015, which issued during the prosecution of U.S. Appl. No. 13/811,308. |
| Notice of Allowance dated Jul. 1, 2016, which issued during the prosecution of U.S. Appl. No. 14/442,541. |
| An Office Action dated Mar. 25, 2019, which issued during the prosecution of European Patent Application No. 14710060.6. |
| An International Search Report and a Written Opinion both dated Nov. 9, 2018, which issued during the prosecution of Applicant's PCT/IL2018/050869. |
| An International Search Report and a Written Opinion both dated Dec. 5, 2018, which issued during the prosecution of Applicant's PCT/IL2018/050725. |
| An International Search Report and a Written Opinion both dated Apr. 25, 2019, which issued during the prosecution of Applicant's PCT/IL2019/050142. |
| An International Preliminary Report on Patentability dated Feb. 12, 2019, which issued during the prosecution of Applicant's PCT/IL2017/050873. |
| An Office Action dated Sep. 13, 2019, which issued during the prosecution of U.S. Appl. No. 16/460,313. |
| An Office Action dated Nov. 26, 2019, which issued during the prosecution of U.S. Appl. No. 16/532,945. |
| An Office Action dated Aug. 16, 2019, which issued during the prosecution of U.S. Appl. No. 15/668,659. |
| An Office Action dated Nov. 1, 2019, which issued during the prosecution of U.S. Appl. No. 15/872,501. |
| An Office Action dated Jun. 14, 2019, which issued during the prosecution of U.S. Appl. No. 15/703,385. |
| An Office Action dated Oct. 4, 2019, which issued during the prosecution of U.S. Appl. No. 16/183,140. |
| An Office Action dated Jun. 13, 2019, which issued during the prosecution of U.S. Appl. No. 16/388,038. |
| An International Preliminary Report on Patentability dated Feb. 4, 2020, which issued during the prosecution of Applicant's PCT/IL2018/050725. |
| An International Search Report and a Written Opinion both dated Jan. 25, 2019, which issued during the prosecution of Applicant's PCT/IL2018/051122. |
| An International Search Report and a Written Opinion both dated May 13, 2019, which issued during the prosecution of Applicant's PCT/IL2018/051350. |
| An International Preliminary Report on Patentability dated Feb. 5, 2019, which issued during the prosecution of Applicant's PCT/IL2017/050849. |
| An Office Action dated Oct. 25, 2018, which issued during the prosecution of U.S. Appl. No. 14/763,004. |
| An Office Action dated Mar. 4, 2019, which issued during the prosecution of U.S. Appl. No. 14/763,004. |
| An Office Action dated Jan. 9, 2019, which issued during the prosecution of U.S. Appl. No. 15/329,920. |
| An Office Action dated Jan. 30, 2019, which issued during the prosecution of U.S. Appl. No. 15/872,501. |
| An Office Action dated Feb. 5, 2019, which issued during the prosecution of U.S. Appl. No. 15/899,858. |
| An Office Action dated May 23, 2019, which issued during the prosecution of U.S. Appl. No. 15/668,659. |
| An Office Action dated May 1, 2019, which issued during the prosecution of U.S. Appl. No. 15/691,032. |
| An Office Action dated Aug. 1, 2019, which issued during the prosecution of U.S. Appl. No. 15/668,559. |
| An Office Action dated Jun. 19, 2019, which issued during the prosecution of U.S. Appl. No. 15/682,789. |
| Notice of Allowance dated Jan. 13, 2020, which issued during the prosecution of U.S. Appl. No. 15/956,956. |
| An Office Action dated Jun. 25, 2019, which issued during the prosecution of U.S. Appl. No. 15/329,920. |
| An Office Action dated May 16, 2019, which issued during the prosecution of U.S. Appl. No. 15/433,547. |
| U.S. Appl. No. 62/560,384, filed Sep. 19, 2017. |
| U.S. Appl. No. 62/112,343, filed Feb. 5, 2015. |
| An International Preliminary Report on Patentability dated Feb. 11, 2020, which issued during the prosecution of Applicant's PCT/IL2018/050869. |
| An International Preliminary Report on Patentability dated Oct. 20, 2020, which issued during the prosecution of Applicant's PCT/IL2019/050142. |
| An Office Action dated Jan. 6, 2020, which issued during the prosecution of U.S. Appl. No. 16/660,231. |
| An Office Action dated Dec. 31, 2019, which issued during the prosecution of U.S. Appl. No. 16/183,140. |
| Notice of Allowance dated Apr. 24, 2019, which issued during the prosecution of U.S. Appl. No. 16/045,059. |
| An Office Action dated Jan. 14, 2020, which issued during the prosecution of U.S. Appl. No. 16/284,331. |
| European Search Report dated Mar. 5, 2020 which issued during the prosecution of Applicant's European App No. 17752184.6. |
| European Search Report dated Mar. 4, 2020 which issued during the prosecution of Applicant's European App No. 16706913.7. |
| Notice of Allowance dated Mar. 12, 2020, which issued during the prosecution of U.S. Appl. No. 16/460,313. |
| An Office Action dated Jan. 9, 2020, which issued during the prosecution of U.S. Appl. No. 15/600,190. |
| An Office Action dated Jan. 3, 2020, which issued during the prosecution of U.S. Appl. No. 16/678,355. |
| An Office Action dated Feb. 6, 2020, which issued during the prosecution of U.S. Appl. No. 15/668,659. |
| Notice of Allowance dated Jan. 16, 2020, which issued during the prosecution of U.S. Appl. No. 16/532,945. |
| Notice of Allowance dated Aug. 19, 2020, which issued during the prosecution of U.S. Appl. No. 16/637,166. |
| Notice of Allowance dated Jul. 27, 2020, which issued during the prosecution of U.S. Appl. No. 16/637,166. |
| Notice of Allowance dated Jun. 23, 2020, which issued during the prosecution of U.S. Appl. No. 16/637,166. |
| Notice of Allowance dated May 7, 2020, which issued during the prosecution of U.S. Appl. No. 16/637,166. |
| Sündermann, Simon H., et al. “Feasibility of the Engager™ aortic transcatheter valve system using a flexible over-the-wire design.” European Journal of Cardio-Thoracic Surgery 42.4 (2012): e48-e52. |
| An Office Action summarized English translation and Search Report dated Jul. 3, 2020, which issued during the prosecution of Chinese Patent Application No. 201780061210.3. |
| Serruys, P. W., Piazza, N., Cribier, A., Webb, J., Laborde, J. C., & de Jaegere, P. (Eds.). (2009). Transcatheter aortic valve implantation: tips and tricks to avoid failure. CRC Press.—Screenshots from Google Books downloaded from: https://books.google.co.il/books?id=FLzLBQAAQBAJ&lpg=PA198&ots=soqWrDH-y_&dq=%20%22Edwards%20SAPIEN%22&lr&pg=PA20#v=onepage&q=%22Edwards%20SAPIEN%22&f=false ; Downloaded on Jun. 18, 2020. |
| An International Search Report and a Written Opinion both dated Jun. 24, 2020, which issued during the prosecution of Applicant's PCT/IL2019/051398. |
| An Office Action dated Jul. 14, 2020, which issued during the prosecution of U.S. Appl. No. 16/324,339. |
| Notice of Allowance dated Aug. 28, 2020, which issued during the prosecution of U.S. Appl. No. 16/324,339. |
| Notice of Allowance dated Jul. 29, 2020, which issued during the prosecution of U.S. Appl. No. 16/132,937. |
| An Office Action dated Jul. 29, 2020, which issued during the prosecution of U.S. Appl. No. 16/269,328. |
| Notice of Allowance dated Aug. 26, 2020, which issued during the prosecution of U.S. Appl. No. 16/269,328. |
| An Office Action dated Aug. 7, 2020, which issued during the prosecution of U.S. Appl. No. 15/668,659. |
| Tchetche, D. and Nicolas M. Van Mieghem: “New-generation TAVI devices: description and specifications” EuroIntervention, 2014, No. 10:U90-U100. |
| An Office Action dated Aug. 23, 2019, which issued during the prosecution of U.S. Appl. No. 15/600,190. |
| Symetis S.A.: “Acurate neo™ Aortic Bioprosthesis for Implantation using the Acurate neo™ TA Transapical Delivery System in Patients with Severe Aortic Stenosis,” Clinical Investigation Plan, Protocol No. 2015-01, Vs. No. 2, 2015:1-76. |
| Notice of Allowance dated Sep. 10, 2020, which issued during the prosecution of U.S. Appl. No. 15/600,190. |
| Notice of Allowance dated Sep. 10, 2020, which issued during the prosecution of U.S. Appl. No. 16/324,339. |
| Notice of Allowance dated Oct. 19, 2020, which issued during the prosecution of U.S. Appl. No. 16/324,339. |
| Notice of Allowance dated Sep. 21, 2020, which issued during the prosecution of U.S. Appl. No. 16/269,328. |
| Notice of Allowance dated Oct. 28, 2020, which issued during the prosecution of U.S. Appl. No. 16/269,328. |
| Notice of Allowance dated Jan. 16, 2020, which issued during the prosecution of U.S. Appl. No. 15/872,501. |
| An Office Action dated May 11, 2020, which issued during the prosecution of U.S. Appl. No. 16/811,732. |
| An Office Action dated Sep. 24, 2020, which issued during the prosecution of U.S. Appl. No. 16/811,732. |
| Notice of Allowance dated Mar. 29, 2017, which issued during the prosecution of U.S. Appl. No. 14/161,921. |
| Agarwal et al. International Cardiology Perspective Functional Tricuspid Regurgitation, Circ Cardiovasc Interv 2009;2;2;565-573 (2009). |
| Alfieri et al., “An effective technique to correct anterior mitral leaflet prolapse,” J Card 14(6):468-470 (1999). |
| Alfieri et al., “The double orifice technique in mitral valve repair: a simple solution for complex problems,” Journal of Thoracic Cardiovascular Surgery 122:674-681 (2001). |
| Alfieri, “The edge-to-edge repair of the mitral valve,” [Abstract] 6th Annual NewEra Cardiac Care: Innovation & Technology, Heart Surgery Forum pp. 103. (2000). |
| Alfieri et al.“Novel Suture Device for Beating-Heart Mitral Leaflet Approximation”, Ann Thorac Surg. 2002, 74:1488-1493. |
| Alfieri et al., “The edge to edge technique,” The European Association for Cardio-Thoracic Surgery 14th Annual Meeting Oct. 7-11, Book of Procees. (2000). |
| Amplatzer Cardiac Plug brochure (English pages), AGA Medical Corporation (Plymouth, MN) (copyright 2008-2010, downloaded Jan. 11, 2011). |
| Amplatzer® Cribriform Occluder. A patient guide to Percutaneous, Transcatheter, Atrial Septal Defect Closuer, AGA Medical Corporation, Apr. 2008. |
| Amplatzer® Septal Occluder. A patient guide to the Non-Surgical Closuer of the Atrial Septal Defect Using the Amplatzer Septal Occluder System, AGA Medical Corporation, Apr. 2008. |
| Brennan, Jennifer, 510(k) Summary of safety and effectiveness, Jan. 2008. |
| Dictionary.com definition of “lock”, Jul. 29, 2013. |
| Dang NC et al. “Simplified Placement of Multiple Artificial Mitral Valve Chords,” The Heart Surgery Forum #2005-1005, 8 (3) (2005). |
| Maisano, The double-orifice technique as a standardized approach to treat mitral . . . , European Journal of Cardio-thoracic Surgery 17 (2000) 201-205. |
| “Two dimensional real-time ultrasonic imaging of the heart and great vessels”, Mayo Clin Proc. vol. 53:271-303, 1978. |
| Odell JA et al., “Early Results o4yf a Simplified Method of Mitral Valve Annuloplasty,” Circulation 92:150-154 (1995). |
| O'Reilly S et al., “Heart valve surgery pushes the envelope,” Medtech Insight 8(3): 73, 99-108 (2006). |
| Swain CP et al., “An endoscopically deliverable tissue-transfixing device for securing biosensors in the gastrointestinal tract,” Gastrointestinal Endoscopy 40(6): 730-734 (1994). |
| An Invitation to pay additional fees dated Jan. 31, 2014, which issued during the prosecution of Applicant's PCT/IL2013/050860. |
| U.S. Appl. No. 62/030,715, filed Jul. 30, 2014. |
| U.S. Appl. No. 62/139,854, filed Mar. 30, 2015. |
| U.S. Appl. No. 61/312,412, filed Mar. 10, 2010. |
| An Invitation to pay additional fees dated Jan. 31, 2014, which issued during the prosecution of Applicant's PCT/IL2013/050861. |
| An International Preliminary Report on Patentability dated Dec. 23, 2013, which issued during the prosecution of Applicant's PCT/IL2012/000250. |
| An International Preliminary Report on Patentability dated Sep. 18, 2007, which issued during the prosecution of Applicant's PCT/IL2006/000342. |
| An International Preliminary Report on Patentability dated Jun. 5, 2012, which issued during the prosecution of Applicant's PCT/IL2010/001024. |
| An International Preliminary Report on Patentability dated Apr. 28, 2015, which issued during the prosecution of Applicant's PCT/IL2013/050861. |
| An International Preliminary Report on Patentability dated Apr. 26, 2016, which issued during the prosecution of Applicant's PCT/IL2014/050914. |
| An International Preliminary Report on Patentability dated Jun. 10, 2009, which issued during the prosecution of Applicant's PCT/IL07/01503. |
| An International Preliminary Report on Patentability dated Dec. 18, 2010, prosecution of Applicant's PCT/IL09/00593. |
| An International Preliminary Report on Patentability dated Jun. 29, 2011, which issued during the prosecution of Applicant's PCT/IL2009/001209. |
| Notice of Allowance dated Aug. 18, 2017, which issued during the prosecution of U.S. Appl. No. 14/689,608. |
| Notice of Allowance dated Jul. 6, 2017, which issued during the prosecution of U.S. Appl. No. 14/689,608. |
| Notice of Allowance dated May 22, 2017, which issued during the prosecution of U.S. Appl. No. 14/689,608. |
| An Office Action dated Apr. 21, 2017, which issued during the prosecution of U.S. Appl. No. 15/213,791. |
| An Office Action dated Sep. 29, 2017, which issued during the prosecution of U.S. Appl. No. 15/197,069. |
| An International Preliminary Report on Patentability dated Nov. 9, 2011, which issued during the prosecution of Applicant's PCT/IL2010/000357. |
| An International Preliminary Report on Patentability dated Nov. 9, 2011 which issued during the prosecution of Applicant's PCT/IL2010/000358. |
| An International Preliminary Report on Patentability dated Nov. 27, 2012, which issued during the prosecution of Applicant's PCT/IL2011/000404. |
| An International Preliminary Report on Patentability dated Feb. 4, 2014, which issued during the prosecution of Applicant's PCT/IL2011/000446. |
| An International Preliminary Report on Patentability dated Jan. 29, 2013, which issued during the prosecution of Applicant's PCT/IL2011/000600. |
| An International Preliminary Report on Patentability dated Dec. 23, 2014, which issued during the prosecution of Applicant's PCT/IL2012/050451. |
| A Notice of Allowance dated Jul. 30, 2015, which issued during the prosecution of U.S. Appl. No. 13/319,007. |
| An Office Action dated Sep. 29, 2014, which issued during the prosecution of U.S. Appl. No. 13/504,870. |
| An Office Action dated Jan. 13, 2015, which issued during the prosecution of U.S. Appl. No. 13/707,013. |
| An Office Action dated Mar. 23, 2015, which issued during the prosecution of U.S. Appl. No. 13/707,013. |
| Notice of Allowance dated Mar. 25, 2015, which issued during the prosecution of U.S. Appl. No. 13/749,153. |
| An Office Action dated Oct. 3, 2014, which issued during the prosecution of U.S. Appl. No. 13/749,153. |
| Notice of Allowance dated May 22, 2015, which issued during the prosecution of U.S. Appl. No. 13/749,153. |
| Notice of Allowance dated Aug. 3, 2015, which issued during the prosecution of U.S. Appl. No. 13/749,153. |
| An Office Action dated Dec. 19, 2013, which issued during the prosecution of U.S. Appl. No. 14/027,934. |
| An Office Action dated Jun. 11, 2014, which issued during the prosecution of U.S. Appl. No. 14/027,934. |
| An Office Action dated Aug. 22, 2014, which issued during the prosecution of U.S. Appl. No. 14/027,934. |
| An Office Action dated Apr. 2, 2015, which issued during the prosecution of U.S. Appl. No. 14/027,934. |
| An Office Action dated Jan. 5, 2016, which issued during the prosecution of U.S. Appl. No. 14/027,934. |
| An Office Action dated Jan. 5, 2016, which issued during the prosecution of U.S. Appl. No. 14/084,426. |
| An Office Action dated Mar. 16, 2015, which issued during the prosecution of U.S. Appl. No. 14/084,426. |
| An Office Action dated Jan. 6, 2016, which issued during the prosecution of U.S. Appl. No. 14/128,756. |
| An Office Action dated May 11, 2016, which issued during the prosecution of U.S. Appl. No. 14/128,756. |
| Notice of Allowance dated Oct. 20, 2015, which issued during the prosecution of U.S. Appl. No. 12/996,954. |
| Notice of Allowance dated Feb. 19, 2014, which issued during the prosecution of U.S. Appl. No. 12/795,192. |
| An Office Action dated Jul. 20, 2012, which issued during the prosecution of U.S. Appl. No. 12/843,412. |
| An Office Action dated Mar. 27, 2013, which issued during the prosecution of U.S. Appl. No. 12/843,412. |
| A Restriction Requirement dated May 1, 2012, which issued during the prosecution of U.S. Appl. No. 12/843,412. |
| A Notice of Allowance dated May 2, 2013, which issued during the prosecution of U.S. Appl. No. 12/843,412. |
| A Restriction Requirement dated Nov. 19, 2012, which issued during the prosecution of U.S. Appl. No. 12/926,673. |
| An Office Action dated Feb. 12, 2013, which issued during the prosecution of U.S. Appl. No. 12/926,673. |
| An Office Action dated Oct. 22, 2013, which issued during the prosecution of U.S. Appl. No. 12/926,673. |
| A Notice of Allowance dated Jan. 7, 2014, which issued during the prosecution of U.S. Appl. No. 12/926,673. |
| An Office Action dated Oct. 9, 2013, which issued during the prosecution of U.S. Appl. No. 12/996,954. |
| An Office Action dated Mar. 24, 2015, which issued during the prosecution of U.S. Appl. No. 12/996,954. |
| An Office Action dated Oct. 5, 2012, which issued during the prosecution of U.S. Appl. No. 12/996,954. |
| Notice of Allowance dated Jul. 7, 2015, which issued during the prosecution of U.S. Appl. No. 12/996,954. |
| An Office Action dated Nov. 16, 2018, which issued during the prosecution of U.S. Appl. No. 16/042,028. |
| An International Search Report with Written Opinion both dated Feb. 2, 2012, which issued during the prosecution of Applicant's PCT/IL2011/000600. |
| An International Search Report together with Written Opinion both dated Mar. 30, 2011, which issued during the prosecution of Applicant's PCT/IL2010/001024. |
| An International Search Report and A Written Opinion both dated Feb. 10, 2011, which issued during the prosecution of Applicant's PCT/IL10/00890. |
| An Office Action dated May 28, 2015, which issued during the prosecution of U.S. Appl. No. 14/128,756. |
| An Office Action dated Sep. 6, 2018, which issued during the prosecution of U.S. Appl. No. 15/994,022. |
| An Office Action dated Sep. 7, 2018, which issued during the prosecution of U.S. Appl. No. 15/995,725. |
| An Office Action dated Nov. 26, 2018, which issued during the prosecution of U.S. Appl. No. 16/040,831. |
| An Office Action dated Jul. 11, 2018, which issued during the prosecution of U.S. Appl. No. 15/978,494. |
| An Office Action dated Nov. 23, 2018, which issued during the prosecution of U.S. Appl. No. 16/041,208. |
| An Office Action dated Jun. 15, 2018, which issued during the prosecution of U.S. Appl. No. 15/970,314. |
| An Office Action dated Oct. 12, 2018, which issued during the prosecution of U.S. Appl. No. 15/970,314. |
| An Office Action dated Jul. 26, 2018, which issued during the prosecution of U.S. Appl. No. 15/979,686. |
| An Office Action dated Sep. 10, 2018, which issued during the prosecution of U.S. Appl. No. 16/008,618. |
| An International Preliminary Report on Patentability dated Apr. 28, 2015, which issued during the prosecution of Applicant's PCT/IL2013/050860. |
| An Office Action dated Apr. 22, 2019, which issued during the prosecution of U.S. Appl. No. 15/668,559. |
| Notice of Allowance dated Aug. 30, 2019, which issued during the prosecution of U.S. Appl. No. 15/682,789. |
| Notice of Allowance dated Mar. 29, 2018, which issued during the prosecution of U.S. Appl. No. 15/541,783. |
| Dieter RS, “Percutaneous valve repair: Update on mitral regurgitation and endovascular approaches to the mitral valve,” Applications in Imaging, Cardiac Interventions, Supported by an educational grant from Amersham Health pp. 11-14 (2003). |
| An Advisory Action dated Dec. 13, 2013, which issued during the prosecution of U.S. Appl. No. 12/961,721. |
| An Office Action dated Aug. 7, 2015, which issued during the prosecution of U.S. Appl. No. 14/128,756. |
| An Office Action dated May 19, 2011, which issued during the prosecution of U.S. Appl. No. 12/706,868. |
| An Office Action dated Sep. 1, 2011, which issued during the prosecution of U.S. Appl. No. 12/706,868. |
| An Office Action dated May 30, 2012, which issued during the prosecution of U.S. Appl. No. 12/706,868. |
| A Notice of Allowance dated Sep. 18, 2012, which issued during the prosecution of U.S. Appl. No. 12/706,868. |
| Restriction Requirement dated May 5, 2011, which issued during the prosecution of U.S. Appl. No. 12/706,868. |
| A Restriction Requirement dated Mar. 30, 2012, which issued during the prosecution of U.S. Appl. No. 12/785,717. |
| An Office Action dated Oct. 5, 2020, which issued during the prosecution of Canadian Patent Application No. 2,973,940. |
| An Office Action dated Nov. 30, 2020, which issued during the prosecution of U.S. Appl. No. 16/138,129. |
| An Office Action summarized English translation and Search Report dated Nov. 25, 2020, which issued during the prosecution of Chinese Patent Application No. 201910449820.1. |
| Notice of Allowance dated Nov. 19, 2020, which issued during the prosecution of U.S. Appl. No. 16/318,025. |
| An Office Action dated Aug. 2, 2011, which issued during the prosecution of U.S. Appl. No. 12/435,291. |
| Notice of Allowance dated Dec. 7, 2011, which issued during the prosecution of U.S. Appl. No. 12/435,291. |
| An Office Action dated Apr. 6, 2010, which issued during the prosecution of Applicant's U.S. Appl. No. 12/484,512. |
| An Office Action dated Oct. 6, 2010, which issued during the prosecution of Applicant's U.S. Appl. No. 12/484,512. |
| Notice of Allowance dated Apr. 20, 2011, which issued during the prosecution of U.S. Appl. No. 12/484,512. |
| Notice of Allowance dated Mar. 23. 2011, which issued during the prosecution of U.S. Appl. No. 12/484,512. |
| An Office Action dated Jan. 27, 2012, which issued during the prosecution of U.S. Appl. No. 12/548,991. |
| An Office Action dated Aug. 6, 2012, which issued during the prosecution of U.S. Appl. No. 12/548,991. |
| An Advisory Action dated Sep. 6, 2012 which issued during the prosecution of U.S. Appl. No. 12/548,991. |
| Notice of Allowance dated Jun. 23, 2014, which issued during the prosecution of U.S. Appl. No. 12/548,991. |
| A Restriction Requirement dated Nov. 14, 2011 which issued during the prosecution of U.S. Appl. No. 12/548,991. |
| Amendment, Terminal Disclaimer and Extension dated Jun. 27, 2012, which issued during the prosecution of U.S. Appl. No. 12/548,991. |
| A Restriction Requirement dated Jul. 5, 2012, which issued during the prosecution of U.S. Appl. No. 12/563,930. |
| An Office Action dated Apr. 2, 2013, which issued during the prosecution of U.S. Appl. No. 12/785,717. |
| An Office Action dated Dec. 27, 2013, which issued during the prosecution of U.S. Appl. No. 12/785,717. |
| An Office Action dated Nov. 5, 2012, which issued during the prosecution of U.S. Appl. No. 12/795,026. |
| An Office Action dated May 10, 2012, which issued during the prosecution of U.S. Appl. No. 12/795,026. |
| Notice of Allowance dated Nov. 13, 2014, which issued during the prosecution of U.S. Appl. No. 12/795,026. |
| Notice of Allowance dated Dec. 24, 2014, which issued during the prosecution of U.S. Appl. No. 12/795,026. |
| A Restriction Requirement dated Jan. 6, 2012, which issued during the prosecution of U.S. Appl. No. 12/795,026. |
| A Restriction Requirement dated Sep. 14, 2012, which issued during the prosecution of U.S. Appl. No. 12/795,192. |
| An Office Action dated Aug. 15, 2013, which issued during the prosecution of U.S. Appl. No. 12/795,192. |
| An Office Action dated Jan. 17, 2013, which issued during the prosecution of U.S. Appl. No. 12/795,192. |
| Notice of Allowance dated Nov. 19, 2013, which issued during the prosecution of U.S. Appl. No. 12/795,192. |
| A Notice of Allowance dated Jun. 26, 2012, which issued during the prosecution of U.S. Appl. No. 12/608,316. |
| An Office Action dated Nov. 14, 2011, which issued during the prosecution of U.S. Appl. No. 12/608,316. |
| A Restriction Requirement dated Apr. 1, 2011, which issued during the prosecution of U.S. Appl. No. 12/608,316. |
| An Office Action dated Jul. 6, 2012, which issued during the prosecution of U.S. Appl. No. 12/692,061. |
| An Office Action dated Jan. 23, 2012, which issued during the prosecution of U.S. Appl. No. 12/692,061. |
| An Office Action dated Mar. 9, 2012, which issued during the prosecution of U.S. Appl. No. 12/689,635. |
| An Office Action dated Nov. 30, 2012, which issued during the prosecution of U.S. Appl. No. 12/689,635. |
| A Notice of Allowance dated May 22, 2013, which issued during the prosecution of U.S. Appl. No. 12/689,635. |
| Restriction Requirement dated Nov. 14, 2011, which issued during the prosecution of U.S. Appl. No. 12/689,635. |
| An Office Action dated May 6, 2013, which issued during the prosecution of U.S. Appl. No. 12/689,693. |
| An Office Action dated Feb. 3, 2014, which issued during the prosecution of U.S. Appl. No. 12/689,693. |
| Notice of Allowance dated Jun. 11, 2014, which issued during the prosecution of U.S. Appl. No. 12/689,693. |
| A Restriction Requirement dated Sep. 17, 2012, which issued during the prosecution of U.S. Appl. No. 12/689,693. |
| A Notice of Allowance dated Sep. 3, 2014, which issued during the prosecution of U.S. Appl. No. 12/689,693. |
| European Search Report dated Jul. 8, 2016, which issued during the prosecution of Applicant's European App No. 13849843.1. |
| A Supplementary European Search Report dated Dec. 4, 2012, which issued during the prosecution of European Patent Application No. EP 09834225.6. |
| A Supplementary European Search Report dated Mar. 28, 2013, which issued during the prosecution of European Patent Application No. EP 1077 2091.4. |
| Search Report in European Patent Application 10772090.6 dated Jan. 17, 2014. |
| Supplementary European Search Report dated Oct. 23, 2014 which issued during the prosecution of Applicant's European App No. 10826224.7. |
| Notice of Allowance dated May 6, 2016, which issued during the prosecution of U.S. Appl. No. 14/667,090. |
| Notice of Allowance dated Apr. 12, 2016, which issued during the prosecution of U.S. Appl. No. 14/667,090. |
| An Office Action dated Jun. 7, 2013, which issued during the prosecution of U.S. Appl. No. 13/141,606. |
| An Office Action dated Jun. 13, 2014, which issued during the prosecution of U.S. Appl. No. 13/141,606. |
| Notice of Allowance dated Sep. 29, 2014, which issued during the prosecution of U.S. Appl. No. 13/141,606. |
| An Office Action dated Feb. 4, 2013 which issued during the prosecution of U.S. Appl. No. 13/141,606. |
| An English translation of an Office Action dated Apr. 23, 2014 which issued during the prosecution of Chinese Patent Application No. 201080059948.4. |
| Communication dated Jul. 25, 2014, issued by the State Intellectual Property Office of the P.R. of China in counterpart Application No. 200980157331.3. |
| An International Search Report and a Written Opinion both dated Jan. 25, 2016, which issued during the prosecution of Applicant's PCT/IL2015/051027. |
| An International Search Report dated May 19, 2011, which issued during the prosecution of Applicant's PCT/IL2011/00064. |
| An International Search Report and a Written Opinion both dated Feb. 22, 2013, which issued during the prosecution of Applicant's PCT/IL201/050451. |
| An International Search Report & Written Opinion both dated Mar. 21, 2014, which issued during the prosecution of Applicant's PCT/IL13/50992. |
| An International Search Report and Written Opinion both dated Apr. 9, 2014, which issued during the prosecution of Applicant's PCT/IL13/50860. |
| An International Search Report and a Written Opinion both dated Apr. 15, 2014, which issued during the prosecution of Applicant's PCT/IL2013/050861. |
| An International Search Report & Written Opinion both dated May 12, 2015, which issued during the prosecution of Applicant's PCT/IL2014/050914. |
| An International Search Report and a Written Opinion both dated May 30, 2007, which issued during the prosecution of Applicant's PCT/IL2006/000342. |
| An International Search Report and a Written Opinion both dated Jun. 10, 2010, which issued during the prosecution of Applicant's PCT/IL09/01209. |
| An International Search Report and a Written Opinion both dated Aug. 17, 2010, which issued during the prosecution of Applicant's PCT/IL10/00357. |
| An International Search Report & Written Opinion both dated Sep. 8, 2009, which issued during the prosecution of Applicant's PCT/IL09/00593. |
| An International Search Report and a Written Opinion both dated Sep. 12, 2008, which issued during the prosecution of Applicant's PCT/IL07/01503. |
| An International Search Report and Written Opinion dated Nov. 8, 2010, which issued during the prosecution of Applicant's PCT/IL2010/000358. |
| An International Search Report and a Written Opinion both dated Nov. 23, 2011, which issued during the prosecution of Applicant's PCT/IL2011/000446. |
| Supplementary European Search Report dated Sep. 25, 2015, which issued during the prosecution of Applicant's European App No. 09794095.1. |
| A Supplementary European Search Report dated Feb. 1, 2011, which issued during the prosecution of European Patent Application No. EP 07849540. |
| An English translation of an Office Action dated Dec. 12, 2013 which issued during the prosecution of Chinese Patent Application No. 200980157331.3. |
| Communication regarding amended claims filed dated Dec. 27, 2012, regarding European App No. 11792047.0. |
| An Office Action dated Mar. 23, 2015, which issued during the prosecution of European Patent Application No. EP 09834225.6. |
| An English translation of an Office Action dated Jul. 17, 2015 which issued during the prosecution of Chinese Patent Application No. 201080059948.4. |
| An English translation of an Office Action dated Dec. 16, 2015 which issued during the prosecution of Chinese Patent Application No. 201080059948.4. |
| Communication from the European Patent Office dated Jun. 11, 2015, which issued during the prosecution of European Patent Application No. 11811934. |
| A communication from the European Patent Office dated Sep. 28, 2011 which issued during the prosecution of European Application No. 09834225.6. |
| A communication from the European Patent Office dated Oct. 19, 2012 which issued during the prosecution of European Application No. 11792047.0. |
| An Office Action dated Oct. 23, 2012, which issued during the prosecution of Japanese Patent Application No. 2009-539871. |
| An English Translation of an Office Action dated Nov. 24, 2015, which issued during the prosecution of Israel Patent Application No. 223448. (the relevant part only). |
| Notice of Allowance dated Nov. 17, 2015, which issued during the prosecution of U.S. Appl. No. 14/486,226. |
| Notice of Allowance dated Jan. 29, 2016, which issued during the prosecution of U.S. Appl. No. 14/551,951. |
| An Office Action dated Jun. 18, 2015, which issued during the prosecution of U.S. Appl. No. 14/551,951. |
| An Office Action dated Jan. 4, 2016, which issued during the prosecution of U.S. Appl. No. 14/589,100. |
| An Office Action dated May 4, 2016, which issued during the prosecution of U.S. Appl. No. 14/589,100. |
| An International Search Report and a Written Opinion both dated Nov. 14, 2011, which issued during the prosecution of Applicant's PCT/IL2011/000404. |
| An International Search Report and a Written Opinion both dated Dec. 6, 2012 which issued during the prosecution of Applicant's PCT/IL2012/000250. |
| A Notice of Allowance dated Apr. 3, 2013, which issued during the prosecution of U.S. Appl. No. 12/563,930. |
| An Office Action dated Aug. 24, 2012, which issued during the prosecution of U.S. Appl. No. 12/563,930. |
| An Office Action dated Dec. 29, 2011, which issued during the prosecution of U.S. Appl. No. 12/563,952. |
| A Restriction Requirement dated Oct. 27, 2011, which issued during the prosecution of U.S. Appl. No. 12/563,952. |
| A Notice of Allowance dated May 24, 2012, which issued during the prosecution of U.S. Appl. No. 12/563,952. |
| An Office Action dated Apr. 1, 2013 which issued during the prosecution of U.S. Appl. No. 13/167,476. |
| An Office Action dated Nov. 21, 2013, which issued during the prosecution of U.S. Appl. No. 13/167,476. |
| An Advisory Action dated Feb. 4, 2014, which issued during the prosecution of U.S. Appl. No. 13/167,476. |
| A Restriction Requirement dated Oct. 25, 2012 which issued during the prosecution of U.S. Appl. No. 13/167,444. |
| An Office Action dated Jan. 17, 2013, which issued during the prosecution of U.S. Appl. No. 13/167,444. |
| An Office Action dated Aug. 26, 2014 which issued during the prosecution of U.S. Appl. No. 13/167,444. |
| An Office Action dated Aug. 23, 2013 which issued during the prosecution of U.S. Appl. No. 13/167,444. |
| Notice of Allowance dated Nov. 12, 2015, which issued during the prosecution of U.S. Appl. No. 13/319,007. |
| Notice of Allowance dated Jan. 7, 2016, which issued during the prosecution of U.S. Appl. No. 13/319,007. |
| An Office Action dated Oct. 2, 2013, which issued during the prosecution of U.S. Appl. No. 13/167,492. |
| A Restriction Requirement dated Nov. 2, 2012, which issued during the prosecution of U.S. Appl. No. 13/167,492. |
| An Office Action dated Feb. 14, 2013 which issued during the prosecution of U.S. Appl. No. 13/167,492. |
| Notice of Allowance dated Nov. 7, 2014, which issued during the prosecution of U.S. Appl. No. 13/167,492. |
| An Office Action dated Jun. 10, 2014, which issued during the prosecution of U.S. Appl. No. 13/167,492. |
| Notice of Allowance dated Dec. 9, 2014, which issued during the prosecution of U.S. Appl. No. 13/167,476. |
| Notice of Allowance dated Jan. 22, 2015, which issued during the prosecution of U.S. Appl. No. 13/167,444. |
| An International Preliminary Report on Patentability dated May 1, 2012, which issued during the prosecution of Applicant's PCT/IL2010/000890. |
| An International Preliminary Report on Patentability dated Jun. 9, 2015, which issued during the prosecution of Applicant's PCT/IL2013/050992. |
| U.S. Appl. No. 60/873,075, filed Dec. 5, 2006. |
| U.S. Appl. No. 60/902,146, filed Feb. 16, 2007. |
| An Office Action dated Mar. 29, 2018, which issued during the prosecution of U.S. Appl. No. 15/188,507. |
| Notice of Allowance dated Sep. 17, 2014, which issued during the prosecution of U.S. Appl. No. 12/961,721. |
| An Office Action dated Oct. 1, 2015, which issued during the prosecution of U.S. Appl. No. 14/141,228. |
| A Restriction Requirement dated Jun. 2, 2014, which issued during the prosecution of U.S. Appl. No. 13/319,030. |
| An Office Action dated Oct. 14, 2014, which issued during the prosecution of U.S. Appl. No. 13/319,030. |
| An Office Action dated Jun. 18, 2015, which issued during the prosecution of U.S. Appl. No. 13/319,030. |
| An Office Action dated May 3, 2016, which issued during the prosecution of U.S. Appl. No. 13/319,030. |
| Notice of Allowance dated Dec. 30, 2016, which issued during the prosecution of U.S. Appl. No. 13/319,030. |
| An Office Action dated Apr. 7, 2015, which issued during the prosecution of U.S. Appl. No. 13/319,007. |
| An Office Action dated Apr. 8, 2016, which issued during the prosecution of U.S. Appl. No. 14/141,228. |
| An Office Action dated Oct. 5, 2015, which issued during the prosecution of U.S. Appl. No. 14/246,417. |
| An Office Action dated Apr. 7, 2016, which issued during the prosecution of U.S. Appl. No. 14/242,151. |
| An Office Action dated May 23, 2016, which issued during the prosecution of U.S. Appl. No. 14/209,171. |
| An Office Action dated Jul. 20, 2016, which issued during the prosecution of U.S. Appl. No. 14/246,417. |
| An Office Action dated Jun. 14, 2016, which issued during the prosecution of U.S. Appl. No. 14/273,155. |
| An Office Action dated Jun. 17, 2016, which issued during the prosecution of U.S. Appl. No. 14/357,040. |
| An Office Action dated Mar. 24, 2015, which issued during the prosecution of U.S. Appl. No. 14/486,226. |
| U.S. Appl. No. 61/001,013, filed Oct. 29, 2007. |
| U.S. Appl. No. 61/132,295, filed Jun. 16, 2008. |
| U.S. Appl. No. 61/265,936, filed Dec. 2, 2009. |
| U.S. Appl. No. 61/283,445, filed Dec. 2, 2009. |
| U.S. Appl. No. 61/207,908, filed Feb. 17, 2009. |
| U.S. Appl. No. 61/733,979, filed Dec. 6, 2012. |
| U.S. Appl. No. 61/717,303, filed Oct. 23, 2012. |
| U.S. Appl. No. 61/820,979, filed May 8, 2013. |
| U.S. Appl. No. 61/745,848, filed Dec. 6, 2012. |
| U.S. Appl. No. 61/555,570, filed Nov. 4, 2011. |
| U.S. Appl. No. 61/557,082, filed Nov. 8, 2011. |
| U.S. Appl. No. 60/662,616, filed Mar. 17, 2005. |
| U.S. Appl. No. 60/700,542, filed Jul. 18, 2005. |
| U.S. Appl. No. 61/782,121, filed Mar. 14, 2013. |
| European Search Report dated Jul. 15, 2016, which issued during the prosecution of Applicant's European App No. 13849947.0. |
| European Search Report dated Nov. 4, 2015, which issued during the prosecution of European Patent Application No. EP 1077 2091.4. |
| Search Report in European Patent Application 10826224.7 dated Nov. 16, 2015. |
| Supplementary European Search Report dated Dec. 23, 2014 which issued during the prosecution of Applicant's European App No. 10834311. |
| Supplementary European Search Report dated Jan. 21, 2014 which issued during the prosecution of Applicant's European App No. 11 78 6226. |
| A Supplementary European Search Report dated Jan. 20, 2015, which issued during the prosecution of European Patent Application No. 12803037.6. |
| Supplementary European Search Report dated Aug. 4, 2014 which issued during the prosecution of Applicant's European App No. 11 81 1934.6. |
| European Search Report dated Jun. 24, 2016, which issued during the prosecution of European Patent Application No. EP 12847363. |
| Supplementary European Search Report dated Apr. 29, 2015, which issued during the prosecution of Applicant's European App No. 14200202. |
| An Office Action dated Dec. 16, 2013, which issued during the prosecution of U.S. Appl. No. 13/666,262. |
| An Office Action dated Dec. 18, 2013, which issued during the prosecution of U.S. Appl. No. 13/666,141. |
| Notice of Allowance dated Jun. 25, 2014, which issued during the prosecution of U.S. Appl. No. 13/666,262. |
| A Notice of Allowance dated Feb. 2, 2015, which issued during the prosecution of U.S. Appl. No. 13/504,870. |
| Notice of Allowance dated Aug. 19, 2013, which issued during the prosecution of U.S. Appl. No. 11/908,906. |
| An Office Action dated Jun. 8, 2012, which issued during the prosecution of U.S. Appl. No. 11/908,906. |
| An Office Action dated Dec. 21, 2013, which issued during the prosecution of U.S. Appl. No. 11/908,906. |
| A Restriction Requirement dated Aug. 5, 2011, which issued during the prosecution of U.S. Appl. No. 11/908,906. |
| An Office Action dated Sep. 16, 2009 which issued during the prosecution of U.S. Appl. No. 11/950,930. |
| Notice of Allowance dated Sep. 12, 2014, which issued during the prosecution of U.S. Appl. No. 11/950,930. |
| An Office Action dated Aug. 5, 2010 which issued during the prosecution of U.S. Appl. No. 11/950,930. |
| An Office Action dated Feb. 17, 2010 which issued during the prosecution of U.S. Appl. No. 11/950,930. |
| A Restriction Requirement dated Apr. 19, 2010 which issued during the prosecution of U.S. Appl. No. 12/341,960. |
| An Office Action dated Sep. 28, 2011, which issued during the prosecution of U.S. Appl. No. 12/437,103. |
| An Office Action dated Jun. 13, 2012, which issued during the prosecution of U.S. Appl. No. 12/437,103. |
| A Restriction Requirement dated Jul. 12, 2011, which issued during the prosecution of U.S. Appl. No. 12/437,103. |
| Notice of Allowance dated Mar. 6, 2014, which issued during the prosecution of U.S. Appl. No. 12/437,103. |
| Notice of Allowance dated Dec. 20, 2013, which issued during the prosecution of U.S. Appl. No. 12/437,103. |
| Notice of Allowance dated Apr. 27, 2012, which issued during the prosecution of U.S. Appl. No. 12/341,960. |
| An Office Action dated Mar. 29, 2011, which issued during the prosecution of U.S. Appl. No. 12/341,960. |
| An Office Action dated Aug. 4, 2010, which issued during the prosecution of U.S. Appl. No. 12/341,960. |
| An Interview Summary dated Jul. 27, 2011, which issued during the prosecution of U.S. Appl. No. 12/341,960. |
| Notice of Allowance dated Aug. 21, 2019, which issued during the prosecution of U.S. Appl. No. 15/703,385. |
| Notice of Allowance dated Oct. 16, 2019, which issued during the prosecution of U.S. Appl. No. 15/703,385. |
| Notice of Allowance dated Dec. 24, 2020, which issued during the prosecution of U.S. Appl. No. 15/668,659. |
| Notice of Allowance dated Oct. 21, 2020, which issued during the prosecution of U.S. Appl. No. 15/668,659. |
| Declaration of Ivan Vesely, Ph.D., in Support of Petition for Inter PartesReview of U.S. Pat. No. 7,563,267—dated May 29, 2019. |
| U.S. Appl. No. 60/128,690, filed Apr. 9, 1999. |
| U.S. Appl. No. 60/613,867, filed Sep. 27, 2004. |
| An Office Action dated Dec. 24, 2020, which issued during the prosecution of U.S. Appl. No. 16/144,054. |
| An Office Action dated Feb. 2, 2021, which issued during the prosecution of U.S. Appl. No. 16/811,732. |
| An Office Action dated Jan. 13, 2021, which issued during the prosecution of European Patent Application No. 15751089.2. |
| An Office Action together with an English summary dated Mar. 3, 2021, which issued during the prosecution of Chinese Patent Application No. 201780047391.4. |
| Declaration of Dr. Ivan Vesely, Ph.D. in Support of Petition for Inter Partes Review of U.S. Pat. No. 10,226,341—dated Dec. 17, 2020. |
| Petition for Inter Partes Review of U.S. Pat. No. 10,226,341 and Exhibits 1001-1013—dated Dec. 29, 2020. |
| Batista, Randas JV, et al. “Partial left ventriculectomy to treat end-stage heart disease.” The Annals of thoracic surgery 64.3 (1997): 634-638. |
| Beall Jr, Arthur C., et al. “Clinical experience with a dacron velour-covered teflon-disc mitral-valve prosthesis.” The Annals of thoracic surgery 5.5 (1968): 402-410. |
| Kalbacher, D., et al. “1000 MitraClip™ procedures: Lessons learnt from the largest single-centre experience worldwide.” (2019): 3137-3139. |
| Maisano, F., et al. “The edge-to-edge technique: a simplified method to correct mitral insufficiency.” European journal of cardio-thoracic surgery 13.3 (1998): 240-246. |
| Fucci, C., et al. “Improved results with mitral valve repair using new surgical techniques.” European journal of cardio-thoracic surgery 9.11 (1995): 621-627. |
| Notice of Allowance dated Nov. 19, 2019, which issued during the prosecution of U.S. Appl. No. 15/668,559. |
| Mitral Valve Academic Research Consortium. “Clinical Trial Design Principles and Endpoint Definitions for Transcatheter Mitral Valve Repair and Replacement: Part 1: Clinical Trial Design Principles A Consensus Document from the Mitral Valve Academic Research Consortium.” Journal of the American College of Cardiology 66.3 (2015): 278-307. |
| An Office Action dated Aug. 29, 2018, which issued during the prosecution of U.S. Appl. No. 15/329,920. |
| An Office Action dated May 8, 2018, which issued during the prosecution of U.S. Appl. No. 15/902,403. |
| An Office Action dated May 11, 2018, which issued during the prosecution of U.S. Appl. No. 15/899,858. |
| Notice of Allowance dated Oct. 5, 2018, which issued during the prosecution of U.S. Appl. No. 15/886,517. |
| Notice of Allowance dated Jul. 19, 2019, which issued during the prosecution of U.S. Appl. No. 15/899,858. |
| Notice of Allowance dated Nov. 16, 2020, which issued during the prosecution of U.S. Appl. No. 16/324,339. |
| Notice of Allowance dated Apr. 27, 2020, which issued during the prosecution of U.S. Appl. No. 16/591,330. |
| An Advisory Action dated Jan. 2, 2020, which issued during the prosecution of U.S. Appl. No. 15/668,659. |
| Notice of Allowance dated Oct. 17, 2019, which issued during the prosecution of U.S. Appl. No. 15/329,920. |
| An Office Action dated Dec. 31, 2019, which issued during the prosecution of U.S. Appl. No. 16/591,330. |
| Notice of Allowance dated Feb. 9, 2021, which issued during the prosecution of U.S. Appl. No. 16/937,216. |
| An International Search Report and a Written Opinion both dated Mar. 27, 2018, which issued during the prosecution of Applicant's PCT/IL2017/050849. |
| Notice of Allowance dated Oct. 30, 2018, which issued during the prosecution of U.S. Appl. No. 15/197,069. |
| Patent Trial and Appeal Board Decision Granting Institution in U.S. Pat. No. 10,226,341—Dated Jul. 20, 2021. |
| European Search Report dated Jun. 10, 2021 which issued during the prosecution of Applicant's European App No. 21157988.3. |
| Notice of Allowance dated Nov. 19, 2018, which issued during the prosecution of U.S. Appl. No. 15/197,069. |
| Poirier, Nancy C., et al. “A novel repair for patients with atrioventricular septal defect requiring reoperation for left atrioventricular valve regurgitation.” European journal of cardio-thoracic surgery 18.1 (2000): 54-61. |
| An Office Action dated Mar. 29, 2021, which issued during the prosecution of U.S. Appl. No. 16/738,516. |
| Ando, Tomo, et al. “Iatrogenic ventricular septal defect following transcatheter aortic valve replacement: a systematic review.” Heart, Lung and Circulation 25.10 (2016): 968-974. |
| Urena, Marina, et al. “Transseptal transcatheter mitral valve replacement using balloon-expandable transcatheter heart valves: a step-by-step approach.” JACC: Cardiovascular Interventions 10.19 (2017): 1905-1919. |
| An English summary of an Official Action dated Mar. 29, 2021, which issued during the prosecution of Chinese Patent Application No. 201780061210.3. |
| An International Search Report and a Written Opinion both dated Jan. 28, 2020, which issued during the prosecution of Applicant's PCT/IL2019/051031. |
| An International Preliminary Report on Patentability dated Mar. 9, 2021, which issued during the prosecution of Applicant's PCT/IL2019/051031. |
| An Office Action dated May 4, 2021, which issued during the prosecution of U.S. Appl. No. 16/636,204. |
| Notice of Allowance dated May 17, 2021, which issued during the prosecution of U.S. Appl. No. 16/138,129. |
| Notice of Allowance dated Jun. 4, 2021, which issued during the prosecution of U.S. Appl. No. 16/802,353. |
| An Office Action dated May 12, 2021, which issued during the prosecution of Canadian Patent Application No. 2,973,940. |
| Petition for Inter Partes Review of U.S. Pat. No. 10,702,385—dated Jun. 4, 2021. |
| Declaration of Ivan Vesely, Ph.D. In Support of Petition for Inter Partes Review of U.S. Pat. No. 10,702,385—dated Jun. 4, 2021. |
| Notice of Allowance dated Oct. 5, 2022, which issued during the prosecution of U.S. Appl. No. 17/101,787. |
| An International Search Report and a Written Opinion both dated Jul. 12, 2021, which issued during the prosecution of Applicant's PCT/IL2021/050132. |
| Notice of Allowance dated Dec. 21, 2022, which issued during the prosecution of U.S. Appl. No. 17/101,787. |
| An Office Action dated Mar. 3, 2023, which issued during the prosecution of European Patent Application No. 17751143.3. |
| An Office Action dated Mar. 20, 2023, which issued during the prosecution of U.S. Appl. No. 17/181,722. |
| Notice of Allowance dated Apr. 6, 2023, which issued during the prosecution of U.S. Appl. No. 16/746,489. |
| Feldman, Ted, et al. “Percutaneous mitral repair with the MitraClip system: safety and midterm durability in the initial EVEREST (Endovascular Valve Edge-to-Edge REpair Study) cohort.” Journal of the American College of Cardiology 54.8 (2009): 686-694. |
| European Search Report dated Mar. 20, 2023 which issued during the prosecution of Applicant's European App No. 22204764.9. |
| Notice of Allowance dated Nov. 12, 2020, which issued during the prosecution of U.S. Appl. No. 16/269,328. |
| IPR2021-00383 Petitioners' Authorized Reply to Patent Owner's Preliminary Response dated May 27, 2021. |
| Exhibit 1014—Transcript of proceedings held May 20, 2021 (Edwards Lifesciences vs. Cardiovalve). |
| Exhibit 1015—Facilitate, Meriam-Webster.com, https://www.merriamwebster.com/dictionary/facilitate (visited May 26, 2021). |
| Patent Owner's Authorized Surreply to Petitioner's Reply to Patent Owner's Preliminary Response dated Jun. 4, 2021(Edwards Lifesciences vs. Cardiovalve). |
| An Invitation to pay additional fees dated May 19, 2021, which issued during the prosecution of Applicant's PCT/IL2021/050132. |
| An Office Action dated Aug. 18, 2021, which issued during the prosecution of U.S. Appl. No. 17/210,183. |
| An Office Action dated Sep. 9, 2021, which issued during the prosecution of U.S. Appl. No. 16/768,909. |
| An Office Action dated Sep. 15, 2021, which issued during the prosecution of U.S. Appl. No. 16/135,599. |
| An Office Action dated Oct. 14, 2021, which issued during the prosecution of U.S. Appl. No. 16/680,739. |
| An Office Action dated May 25, 2023, which issued during the prosecution of U.S. Appl. No. 17/397,235. |
| European Search Report dated Oct. 11, 2021 which issued during the prosecution of Applicant's European App No. 21176010.3. |
| Fann, James I., et al. “Beating heart catheter-based edge-to-edge mitral valve procedure in a porcine model: efficacy and healing response.” Circulation 110.8 (2004): 988-993. |
| IPR2021-00383 Patent Owner's Contingent Motion to Amend Under 37 C.F.R. §42.121 dated Oct. 13, 2021. |
| IPR2021-00383 Patent Owner's Response Pursuant to 37 C.F.R. § 42.120 dated Oct. 13, 2021. |
| IPR2021-00383 Second Declaration of Dr. Michael Sacks dated Oct. 13, 2021. |
| An Office Action dated Oct. 21, 2021, which issued during the prosecution of U.S. Appl. No. 17/306,231. |
| Maisano, Francesco, et al. “The evolution from surgery to percutaneous mitral valve interventions: the role of the edge-to-edge technique.” Journal of the American College of Cardiology 58.21 (2011): 2174-2182. |
| An Office Action dated Sep. 29, 2022, which issued during the prosecution of U.S. Appl. No. 17/010,886. |
| An Office Action dated Jan. 26, 2022, which issued during the prosecution of U.S. Appl. No. 16/888,210. |
| IPR2021-00383 Deposition of Dr. Ivan Vesely, dated Sep. 22, 2021. |
| Cardiovalve Exhibit 2009—Percutaneous Mitral Leaflet Repair: MitraClip® Therapy for Mitral Regurgitation (2012). |
| Feldman, Ted, et al. “Percutaneous mitral valve repair using the edge-to-edge technique: six-month results of the Everest Phase I Clinical Trial.” Journal of the American College of Cardiology 46.11 (2005): 2134-2140. |
| An Office Action summarized English translation and Search Report dated Oct. 8, 2021, which issued during the prosecution of Chinese Patent Application No. 201780061210.3. |
| An Office Action dated Nov. 4, 2021, which issued during the prosecution of U.S. Appl. No. 17/366,711. |
| An Office Action summarized English translation and Search Report dated Aug. 12, 2021, which issued during the prosecution of Chinese Patent Application No. 201880058940.2. |
| An Office Action dated Nov. 25, 2021, which issued during the prosecution of European Patent Application No. 18826823.9. |
| IPR2021-01051 Institution decision dated Dec. 10, 2021. |
| Notice of Allowance dated Dec. 7, 2021, which issued during the prosecution of U.S. Appl. No. 17/394,807. |
| Notice of Allowance dated Dec. 6, 2021, which issued during the prosecution of U.S. Appl. No. 16/738,516. |
| Notice of Allowance dated Dec. 29, 2021, which issued during the prosecution of U.S. Appl. No. 17/210,183. |
| IPR2021-00383 Petitioners' Reply to Patent Owner's Response dated Jan. 5, 2022. |
| IPR2021-00383 Petitioners' Opposition to Patent Owner's Contingent Motion to Amend dated Jan. 5, 2022. |
| An Office Action dated Sep. 22, 2021, which issued during the prosecution of European Patent Application No. 20714289.4. |
| Summary of Examination Notice dated Jan. 6, 2022, which issued during the prosecution of Chinese Patent Application No. 201880064313.X. |
| An Office Action dated Jan. 12, 2022, which issued during the prosecution of U.S. Appl. No. 17/101,787. |
| An Office Action dated Sep. 6, 2018, which issued during the prosecution of U.S. Appl. No. 15/213,791. |
| An Office Action dated Jul. 20, 2022, which issued during the prosecution of U.S. Appl. No. 17/101,787. |
| Notice of Allowance dated Jan. 31, 2022, which issued during the prosecution of U.S. Appl. No. 17/479,418. |
| An Office Action dated Aug. 1, 2022, which issued during the prosecution of European Patent Application No. 18826823.9. |
| An Office Action dated Apr. 11, 2022, which issued during the prosecution of U.S. Appl. No. 17/473,472. |
| IPR2021-00383 Preliminary Guidance dated Jan. 31, 2022. |
| An Office Action dated Mar. 18, 2022, which issued during the prosecution of U.S. Appl. No. 16/746,489. |
| Notice of Allowance dated Mar. 22, 2022, which issued during the prosecution of U.S. Appl. No. 17/366,711. |
| Notice of Allowance dated Mar. 4, 2022, which issued during the prosecution of U.S. Appl. No. 16/768,909. |
| An Office Action dated Dec. 9, 2021, which issued during the prosecution of U.S. Appl. No. 16/135,969. |
| An Office Action dated Jan. 24, 2022, which issued during the prosecution of U.S. Appl. No. 16/135,466. |
| An Office Action dated May 15, 2023, which issued during the prosecution of U.S. Appl. No. 16/656,790. |
| An Office Action dated Aug. 5, 2022, which issued during the prosecution of U.S. Appl. No. 16/760,147. |
| An Office Action dated Jul. 27, 2022, which issued during the prosecution of U.S. Appl. No. 16/881,350. |
| IPR2021-01051 Patent Owner's Sur-Reply to Petitioners' Reply to Preliminary Guidance dated Aug. 23, 2022. |
| IPR2021-01051 Preliminary Guidance Patent Owner's Motion to Amend dated Jun. 24, 2022. |
| Ex Parte Quayle dated May 2, 2022, which issued during the prosecution of U.S. Appl. No. 16/879,952. |
| An International Search Report and a Written Opinion both dated May 3, 2022, which issued during the prosecution of Applicant's PCT/IL2021/051433. |
| An Office Action together with an English Summary dated May 7, 2022 which issued during the prosecution of Chinese Patent Application No. 201880058940.2. |
| Notice of Allowance dated May 4, 2022, which issued during the prosecution of U.S. Appl. No. 16/680,739. |
| An Office Action dated Jun. 28, 2022, which issued during the prosecution of U.S. Appl. No. 16/135,969. |
| An Office Action dated Jul. 8, 2022, which issued during the prosecution of U.S. Appl. No. 16/144,054. |
| An Office Action dated Oct. 19, 2022, which issued during the prosecution of U.S. Appl. No. 17/875,589. |
| An International Preliminary Report on Patentabilty dated Jun. 16, 2020, which issued during the prosecution of Applicant's PCT/IL2018/051350. |
| An Office Action dated Jul. 6, 2022, which issued during the prosecution of U.S. Appl. No. 16/656,790. |
| An Office Action dated Sep. 29, 2022, which issued during the prosecution of U.S. Appl. No. 16/656,790. |
| European Search Report dated Sep. 6, 2022, which issued during the prosecution of Applicant's European App No. 22161862.2. |
| IPR2021-01051 Petitioners' Reply to Preliminary Guidance dated Aug. 2, 2022. |
| An International Preliminary Report on Patentabilty dated Jul. 28, 2022, which issued during the prosecution of Applicant's PCT/IL2021/050132. |
| An Invitation to pay additional fees dated Mar. 14, 2019, which issued during the prosecution of Applicant's PCT/IL2018/0051350. |
| An Office Action dated Nov. 28, 2022, which issued during the prosecution of U.S. Appl. No. 17/141,853. |
| An Office Action dated Nov. 2, 2022, which issued during the prosecution of U.S. Appl. No. 17/004,693. |
| An Office Action dated Sep. 8, 2022, which issued during the prosecution of U.S. Appl. No. 16/896,858. |
| An Office Action dated Sep. 21, 2022, which issued during the prosecution of U.S. Appl. No. 16/776,581. |
| An Office Action dated Sep. 16, 2022, which issued during the prosecution of U.S. Appl. No. 16/135,466. |
| An Office Action dated May 16, 2023, which issued during the prosecution of U.S. Appl. No. 17/114,771. |
| An Office Action dated Apr. 14, 2023, which issued during the prosecution of U.S. Appl. No. 16/144,054. |
| Notice of Allowance dated Jun. 22, 2023, which issued during the prosecution of U.S. Appl. No. 17/141,853. |
| An Office Action dated May 17, 2023, which issued during the prosecution of U.S. Appl. No. 17/466,785. |
| An Office Action dated Oct. 26, 2022, which issued during the prosecution of U.S. Appl. No. 16/746,489. |
| An International Preliminary Report on Patentability dated May 30, 2023, which issued during the prosecution of Applicant's PCT/IL2021/051433. |
| IPR2021-00383 Final Written Decision Determining All Challenged Claims Unpatentable Denying Patent Owner's Contingent Motion to Amend Granting-in-Part and Denying-in-Part Petitioner's Motion to Strike Denying Patent Owner's Motion to Exclude dated Jul. 18, 2022. |
| An Office Action dated Oct. 21, 2021, which issued during the prosecution of U.S. Appl. No. 17/335,845. |
| Notice of Allowance dated Sep. 20, 2023, which issued during the prosecution of U.S. Appl. No. 17/839,538. |
| An Office Action dated Oct. 13, 2023, which issued during the prosecution of U.S. Appl. No. 17/181,722. |
| Grounds of Opposition to European Patent No. EP 2 948 103, filed Sep. 6, 2023. |
| An Office Action dated Aug. 31, 2023, which issued during the prosecution of U.S. Appl. No. 17/397,235. |
| An International Search Report and a Written Opinion both dated Aug. 23, 2023, 2023, which issued during the prosecution of Applicant's PCT/IL2023/050586. |
| An Office Action dated Sep. 8, 2023, which issued during the prosecution of U.S. Appl. No. 18/218,419. |
| An International Search Report and a Written Opinion both dated Sep. 13, 2023, which issued during the prosecution of Applicant's PCT/IL2023/050587. |
| An Office Action dated Aug. 3, 2023, which issued during the prosecution of U.S. Appl. No. 17/683,875. |
| Opposition to European Patent No. EP 2 948 103, filed Sep. 6, 2023. |
| Communication dated Jan. 25, 2024, issued in U.S. Appl. No. 18/090,058. |
| Number | Date | Country | |
|---|---|---|---|
| 20230346549 A1 | Nov 2023 | US |
| Number | Date | Country | |
|---|---|---|---|
| 62560384 | Sep 2017 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 18090058 | Dec 2022 | US |
| Child | 18216391 | US | |
| Parent | 17101787 | Nov 2020 | US |
| Child | 18090058 | US | |
| Parent | PCT/IL2018/050725 | Jul 2018 | WO |
| Child | 16776581 | US | |
| Parent | 15956956 | Apr 2018 | US |
| Child | 16776581 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 16269328 | Feb 2019 | US |
| Child | 17101787 | US | |
| Parent | PCT/IL2018/050725 | Jul 2018 | WO |
| Child | 16269328 | US | |
| Parent | 16135969 | Sep 2018 | US |
| Child | 16269328 | US | |
| Parent | 16135979 | Sep 2018 | US |
| Child | 16269328 | US | |
| Parent | 16776581 | Jan 2020 | US |
| Child | 17101787 | US | |
| Parent | 15668559 | Aug 2017 | US |
| Child | PCT/IL2018/050725 | US |
